To provide a method for directly and efficiently producing methacrylic acid in a single step from renewable raw materials and/or biomass arising from the utilization of the renewable raw materials. Further provided is a method for producing methacrylic acid using microbes having the ability to produce methacrylic acid, from renewable raw materials and/or biomass arising from the utilization of the renewable raw materials, as a carbon source and/or energy source. The method for producing methacrylic acid enables methacrylic acid to be safely and easily produced from biomass, without using petroleum-derived raw materials, by utilizing microbes having the ability to produce methacrylic acid.
1. A method, comprising contacting or culturing one or more microbes or genetically engineered strain thereof having an ability to produce methacrylic acid with a renewable raw material which gives rise to a biomass that acts as a carbon and/or energy source, wherein said methacrylic acid, an ester of methacrylic acid, or a mixture thereof can be produced from a pathway that utilizes isobutyric acid or valine,
wherein the one or more microbes can grow on about 0.1 to 1% of valine as a sole nitrogen and/or carbon source, or about 0.1 to 1% of isobutyric acid as a sole carbon source and wherein the genetically engineered strain thereof is obtained by deletion or inactivation of one or more endogenous genes selected from the group consisting of enoyl CoA hydratase gene, 3-hydroxyisobutyryl CoA hydrolase gene, and 3-hydroxyisobutyric acid dehydrogenase gene. 2. The method of 3. The method of 4. The method of 5. The production method according to
The present invention relates to a method for producing methacrylic acid and/or an ester thereof. More specifically, it relates to a method for producing methacrylic acid using microbes having the ability to produce methacrylic acid, the microbes, methacrylic acid obtained by the production method, and the like. Methacrylic acid is useful as a raw material for paint or resin modifying agent, and its esters are an industrially significantly important compound as a raw material for acrylic resin. As a method for chemical production of methacrylic acid derivatives, the ACH method intermediated by acetone cyanhydrin using cyanide and acetone as a raw material, the C4 oxidation using isobutylene or tert-butanol as a raw material, and the like are practically used. Those chemical production methods rely on fossil fuels and also require a large amount of energy. Recently, from the viewpoint of preventing global warming and environmental protection, use of renewable biogenous resources (renewable raw materials) as a carbon source to be a substitute of fossil fuels of the related art receives attention. For example, a method for producing 2-hydroxyisobutyric acid and 3-hydroxyisobutyric acid, which are a precursor of methacrylic acid, from a natural product such as sugar using microbes existing in nature has been suggested (see, Patent Documents 1 and 2 and Non-Patent Document 1). However, those methods still rely on a chemical method in terms of the process for producing methacrylic acid by dehydration of a precursor. Further, although a method for producing methacrylic acid from glucose using a recombinant microbe introduced with plural enzyme genes, which is not exist in nature, has been suggested, it is a mere suggestion of simple combination between known enzyme reactions and imaginary enzyme reactions deduced therefrom, and has not been practically proved (see, Patent Documents 3 to 5). Meanwhile, as a naturally occurring microbe, a photosynthetic microbe having the ability to produce methacrylic acid is known (Non-Patent Document 2). However, the photosynthetic microbe only converts 3-mercaptoisobutyric acid, which is a special compound not existing in nature, to methacrylic acid. Further, in Patent Document 6, a method for producing an acrylic acid ester according to an action of a hydrolase in the presence of Acryloyl-CoA and an alcohol is disclosed. It is suggested in the same literature that a methacrylic acid ester can be also similarly produced. However, considering diversity and substrate specificity of an enzyme, it only demonstrates that an acrylic acid ester can be produced with few limited hydrolases, and it remains uncertain whether or not a methacrylic acid ester having a different structure can be also similarly produced by the hydrolase. Further, it remains completely uncertain whether or not production can be made with a different kind of enzyme having a different reaction mechanism. Further, when an ester is synthesized with the hydrolase described in Patent Document 6, it is expected that an ester produced is basically dissociated due to hydrolysis activity, and thus it is difficult to be considered as an effective production method. Meanwhile, alcohol acyl transferase (hereinbelow, “ATT”) is known as an enzyme for synthesis of fruity flavor. In Patent Document 7, a method for producing various esters as fruit flavor by identifying the gene of the same enzyme, which is contained in specific fruits, is suggested. However, the possibility of synthesizing a methacrylic acid ester with the enzyme is not described and remains completely uncertain. As described above, although several suggestions or discussions have been made, there is no example showing actual production of methacrylic acid derivatives using microbes, and thus an effective production method needs to be established. According to a chemical production method of the related art, for example, the ACH method, an oxidation treatment of acetone cyanhydrin with an acid is required so that a waste acid is generated in a large amount. Further, as separation or purification is required for each step, there is a problem of having high energy consumption. For such reasons, a method for directly and efficiently producing methacrylic acid in a single step using microbes capable of producing methacrylic acid from renewable raw materials and/or biomass arising from the utilization of the renewable raw materials, as a carbon source and/or energy source, is needed. To solve the problems described above, inventors of the invention conducted extensive searches for microbes having the ability to produce methacrylic acid derivatives, and as a result, found that methacrylic acid can be produced with many microbes. Further, as described below, the inventors found that the microbes having the ability to produce methacrylic acid derivatives are a group of microbes having a certain specific function and a constant common property, and they also succeeded in finding a method for searching them. First, the inventors of the invention tried to produce methacrylic acid derivatives, which are an intermediate of the valine metabolism pathway, from 2-oxoisovaleric acid based on a microbial reaction by producing recombinant In mammals, it is known that the dehydrogenase reaction known as metabolism of branched amino acid or β-oxidation of fatty acid occurs in a mitochondria and liberated electrons are transferred to a respiratory chain via an electron transferring flavoprotein. In other words, it was assumed that the main reaction does not occur only by adding foreign ACD to a microbe which does not have the same function as them. The ACD reaction actually did not occur in the recombinant To solve this new problem, the inventors of the invention conducted extensive searches for the microbes having the ability to produce methacrylic acid derivatives by microbes, and found that the problem can be solved using microbes capable of producing methacrylic acid and microbes capable of metabolizing isobutyryl-CoA as a substrate of ACD. Examples of the microbes capable of metabolizing isobutyryl-CoA include valine assimilating viable microbes and isobutyric acid assimilating viable microbes. Those microbes can be obtained from nature by growing them with use of valine as a sole carbon source and/or a nitrogen source or isobutyric acid as a sole carbon source. The inventors of the invention further found that, by adding the action of AAT to the microbes having the ability to produce methacrylic acid, a methacrylic acid ester can be produced in the presence of an alcohol. In addition, the inventors of the invention intensively studied the enzymes involved with methacrylic acid synthesis, which are derived from the aforementioned microbes, and genes which encode the enzymes. As a result, they found that there was an enzyme useful for production of methacrylic acid derivatives and succeeded in characterizing the enzyme protein. They also found that, according to combination of those enzyme proteins, synthesis of methacrylic acid derivatives can be achieved. Accordingly, the invention was completed. Specifically, the invention is as described below. (1) A method for producing methacrylic acid and/or an ester thereof using microbes having the ability to produce methacrylic acid. (2) The production method of (1), in which methacrylic acid and/or an ester thereof is accumulated at 0.04 ppm or more. (3) The production method of (1) or (2), in which methacrylic acid and/or an ester thereof is produced using the microbes having the ability to produce methacrylic acid from renewable raw materials and/or biomass arising from the utilization of the renewable raw materials as a carbon source and/or energy source.
The inventors of the invention also found that the AAT has an activity of synthesizing a methacrylic acid ester. Specifically, the invention is as follows according to another aspect. (1A) A method for producing a methacrylic acid ester including a step of synthesizing a methacrylic acid ester by having an alcohol or a phenol to act on methacrylyl-CoA in the presence of AAT. (2A) The production method for producing a methacrylic acid ester of (1A), in which the methacrylic acid ester is accumulated at 0.001 mM or more. (3A) The production method for producing a methacrylic acid ester of (1A) or (2A), in which it further has a step of producing methacrylyl-CoA from isobutyryl-CoA or 3-hydroxyisobutyryl-CoA. (4A) The production method for producing a methacrylic acid ester of (3A), in which the isobutyryl-CoA is produced from 2-oxoisovaleric acid. (5A) The production method for producing a methacrylic acid ester of any one of (1A) to (4A), in which AAT is derived from a plant. (6A) The production method for producing a methacrylic acid ester of (5A), in which the plant belongs to an order selected from the group consisting of the order Zingiberales, the order Rosales, the order Ericales, the order Cucurbitales, the order Brassicales, and the order Laurales.
The inventors of the invention also found that a specific protein which is derived from a microbe and has a function of ACD has an ability of converting isobutyryl-CoA to methacrylyl-CoA at high efficiency. It is also found that 1) according to combination with BCKAD as an enzyme for producing isobutyryl-CoA, methacrylyl-CoA is synthesized from 2-oxoisovaleric acid, 2) according to combination with AAT, a methacrylic acid ester is synthesized from isobutyryl-CoA, and 3) according to combination with an enzyme having an activity of hydrolyzing methacrylyl-CoA, methacrylic acid is synthesized from isobutyryl-CoA. Specifically, the invention is as follows according to still another aspect. (1B) A transformant which is introduced with ACD gene selected from the group consisting of the following (a) to (d): (a) a gene encoding a protein consisting of an amino acid sequence represented by SEQ ID NO. 50 or 52 (b) a gene consisting of a nucleotide sequence represented by SEQ ID NO. 51 or 53 (c) a gene encoding a protein which consists of an amino acid sequence showing an identity of 45% or more to a protein consisting of an amino acid sequence represented by SEQ ID NO. 50 or 52 and which has the ACD activity, and (d) a gene encoding a protein which consists of an amino acid sequence with deletion, substitution, or addition of one or several amino acids in an amino acid sequence represented by SEQ ID NO. 50 or 52 and which has the ACD activity. (2B) The transformant of (1B), which is introduced with BCKAD complex gene in addition to ACD gene. (3B) The transformant of (2B), in which the BCKAD complex gene is a gene selected from the group consisting of the following (e) to (h): (e) a gene encoding four polypeptides having an amino acid sequence represented by SEQ ID NOS. 54, 56, 58 and 60 (f) a gene consisting of a nucleotide sequence represented by SEQ ID NOS. 55, 57, 59 and 61 (g) a gene encoding a protein which hybridizes under a stringent condition to a complementary strand of a gene encoding four polypeptides having an amino acid sequence represented by SEQ ID NOS. 54, 56, 58 and 60 and which has the BCKAD activity, and (h) a gene encoding a protein which consists of an amino acid sequence with deletion, substitution, or addition of one or several amino acids in an amino acid sequence represented by SEQ ID NOS. 54, 56, 58 and 60 and which has the BCKAD activity. (4B) The transformant of (2B), in which the BCKAD complex gene is a gene selected from the group consisting of the following (i) to (l): (i) a gene encoding four polypeptides having an amino acid sequence represented by SEQ ID NOS. 62, 64, 66 and 68 (j) a gene consisting of a nucleotide sequence represented by SEQ ID NOS. 63, 65, 67 and 69 (k) a gene encoding a protein which hybridizes under a stringent condition to a complementary strand of a gene encoding four polypeptides having an amino acid sequence represented by SEQ ID NOS. 62, 64, 66 and 68 and which has the BCKAD activity, and (1) a gene encoding a protein which consists of an amino acid sequence with deletion, substitution, or addition of one or several amino acids in an amino acid sequence represented by SEQ ID NOS. 62, 64, 66 and 68 and which has the BCKAD activity. (5B) The transformant of (2B), in which the BCKAD complex gene is a gene selected from the group consisting of the following (m) to (p): (m) a gene encoding three polypeptides having an amino acid sequence represented by SEQ ID NOS. 70, 72 and 74 (n) a gene consisting of a nucleotide sequence represented by SEQ ID NOS. 71, 73 and 75 (o) a gene encoding a protein which hybridizes under a stringent condition to a complementary strand of a gene encoding three polypeptides having an amino acid sequence represented by SEQ ID NOS. 70, 72 and 74 and which has the BCKAD activity, and (p) a gene encoding a protein which consists of an amino acid sequence with deletion, substitution, or addition of one or several amino acids in an amino acid sequence represented by SEQ ID NOS. 70, 72 and 74 and which has the BCKAD activity. (6B) The transformant of any one of (1B) to (5B), in which the transformant is genetically introduced into a host which has a pathway of metabolizing glucose to 2-oxoisovaleric acid. (7B) The transformant of any one of (1B) to (6B), in which a gene of enzyme having the AAT activity is additionally introduced. (8B) The transformant of any one of (1B) to (7B), in which a gene of an enzyme having an activity of hydrolyzing methacrylyl-CoA is additionally introduced. (9B) A method for producing methacrylyl-CoA including expressing a protein having the ACD activity using the transformant of (1B) and using the protein. (10B) A method for producing methacrylyl-CoA including expressing a protein having the ACD activity and 2-oxoisovalerate dehydrogenase activity using the transformant of any one of (2B) to (5B) and using the protein. (11B) A method for producing methacrylyl-CoA including expressing a protein having the ACD activity and 2-oxoisovalerate dehydrogenase activity by introducing the ACD gene selected from the group consisting of (a) to (d) of (1B) to a host and introducing the BCKAD complex gene which is selected from (e) to (h), (i) to (l), and (m) to (p) of
Hereinbelow, the terminology of the invention is explained. The “methacrylic acid” (IUPAC name: 2-methyl-2-propenoic acid) means a compound with a chemical formula CH2═C(CH3)COOH, and it encompasses any salt or ionized form thereof. Examples of the salt of methacrylic acid include a sodium salt, a potassium salt, a calcium salt, and a magnesium salt. The “methacrylic acid ester” means a compound represented by Formula 1. In Formula 1, R represents a linear or branched hydrocarbon group with 1 to 20 carbon atoms. The hydrocarbon group can be either a saturated or unsaturated noncyclic type, or a saturated or unsaturated cyclic type. Preferably, it is a linear or branched and unsubstituted alkyl group, an aralkyl group, or an aryl group having 1 to 10 carbon atoms. Examples of the particularly preferred include an alkyl group with 1 to 8 carbon atoms such as a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a n-pentyl group, an isopentyl group, a tert-pentyl group, a n-hexyl group, an isohexyl group, a 2-hexyl group, a dimethylbutyl group, an ethylbutyl group, a heptyl group, an octyl group, or a 2-ethylhexyl group, a benzyl group, and a phenyl group.
The “methacrylic acid derivatives” is a general name of the compounds containing a methacryloyl group (CH2═CCH3COO—) in addition to the aforementioned methacrylic acid and methacrylic acid ester. Examples of the compound containing a methacryloyl group include methacrylyl-CoA. The “ability to produce methacrylic acid” means ability for producing methacrylic acid using renewable raw materials as a carbon source and/or energy source. The “produce” means both the synthesis and decomposition of methacrylic acid in a living body (that is, balance), and it is not limited to the synthesis. The “renewable raw materials” indicate natural resources, for example, resources derived from an animal, a plant, or a microbe, in which the resources can be reconstructed by a process of the nature at a rate which is faster than the rate consumed by human beings or the like. The resources should be self-renewable at a rate which is the same as the rate of the consumption. For example, a plant material has an advantage that it can be cultivated without consuming it to cause a significant decrease in natural sources. The “biomass” means general resources that can be utilized as an organic energy source derived from a living organism. Examples of the biomass include a plant material, an animal material, and a biodegradable waste. The “carbon source” means an organic compound which can be assimilated by a microbe and used for producing a new cell. The “energy source” is a general name of the compounds for producing an energy molecule (ATP), which is required for a carbon source to get assimilated into a cell constitutional component via a metabolism intermediate. When an energy source required for metabolism to produce ATP, that is, a catabolism process, is needed for an oxidation reaction of various compounds in microbes, those compounds become the “energy source.” The “utilization of the renewable raw materials” means a method for general utilization of the renewable raw materials for obtaining fuel components and various organic substances from the renewable raw materials, which includes at least one processing step like gasification, liquidification, saccharification, enzyme treatment, fermentation, distillation of fermentation product, hydrolysis, dehydration, concentration, and drying. The “microbes” indicate, according to general definition, prokaryotes like bacteria of any type, arcahea, and cyanobacteria, eukaryotes like yeast, mold, acrasis, and protozoa, and viruses. It further includes undifferentiated cells of an animal or a plant, and also a tissue culture product. As described herein, the “microbes” specifically means the microbes having the ability to produce methacrylic acid. Further, with regard to those having the ability to produce methacrylic acid, it is also used as a concept which includes a culture product, a medium (a culture product from which microbial cells are removed), microbial cells (including both cultured microbial cells or washed microbial cells), a processed product of microbial cells in which the microbial cells are disrupted or lysed, and a composition having an activity of producing methacrylic acid which is obtained by purifying and processing of the medium and/or cells (crude enzyme solution and purified enzyme). The “derived strainstrain” means a strainstrain which is derived from a certain microbe strainstrain either naturally, or by a chemical or physical treatment. In the invention, it specifically means a strain which is derived from a microbe strain having the ability to produce methacrylic acid and maintains the ability to produce methacrylic acid from renewable raw material as a carbon source and/or energy source. The “contact” means an exposure treatment of the microbes and materials (renewable raw materials) for a certain period of time. Specifically, it indicates that microbes are added to an aqueous medium containing renewable raw materials followed by suspension mixing. At that time, it is acceptable to have proliferation of the microbes. The “aqueous medium” means water, an aqueous solution having water as a main component, and gel (agar), and those having undissolved liquid and solid dispersed therein are also included. The “vapor phase” means the portion taken by gas or water vapor in a culture tank (a vessel for culturing microbes) or a reaction tank (a vessel for performing the reaction), excluding the portion taken by the liquid (medium or the like). The “culture” means a process proliferating cells of microbes or a multicellular organisms in an artificial environment. The “culture product” means those obtained by culture of microbial cells, a broth, a cell-free extract, or cell membranes. The cell-free extract can be obtained by, after physically disrupting microbial cells after culture with a homogenizer or the like with addition of a sodium phosphate buffer solution followed by centrifuge (15,000 rpm, 10 min, 4° C.), collecting the supernatant from which non-disrupted microbes or cell membranes are removed, The “esterification” indicates the reaction for producing an ester from an alcohol and a fatty acid based on dehydration. Further, it also includes the reaction for producing a new ester based on an alcohol exchange reaction with another alcohol or a partial ester of a polyhydric alcohol. According to the invention, a method for directly and efficiently producing methacrylic acid in a single step from renewable raw materials and/or biomass arising from the utilization of the renewable raw materials, as a carbon source and/or energy source, is provided. Hereinbelow, preferred embodiments for carrying out the invention are explained. Meanwhile, the embodiments that are explained hereinbelow are to illustrate an example of the representative embodiment of the invention, and by no means the scope of the invention is construed narrowly by them. 1. Method for Producing Methacrylic Acid and/or Ester Thereof According to the method for producing methacrylic acid and/or an ester thereof of the invention (hereinbelow, also simply referred to as the “production method for methacrylic acid”), methacrylic acid is produced using microbes having the ability to produce methacrylic acid from renewable raw materials and/or biomass arising from the utilization of the renewable raw materials, as a carbon source and/or energy source. Specifically, according to a step of contacting the microbes having the ability to produce methacrylic acid with renewable raw materials and/or biomass, methacrylic acid is produced. More specifically, by culturing the microbes in an aqueous medium containing the renewable raw materials and/or biomass, methacrylic acid is obtained in the aqueous medium. (1) Microbes With regard to the microbes that are used for production method for methacrylic acid according to the invention, they are not particularly limited as long as they are the microbes having the ability to produce methacrylic acid. As for the microbes, the microbes as follows can be used, for example. The microbes can be used either singly or as a combination of two or more types that are selected from the following microbes. [Preferred Order of Prokaryotes] Specific examples of the prokaryotes that are suitable for the invention include microbes belonging to Rhodospirillales, Rhodobacterales, Sphingomonadales, Caulobacterales, Rhizobiales, Parvularculales, Burkholderiales, Hydrogenophilales, Neisseriales, Nitrosomonadales, Rhodocyclales, Chromatiales, Acidithiobacillales, Xanthomonadales, Thiotrichales, Oceanospirillales, Pseudomonadales, Alteromonadales, Vibrionales, Aeromonadales, Salinisphaerales, Legionellales, Desulfobacterales, Desulfarculales, Desulfuromonadales, Syntrophobacterales, Bdellovibrionales, Myxococcales, Acidobacteriales, Actinomycetales, Bifidobacteriales, Rubrobacterales, Solirubrobacterales, Bacillales, Lactobacillales, Clostridiales, Thermoanaerobacterales, Natranaerobiales, Sphingobacteriales, Bacteroidales, Cytophagales, Flavobacteriales, Deinococcales, Thermales, Gemmatimonadales, Fusobacteriales, Chloroflexales, Herpetosiphonales, Thermomicrobiales, Thermotogales, Deferribacterales, Sulfolobales, Desulfurococcales, Thermoproteales, Acidilobales, Halobacteriales, Thermoplasmatales, or Archaeoglobales. Among them, preferred microbes are the microbes belonging to Rhodospirillales, Rhodobacterales, Sphingomonadales, Caulobacterales, Rhizobiales, Parvularculales, Burkholderiales, Hydrogenophilales, Neisseriales, Nitrosomonadales, Rhodocyclales, Chromatiales, Xanthomonadales, Thiotrichales, Oceanospirillales, Pseudomonadales, Alteromonadales, Vibrionales, Aeromonadales, Salinisphaerales, Legionellales, Desulfobacterales, Desulfarculales, Desulfuromonadales, Syntrophobacterales, Bdellovibrionales, Myxococcales, Acidobacteriales, Actinomycetales, Rubrobacterales, Solirubrobacterales, Bacillales, Lactobacillales, Clostridiales, Thermoanaerobacterales, Natranaerobiales, Sphingobacteriales, Bacteroidales, Cytophagales, Flavobacteriales, Deinococcales, Thermales, Gemmatimonadales, Fusobacteriales, Chloroflexales, Herpetosiphonales, Thermomicrobiales, Thermotogales, Deferribacterales, Sulfolobales, Desulfurococcales, Thermoproteales, Acidilobales, Halobacteriales, Thermoplasmatales, or Archaeoglobales. Further, examples of the particularly preferred microbes which allow experimental confirmation of the production of methacrylic acid derivatives include the microbes belonging to Rhodobacterales, Sphingomonadales, Caulobacterales, Rhizobiales, Burkholderiales, Pseudomonadales, Alteromonadales, Vibrionales, Actinomycetales, Bacillales, or Sphingobacteriales. [Preferred Family of Prokaryotes] Examples may include, as those belonging to Rhodospirillales, Rhodospirillaceae and Acetobacteraceae, as those belonging to Rhodobacterales, Rhodobacteraceae and Hyphomonadaceae, as those belonging to Sphingomonadales, Sphingomonadaceae and Erythrobacteraceae, as those belonging to Caulobacterales, Caulobacteraceae, as those belonging to Rhizobiales, Rhizobiaceae, Xanthobacteraceae, Brucellaceae, Phyllobacteriaceae, Aurantimonadaceae, Bradyrhizobiaceae, Methylobacteriaceae, Hyphomicrobiaceae, Rhodobiaceae and Methylocystaceae, as those belonging to Parvularculales, Parvularculaceae, as those belonging to Burkholderiales, Burkholderiaceae, Alcaligenaceae, Comamonadaceae and Oxalobacteraceae, as those belonging to Hydrogenophilales, Hydrogenophilaceae, as those belonging to Neisseriales, Neisseriaceae, as those belonging to Nitrosomonadales, Nitrosomonadaceae, as those belonging to Rhodocyclales, Rhodocyclaceae, as those belonging to Chromatiales, Chromatiaceae and Ectothiorhodospiraceae, as those belonging to Acidithiobacillales, Acidithiobacillaceae, as those belonging to Xanthomonadales, Xanthomonadaceae, as those belonging to Thiotrichales, Francisellaceae and Piscirickettsiaceae, as those belonging to Oceanospirillales, Oceanospirillaceae, Hahellaceae, Halomonadaceae and Alcanivoracaceae, as those belonging to Pseudomonadales, Pseudomonadaceae and Moraxellaceae, as those belonging to Alteromonadales, Alteromonadaceae, Shewanellaceae, Ferrimonadaceae, Idiomarinaceae, Colwelliaceae and Pseudoalteromonadaceae, as those belonging to Vibrionales, Vibrionaceae, as those belonging to Aeromonadales, Aeromonadaceae, as those belonging to Salinisphaerales, Salinisphaeraceae, as those belonging to Legionellales, Legionellaceae and Coxiellaceae, as those belonging to Desulfobacterales, Desulfobulbaceae, as those belonging to Desulfarculales, Desulfarculaceae, as those belonging to Desulfuromonadales, Geobacteraceae, as those belonging to Syntrophobacterales, Syntrophobacteraceae and Syntrophaceae, as those belonging to Bdellovibrionales, Bdellovibrionaceae and Bacteriovoracaceae, as those belonging to Myxococcales, Cystobacteraceae, Myxococcaceae, Polyangiaceae and Kofleriaceae, as those belonging to Acidobacteriales, Acidobacteriaceae, as those belonging to Acidimicrobiales, Acidimicrobiaceae, as those belonging to Actinomycetales, Streptosporangiaceae, Nocardiopsaceae, Thermomonosporaceae, Pseudonocardiaceae, Actinosynnemataceae, Micromonosporaceae, Actinopolysporaceae, Propionibacteriaceae, Nocardioidaceae, Corynebacteriaceae, Nocardiaceae, Gordoniaceae, Dietziaceae, Mycobacteriaceae, Tsukamurellaceae, Segniliparaceae, Microbacteriaceae, Micrococcaceae, Dermabacteraceae, Dermatophilaceae, Brevibacteriaceae, Cellulomonadaceae, Intrasporangiaceae, Jonesiaceae, Rarobacteraceae, Frankiaceae, Acidothermaceae, Nakamurellaceae, Cryptosporangiaceae, Geodermatophilaceae, Glycomycetaceae, Actinomycetaceae, Streptomycetaceae, Catenulisporaceae and Kineosporiaceae, as those belonging to Bifidobacteriales, Bifidobacteriaceae, as those belonging to Rubrobacterales, Rubrobacteraceae, as those belonging to Solirubrobacterales, Conexibacteraceae, as those belonging to Bacillales, Bacillaceae, Alicyclobacillaceae, Paenibacillaceae, Planococcaceae, Sporolactobacillaceae and Thermoactinomycetaceae, as those belonging to Lactobacillales, Lactobacillaceae, Leuconostocaceae, Aerococcaceae, Carnobacteriaceae and Streptococcaceae, as those belonging to Clostridiales, Clostridiaceae, Syntrophomonadaceae, Eubacteriaceae, Peptococcaceae, Peptostreptococcaceae, Lachnospiraceae and Oscillospiraceae, as those belonging to Thermoanaerobacterales, Thermoanaerobacteraceae, as those belonging to Natranaerobiales, Natranaerobiaceae, as those belonging to Sphingobacteriales, Sphingobacteriaceae and Saprospiraceae, as those belonging to Bacteroidales, Bacteroidaceae, Marinilabiliaceae, Prevotellaceae and Porphyromonadaceae, as those belonging to Cytophagales, Cytophagaceae and Flammeovirgaceae, as those belonging to Flavobacteriales, Flavobacteriaceae, as those belonging to Deinococcales, Deinococcaceae, as those belonging to Thermales, Thermaceae, as those belonging to Gemmatimonadales, Gemmatimonadaceae, as those belonging to Fusobacteriales, Fusobacteriaceae, as those belonging to Chloroflexales, Chloroflexaceae, as those belonging to Herpetosiphonales, Herpetosiphonaceae, as those belonging to Thermomicrobiales, Thermomicrobiaceae, as those belonging to Thermotogales, Thermotogaceae, as those belonging to Deferribacterales, Deferribacteraceae, as those belonging to Sulfolobales, Sulfolobaceae, as those belonging to Desulfurococcales, Desulfurococcaceae, as those belonging to Thermoproteales, Thermoproteaceae, as those belonging to Acidilobales, Acidilobaceae, as those belonging to Halobacteriales, Halobacteriaceae, as those belonging to Thermoplasmatales, Thermoplasmataceae, Picrophilaceae and Ferroplasmaceae, and as those belonging to Archaeoglobales, Archaeoglobaceae. Among them, preferred microbes are the microbes belonging to Rhodospirillaceae, Acetobacteraceae, Rhodobacteraceae, Hyphomonadaceae, Sphingomonadaceae, Erythrobacteraceae, Caulobacteraceae, Rhizobiaceae, Xanthobacteraceae, Brucellaceae, Phyllobacteriaceae, Aurantimonadaceae, Bradyrhizobiaceae, Methylobacteriaceae, Hyphomicrobiaceae, Rhodobiaceae, Methylocystaceae, Parvularculaceae, Burkholderiaceae, Alcaligenaceae, Comamonadaceae, Oxalobacteraceae, Neisseriaceae, Nitrosomonadaceae, Rhodocyclaceae, Chromatiaceae, Ectothiorhodospiraceae, Xanthomonadaceae, Francisellaceae, Piscirickettsiaceae, Oceanospirillaceae, Hahellaceae, Halomonadaceae, Alcanivoracaceae, Pseudomonadaceae, Moraxellaceae, Alteromonadaceae, Shewanellaceae, Ferrimonadaceae, Idiomarinaceae, Colwelliaceae, Pseudoalteromonadaceae, Vibrionaceae, Aeromonadaceae, Salinisphaeraceae, Legionellaceae, Coxiellaceae, Desulfobulbaceae, Desulfarculaceae, Geobacteraceae, Syntrophobacteraceae, Syntrophaceae, Bdellovibrionaceae, Bacteriovoracaceae, Cystobacteraceae, Myxococcaceae, Polyangiaceae, Kofleriaceae, Acidobacteriaceae, Acidimicrobiaceae, Streptosporangiaceae, Nocardiopsaceae, Thermomonosporaceae, Pseudonocardiaceae, Actinosynnemataceae, Micromonosporaceae, Nocardioidaceae, Corynebacteriaceae, Nocardiaceae, Gordoniaceae, Dietziaceae, Mycobacteriaceae, Tsukamurellaceae Segniliparaceae, Microbacteriaceae, Micrococcaceae, Dermabacteraceae, Cellulomonadaceae, Intrasporangiaceae, Frankiaceae, Acidothermaceae, Nakamurellaceae, Geodermatophilaceae, Glycomycetaceae, Streptomycetaceae, Catenulisporaceae, Rubrobacteraceae, Conexibacteraceae, Bacillaceae, Alicyclobacillaceae, Paenibacillaceae, Lactobacillaceae, Carnobacteriaceae Clostridiaceae, Syntrophomonadaceae, Eubacteriaceae, Peptococcaceae, Lachnospiraceae, Oscillospiraceae, Thermoanaerobacteraceae, Natranaerobiaceae, Sphingobacteriaceae, Saprospiraceae, Porphyromonadaceae, Cytophagaceae, Flavobacteriaceae, Deinococcaceae, Thermaceae, Gemmatimonadaceae, Fusobacteriaceae, Chloroflexaceae, Herpetosiphonaceae, Thermomicrobiaceae, Thermotogaceae, Deferribacteraceae, Sulfolobaceae, Desulfurococcaceae, Thermoproteaceae, Acidilobaceae, Halobacteriaceae, Thermoplasmataceae, Picrophilaceae, Ferroplasmaceae, or Archaeoglobaceae. Further, examples of the particularly preferred microbes which allow experimental confirmation of the production of methacrylic acid derivatives include the microbes belonging to Rhodobacteraceae, Sphingomonadaceae, Caulobacteraceae, Rhizobiaceae, Xanthobacteraceae, Brucellaceae, Phyllobacteriaceae, Alcaligenaceae, Comamonadaceae, Pseudomonadaceae, Moraxellaceae, Shewanellaceae, Vibrionaceae, Nocardiaceae, Streptomycetaceae, Bacillaceae, Paenibacillaceae or Sphingobacteriaceae. [Preferred Genus of Prokaryotes] Examples may include, as those belonging to Rhodospirillaceae, the genus Among them, preferred microbes are the microbes which have been demonstrated to have an enzyme for the metabolism pathway of branched amino acids, that is, microbes belonging to the genus Further, examples of the particularly preferred microbes which allow experimental confirmation of the production of methacrylic acid derivatives include the microbes belonging to the genus [Preferred Species of [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Other Preferred Species of Prokaryotes] Further, as the microbes that are classified as the genus [Preferred Order of Eukaryotes] Examples of the microbes which belong to the eukaryotes include microbes belonging to Eurotiales, Saccharomycetales, Capnodiales, Pleosporales, Ustilaginales, Tremellales, Cystofilobasidiales, Helotiales, Pezizales, Polyporales, Agaricales, Pucciniales, Magnaporthales, Sordariales, Microascales, Hypocreales, Sporidiobolales, Exobasidiales, Malasseziales, Onygenales, Laboulbeniales, or Mucorales. Further, examples of the particularly preferred microbes which allow experimental confirmation of the production of methacrylic acid derivatives include the microbes belonging to Eurotiales and Saccharomycetales. [Preferred Family and the Genus of Eukaryotes] As the microbes that are classified as Capnodiales, the genus As the microbes that are classified as Eurotiales, the genus As the microbes that are classified as Saccharomycetales, the genus Further, as the microbes belonging to Saccharomycetales, preferred examples include the microbes that are classififed as Saccharomycodaceae, Pichiaceae, Dipodascaceae or mitosporic Saccharomycetales. Examples of the microbes belonging to that family include the genus Among those belonging to the eukarytoes, examples of other genus include the genus Among them, the preferred microbes are the microbes which have been demonstrated to have an enzyme for the metabolism pathway of branched amino acids, that is, microbes classified as the genus Further, examples of the particularly preferred microbes which allow experimental confirmation of the production of methacrylic acid derivatives include the microbes that are classified as the genus [Preferred Species of Eukaryotes] [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Genus Examples of the microbes that are classified as the genus [Other Preferred Species of Eukaryotes] Further, as the microbes that are classified as the genus Among the aforementioned prokaryotes and eukaryotes, examples of the particularly preferred microbes which allow experimental confirmation of the production of methacrylic acid derivatives include the microbes which belong to the genus Among them, more preferred are the microbes which belong to the genus [Preferred Microbial Strains] Particularly preferred examples of the microbes having the ability to produce methacrylic acid, which are used for the method for producing methacrylic acid of the invention, include the following microbial strains having high ability to produce methacrylic acid (see, Examples described below). [Correction of Nov. 27, 2013 Based on Rule 91] (i) B25-2 strain (The National Institute of Technology and Evaluation (NITE), Patent Microorganisms Depository (zip code 292-0818, 2-5-8 Kazusakamatari, Kisarazu-shi, Chiba-ken, 292-0818, Japan), Accession number: NITE BP-1451), D22-1 strain (Accession number: NITE BP-1452), D43-1 strain (Accession number: NITE BP-1453), D25 strain (Accession number: NITE BP-1454), D26 strain (Accession number: NITE BP-1455), D29 strain (Accession number: NITE BP-1456), D41-2 strain (Accession number: NITE BP-1457), and The microbes having the ability to produce methacrylic acid can be identified from soil, river water, lake water, sea water, sludge, animal, plant, insect, or the like based on screening such as a flat plate separation or direct culture method by using the assimilating property of amino acids or fatty acids. Specifically, according to evaluation of the assimilating property of valine or isobutyric acid and/or the property for producing methacrylic acid, the microbes appropriate for the invention can be selected. The assimilating property of valine or isobutyric acid can be evaluated by observing the growth on a synthetic medium which uses 0.1 to 1% valine or isobutyric acid as a carbon source. The property for producing methacrylic acid can be evaluated by analyzing the production of methacrylic acid in the aforementioned broth. Alternatively, the evaluation can be made by contacting the cells obtained by the culture with a solution containing valine or isobutyric acid at 0.1 to 1% and analyzing the production of methacrylic acid in the same reaction solution. The reaction can be performed at 30° C. with shaking for 5 to 120 hours. Preferably, it is the microbes having the ability to produce methacrylic acid derivatives at 0.04 ppm or more as determined by the aforementioned evaluation. Alternatively, the microbes appropriate for the invention can be selected according to mycological properties of microbes (that is, cultural property, morphological property, physiological property, chemosystematic property, and genetic property). For example, the microbes of the invention can be selected in view of the identity of the rRNA gene of the microbes. Specifically, the selection can be made from the microbes having rRNA gene which includes a nucleotide sequence having the identity of 81% or more, preferably 88% or more, more preferably 95% or more, more preferably 97% or more, more preferably 98% or more, and even more preferably 99.5% or more to any one of the nucleotide sequences described in SEQ ID NOS. 1 to 49. Further, the microbes appropriate for the invention can be efficiently narrowed by selecting from microbes belonging to the taxonomic order including the order, family, or the genus described above and combining the information of rRNA gene. Meanwhile, with regard to the method for analyzing and identifying the rRNA gene, reference can be made to “Determination method of 16S rRNA gene sequence (In The Isolation and Characterization of Actinomycetes, pp. 88-117, Edited by The Society Actinomycetes, Japan, 2001)”, “Bulletin of Japanese Society of Microbial Ecology Vol. 10, 31-42, 1995”, and “Japanese Pharmacopoeia, 16 revised edition; Method for quick identification of microbes based on gene analysis”), or the like. Preferably, the microbes appropriate for the invention are selected by combining those mycological properties, property of assimilating valine or isobutyric acid, and property for producing methacrylic acid. It is also possible to select them from existing type culture according to the same procedure. [Derivative Strain] A derivative strain which is derived either naturally or by a chemical or physical treatment from the microbes having the ability to produce methacrylic acid (for example, the aforementioned microbial strains of (i) to (xxiv)) and maintains the ability to produce methacrylic acid by using renewable raw materials and/or biomass as a carbon source and/or energy source can be also used as microbes. The derivative strain encompasses the “variant strain” and “gene modified strain” that are described below. [Variant Strain] The variant strain can be obtained by causing a genetic variation in the microbes having the ability to produce methacrylic acid according to a chemical or physical treatment (for example, γ ray irradiation). [Gene Modified Strain] The gene modified strain is a strain of the microbes having the ability to produce methacrylic acid with enhanced activity or deleted or lowered activity as described below. Enhanced activity means that the expression amount of an enzyme gene (regardless of its origin) is increased in microbes based on the gene incorporated from outside of the microbial cells to the microbes. In addition to the incorporation of a gene encoding an enzyme from outside of the microbial cells to inside of the microbial cells, enhancing the promoter activity of an enzyme gene which is included on the microbes on genome, expressing strongly an enzyme gene by substituting with other promoter, and enhancing the activity of an enzyme gene as a result of lowering or inactivating the activity of the repressor of the enzyme gene are included. Meanwhile, the gene introduction or substitution of a gene on genome can be performed according to a general method. The gene modified strain can be a modified strain having gene modification for deleting or lowering the activity of an enzyme which suppresses the reaction for synthesizing methacrylic acid. “Deleting” or “lowering” the activity means that completely removed or lowered expression of the enzyme gene, and in addition to an occurrence of substitution, deletion, or insertion in the enzyme gene, suppressing the activity of the promoter of the enzyme gene which is contained on a gene of the microbes, suppressing the expression of the enzyme gene by substituting with other promoter, and lowering the activity of an enzyme gene as a result of enhancing or activating the activity of the repressor of the enzyme are included. Meanwhile, those gene modifications can be performed to a general method. Examples of the preferred modified gene include a modified gene having at least one of the following (a) and (b).
Further, a strain newly given with an ability to produce methacrylic acid by using renewable raw materials and/or biomass as a carbon source and/or energy source according to introduction of an enzyme involved with methacrylic acid synthesis, which is identified from microbes having the ability to produce methacrylic acid, to microbes not having the ability to produce methacrylic acid can be also used as microbes. With regard to the production of the gene recombinant strain, it can be performed with the same method as the production of a gene modified strain described above. [Homologous Strain] Further, a strain which is a homologous strain of the microbes having the ability to produce methacrylic acid (for example, the aforementioned microbial strains of (i) to (xxiv)) and maintains the ability to produce methacrylic acid by using renewable raw materials and/or biomass as a carbon source and/or energy source can be also used as microbes. The homologous strain can be obtained by performing molecular phylogenetic analysis based on the base sequence information of nucleic acid, for example. Specifically, the homologous strain can be obtained by a homology analysis of the nucleotide sequence of ribosomal RNA gene (rRNA gene; hereinbelow, rDNA). Examples of the preferred homologous strain include the followings. (1) Microbes which belong to the genus Further, the homologous strain can be selected from existing type culture based on the information in which mycological properties are suitably combined. As described herein, the “identity” of a sequence indicates the percentage that is obtained by, in case of a nucleotide sequence, aligning two nucleotide sequences for comparison such that they are in match with each other as much as possible and dividing the number of nucleotides in match by the number of total nucleotides. For the aligning, a gap is suitably inserted to one or both sequences for comparison, if necessary. The aligning of a sequence can be performed by using a known program such as BLAST, FASTA, or CLUSTALW. In case of inserting a gap, the number of total nucleotides corresponds to the number of nucleotides after counting one gap as one nucleotide. When the number of total nucleotides counted as above is different between two sequences for comparison, the identity (%) is calculated by dividing the number of nucleotides in match by the number of total nucleotides with longer length. The same applies to the identity of an amino acid sequence. Further, according to the method for producing methacrylic acid and/or a methacrylic acid ester of the invention, it is also possible that, with a step of using recombinant microbes in which AAT gene and/or ACD gene is introduced to the microbes having the ability to produce methacrylic acid and contacting them with renewable raw materials and/or biomass, methacrylic acid and/or a methacrylic acid ester is produced. [Production of Recombinant Microbes in which AAT Gene is Introduced to the Microbes Having Ability to Produce Methacrylic Acid] [AAT] AAT is an enzyme having a catalytic function of transferring an acyl group of acyl-CoA to alcohols or phenols to synthesize ester. AAT is believed to be involved with production of esters in various fruits. AAT is known to be present in a plant such as Zingiberales (banana), Rosales (strawberry, apple, pear, and peach), Cucurbitales (melon), Ericales (kiwi), Lamiales (olive), Solanales (tomato), and Sapindales (lemon and mango). Regardless of the type and origin, the AAT used in the invention is not particularly limited if it is a catalyst derived from a living microorganism having the ability to produce methacrylic acid by using methacrylyl-CoA and alcohols or phenols as a raw material. As an enzyme source, those derived from a plant are preferable. Among them, those classified as an angiosperm plant are preferable. The AAT suitable for the invention can be selected from the aforementioned plants according to the following method. A suitable area of a tissue is obtained by cutting, if necessary. To the cut area, a solution containing methacrylyl-CoA and alcohols or phenols is added, shaken, and allowed to proceed with the reaction for a certain time. By confirming the presence or absence of a methacrylic acid ester in the reaction solution using GC (gas chromatography), the synthetic activity can be confirmed. Specifically, fruit flesh or fruit skin is cut and added with a solution containing 1 to 10 mM methacrylyl-CoA, 0.35 M KCl, and 5 to 50× molar amount of n-butanol, and shaken for 1 to 10 hours at 30° C. Once the reaction is completed, by confirming the presence or absence of a methacrylic acid ester by GC, the AAT applicable to the invention can be selected. The alcohols or phenols are a compound represented by the following formula “R—OH”. Because the structure of the alcohols or phenols corresponds to methacrylic acid ester, the structure has the same definition as R of Formula 1 above, and it represents a linear or branched hydrocarbon group having 1 to 20 carbon atoms. The hydrocarbon group can be a saturated or unsaturated noncyclic type, or a saturated or unsaturated cyclic type. Preferably, it is a linear or branched unsubstituted alcohol, aralkyl alcohols or phenols having 1 to 10 carbon atoms. Particularly preferred examples include alkyl alcohol having 1 to 8 carbon atoms such as a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a n-pentyl alcohol, isopentyl alcohol, tert-pentyl alcohol, n-hexyl alcohol, isohexyl alcohol, 2-hexyl alcohol, dimethylbutyl alcohol, or ethylbutyl alcohol, heptyl alcohol, octyl alcohol, or 2-ethylhexyl alcohol, benzyl alcohol, and phenol. Specific examples of the AAT enzyme source which is suitable for the invention include those belonging to any order selected from a group consisting of Zingiberales, Rosales, Ericales, Cucurbitales, Brassicales, Laurales, Poales, Arecales, Asparagales, Saxifragales, Caryophyllales, Vitales, Malpighiales, Oxalidales, Fabales, Sapindales, Malvales, Myrtales, Ranunculales, Solanales, Lamiales, Gentianales, and Asterales. Among them, preferred are those belonging to any order selected from a group consisting of Zingiberales, Rosales, Ericales, Cucurbitales, Brassicales, and Laurales. Preferred are as follows; Musaceae and Zingiberaceae as those belonging to the order Zingiberales, Rosaceae and Moraceae as those belonging to the order Rosales, Ericaceae, Actinidiaceae, Ebenaceae and Theaceae as those belonging to the order Ericales, Cucurbitaceae as those belonging to the order Cucurbitales, Caricaceae and Brassicaceae as those belonging to the order Brassicales, Lauraceae as those belonging to the order Laurales, Bromeliaceae and Poaceae as those belonging to the order Poales, Arecaceae as those belonging to the order Arecales, Orchidaceae and Iridaceae as those belonging to the order Asparagales, Grossulariaceae as those belonging to the order Saxifragales, Caryophyllaceae as those belonging to the order Caryophyllales, Vitaceae as those belonging to the order Vitales, Malpighiaceae, Passifloraceae, Euphorbiaceae and Salicaceae as those belonging to the order Malpighiales, Oxalidaceae as those belonging to the order Oxalidales, Fabaceae as those belonging to the order Fabales, Rutaceae, Sapindaceae and Anacardiaceae as those belonging to the order Sapindales, Malvaceae as those belonging to the order Malvales, Lythraceae, Onagraceae and Myrtaceae as those belonging to the order Myrtales, Ranunculaceae and Papaveraceae as those belonging to the order Ranunculales, Solanaceae as those belonging to the order Solanales, Oleaceae, Verbenaceae and Lamiaceae as those belonging to the order Lamiales, Apocynaceae as those belonging to the order Gentianales, and Asteraceae as those belonging to the order Asterales. Homologous species of the aforementioned plant can be also used. Among them, more preferred is a plant belonging to Musaceae, Rosaceae, Ericaceae, Actinidiaceae, Cucurbitaceae, Caricaceae or Lauraceae. Specifically, preferred are as follows: the genus Further, specific examples of the particularly preferred are as follows: In the invention, plant classification is based on the APG plant classification system III (Botanical Journal of the Linnean Society, 2009, 161, 105121). At the time of selecting AAT, it is also possible that the AAT gene is isolated, introduced to a common host vector system, for example, and then evaluated and selected by using microbes that are transformed with the vector system. For example, several AAT genes have been known (for example, see Patent Document 7). Based on the information, the gene can be isolated by producing a DNA probe, producing a primer used for PCR, for example, and performing PCR. It is also possible that the entire nucleotide sequence of AAT gene is synthesized by a general method. According to the same method as described above, it is possible to determine whether or not the genetic information has the activity of synthesizing a methacrylic acid ester of known AAT. Meanwhile, with regard to the AAT with unclear genetic information, it is possible that the genetic information can be obtained based on genetic engineering of a protein resulting from purification of the AAT. As for the AAT gene preferred in the invention, it is not particularly limited if the translated product has an ability to produce a methacrylic acid ester, and it is suitably selected from the AAT enzyme sources described above. Examples of the particularly preferred include the AAT gene derived from an apple (SEQ ID NO. 77), the AAT gene derived from strawberry (SEQ ID NO. 79), and the AAT gene derived from strawberry (SEQ ID NO. 81). Meanwhile, the AAT gene of the invention also encompasses a gene which contains an amino acid sequence of having one or several substitutions, deletions, or additions of the amino acids in the amino acid sequence of the wild type and encodes a protein having an activity of producing a methacrylic acid ester from methacrylyl-CoA and alcohol. As described herein, the term “several” indicates 1 to 40, preferably 1 to 20, and more preferably 10 or less. In order to introduce a mutation to a gene, a kit for introducing mutation which uses a site specific mutagenesis, such as QuikChange™ Site-Directed Mutagenesis Kit (manufactured by Stratagene), GeneTailor™ Site-Directed Mutagenesis System (manufactured by Invitrogen), TaKaRa Site-Directed Mutagenesis System (manufactured by Takara Bio Inc., Mutan-K, Mutan-Super Express Km or the like), can be used based on a known method like Kunkel method or Gapped duplex method. Alternatively, the entire gene having a sequence in which a mutation is contained can be artificially synthesized. In the invention, identification of the nucleotide sequence of a DNA can be performed by determining the sequence by a commonly used method. For example, the sequence can be identified based on Sanger method by using a suitable DNA sequencer. Further, the AAT gene of the invention encompasses a gene which exhibits the identity of 90% or more, preferably 95% or more, more preferably 99.5% or more, and even more preferably 99.9% or more to the protein consisting of an amino acid sequence of the wild type and encodes a protein having an activity of producing a methacrylic acid ester from methacrylyl-CoA and alcohol. Further, the AAT gene of the invention encompasses a gene which hybridizes under stringent conditions to a polynucleotide having a nucleotide sequence complementary to the nucleotide sequence of the wild type and encodes a protein having an activity of producing a methacrylic acid ester from methacrylyl-CoA and alcohol. In the specification, reference can be made to “Molecular Cloning, A Laboratory Manual 2nd ed.” (Cold Spring Harbor Laboratory Press (1989)), “Current Protocols in Molecular Biology” (John Wiley & Sons (1987-1997)) or the like with regard to the method for hybridization. In the specification, the stringent conditions may be a condition in which the hybridization is performed by incubating a nylon membrane having immobilized DNA with a probe in a solution containing 6×SSC (1×SSC indicates 8.76 g of sodium chloride and 4.41 g of sodium citrate are dissolved in 1 liter water), 1% SDS, 100 μg/ml salmon sperm DNA, 0.1% bovine serum albumin, 0.1% polyvinylpyrrolidone, and 0.1% Ficoll for 20 hours at 65° C., but it is not limited thereto. A skilled person in the pertinent art can set the conditions for hybridization by considering, in addition to the conditions like salt concentration of a buffer, temperature, or the like, various conditions such as probe concentration, probe length, or reaction time. For example, with regard to cleaning condition after the hybridization, a condition like “1×SSC, 0.1% SDS, 65° C.”, “0.5×SSC, 0.1% SDS, 50° C.” can be mentioned as a more stringent condition than “2×SSC, 0.1% SDS, 42° C.”, “1×SSC, 0.1% SDS, 37° C.”. Further, in the invention, the AAT gene also encompasses a gene consisting of a nucleotide sequence having the identity of 80% or more, preferably 90% or more, and most preferably 95% or more to the nucleotide sequence of the wild type when calculation is made by using BLAST (for example, default, that is, parameters of initial setting) and encoding the protein having an activity of producing a methacrylic acid ester from methacrylyl-CoA and alcohol. Further, the codon of the AAT gene may be modified in response to the codon usage frequency of the microbes that are used for transformation. [Production of Recombinant Microbes Introduced with AAT Gene] By introducing the DNA encoding the AAT gene to the microbes having the ability to produce methacrylic acid as a host and performing transcription and translation into a protein in the microbes, methacrylic acid ester can be produced. It is also possible that a gene of the enzyme which enhances the methacrylic acid producing activity (for example, gene like ACD and BCKAD) can be simultaneously introduced. The gene introduction method is not particularly limited. However, the DNA to be introduced is preferably in a state in which it is bound to a vector. Specifically, the AAT gene is bound to the vector in a state in which it can be expressed in a host cell, and introduced to the host cell. Examples of the vector include those capable of self-replication in host microbes and those capable of binding to the genome of microbes. However, as long as the AAT gene is maintained, it is not limited and a vector that is suitable for each microbe can be used. In case of bacteria of the genus The vector which may be used in the invention encompasses a plasmid vector, a phage (virus) vector, a cosmid vector, and an artificial chromosome vector, and it may also contain one or several selectable marker genes and suitable sequence for expression regulation. Although many host and vector systems are known, they can be developed by the same method, if necessary. As for the vector for introduction into microbes which belong to the genus Insertion of the AAT gene to a vector can be performed by using a genetic recombination technique which is known to a skilled person in the pertinent art. Examples of the method which can be used include a method of using restriction with a restriction enzyme and a ligation kit, a method of using topoisomerase, and a method of using In Fusion kit (Takara Bio). The gene to be inserted to a vector is inserted by ligating it to the downstream of a promoter, which can regulate transcription and translation of a protein encoded by each gene in a host organism. Further, if required for insertion, a suitable linker may be added. Further, if necessary, a terminator sequence, an enhancer sequence, a splicing signal sequence, a signal sequence for adding polyA, a ribosome-binding sequence such as SD sequence or Kozak sequence, and a selection marker gene, which can be used in a host microbe to which a gene is introduced, can be added. Examples of the selection marker gene include, in addition to a drug-resistant gene such as ampicillin resistant gene, tetracycline resistant gene, neomycin resistant gene, kanamycin resistant gene, or chloramphenicol resistant gene, a gene involved with cellular biosynthesis of nutrients such as amino acid or nucleic acid, and a gene encoding a fluorescent protein such as luciferase. Part of the amino acid sequence encoded by DNA can be also substituted in conjunction with the insertion. In view of the above, it is particularly preferable to use, in an example of the invention, pLK005 obtained by performing a mutagenic treatment of pK4 as a vector for the genus In the vector, the AAT gene alone or any one gene selected from a group consisting of enzyme genes which enhance the activity of producing methacrylic acid can be inserted. It is also possible that two or more genes are inserted. When used in relation to the gene to be introduced to a vector, the term “two or more” means that 2 to 5, 2 to 4, and preferably 2 to 3 genes can be inserted. Further, when two or more genes are inserted to a single vector, it is preferable that those genes form an operon. As described herein, the term “operon” means a unit of nucleic acids consisting of one or more genes that are transcribed under control of the same promoter. The aforementioned gene, and preferably the gene present in the form of a vector, is introduced to a host microbe according to a method known to a person skilled in the pertinent art. Examples of the method for introducing a recombinant vector to a host microbe is not particularly limited if it is a method suitable for the host microbe. Examples thereof include electroporation, spheroplasting, lithium acetate method, calcium phosphate method, lipofection, and transconjugation. (2) Step for Producing Methacrylic Acid (2-1) Production of Methacrylic Acid by Culture With the method for producing methacrylic acid according to the invention, methacrylic acid can be obtained in culture by culturing the aforementioned microbes in an aqueous medium containing renewable raw materials and/or biomass. [Medium] The aqueous medium containing renewable raw materials and/or biomass (that is, medium) which is used for the culture of microbes is a solid medium or a liquid medium containing sufficient nutrients which include at least one kind of carbon source, on which the microbes can proliferate. According to one embodiment, the medium is prepared advantageously to have pH and salt concentration that are optimum for survival and proliferation of cells. The renewable raw materials and biomass are not particularly limited if it can produce methacrylic acid. The renewable raw materials and biomass can be a plant material, an animal material, or a biodegradable waste. Examples of the preferred renewable raw materials and biomass include polypeptone, meat extract, yeast extract, corn steep liquor, or an extract of bean or the like. The extract is used as it is or after partial purification. The renewable raw materials can be polysaccharides, oligosaccharides and monosaccharides such as glucose, galactose, mannose, fructose, xylose, or arabinose, or derivatives thereof. Further, as the renewable raw materials and biomass, lipids, amino acids, organic acids, and alcohols that are generated by derivatization or metabolism of those sugars can be used. Examples of the preferred renewable raw materials include sugars such as glucose, fructose, or xylose; amino acids such as valine, alanine, leucine, lysine, or glutamic acid; acids such as acetic acid, pyruvic acid, lactic acid, acetoacetic acid, acetolactic acid, 2-oxoisovaleric acid, butyric acid, isobutyric acid, propionic acid, malic acid, fumaric acid, citric acid, or succinic acid; and alcohols such as ethanol, n-propanol, isopropanol, n-butanol, or isobutanol. The renewable raw materials can be used either singly or in combination of two or more types. A concentration of the renewable raw materials and/or biomass in the medium is not particularly limited as long as methacrylic acid can be produced. The concentration is, for example, 0.05 to 20 (w/v) %, preferably 0.1 to 15 (w/v) %, and more preferably 0.2 to 10 (w/v) %. The reason for using them at 0.2 (w/v) % or higher is to have enhanced property of the microbes to produce methacrylic acid, and the reason for using them at 10 (w/v) % or lower is that no significant increase in effect is observed even when they are added at higher concentration. An inorganic nitrogen source or an inorganic metal salts may be added to the medium. As the inorganic nitrogen source, ammonium salts of inorganic acid or organic acid such as ammonium chloride, ammonium sulfate, ammonium acetate, or ammonium phosphate are used. A concentration of the nitrogen source in the medium is not particularly limited as long as methacrylic acid can be produced. The concentration is, for example, 0.01 to 10 (w/v) %, preferably 0.05 to 8 (w/v) %, and more preferably 0.1 to 4 (w/v) %. Examples of the inorganic metal salt which can be used include monobasic potassium phosphate, dibasic potassium phosphate, magnesium phosphate, magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate, copper sulfate, and calcium carbonate. A concentration of the inorganic salts in the medium is not particularly limited as long as methacrylic acid can be produced. The concentration is, for example, 0.001 to 1.6 (w/v) %, preferably 0.005 to 1.3 (w/v) %, and more preferably 0.01 to 1 (w/v) %. The reason for using them at 0.01 (w/v) % or higher is to have enhanced property of the microbes to produce methacrylic acid, and the reason for using them at 1 (w/v) % or lower is that no significant increase in effect is observed even when they are added at higher concentration. In addition to them, a trace amount of a metal, a vitamin, or the like can be added to the medium, if necessary. Further, if necessary, various organic substances, inorganic substances, surfactants, that are required for growth of microbes, or anti-foaming agents that are generally used can be added to the medium. [Culture Conditions] Seeding of the microbes on the medium can be performed by a known method of the related art. The culture method is not particularly limited either, and a known method such as shaking culture, aeration and agitation culture, or static culture can be used. Conditions for culturing microbes are not particularly limited as long as the microbes can grow and produce methacrylic acid. Culture can be performed under aerobic conditions or anaerobic conditions. A pH, temperature, and culture time are not particularly limited as long as they are the conditions allowing growth of the microbes and production of methacrylic acid. pH is preferably 3 to 10, more preferably 4 to 9, and even more preferably 5 to 8. The temperature is preferably 10 to 45° C., more preferably 15 to 40° C., and even more preferably 20 to 35° C. The culture time is preferably 10 to 1000 hours, more preferably 15 to 480 hours, and even more preferably 20 to 240 hours. Those culture conditions are selected or optimized for each strain so as to maximize the ratio of the methacrylic acid production amount compared to the use amount of the renewable raw materials and/or biomass. Meanwhile, by suitably controlling the amount of carbon sources and culture conditions, the methacrylic acid production amount can be also controlled. As the conditions preferred for accumulating methacrylic acid at 0.04 ppm or higher, the reaction is allowed to occur for three hours or longer at conditions of pH 5.5 to 7.5, while maintaining directly or indirectly the concentration of the renewable raw materials and/or biomass at 0.1% or higher and adjusting the temperature in the range of 20 to 40° C. Further, within the range that death ratio does not increase as the environment of broth becomes inappropriate for growth of microbes or cultured cells, the concentration of the microbes in broth is preferably maintained at high level in terms of obtaining efficient productivity. For example, by maintaining it at 2 g/l or more in dry weight, good production efficiency is obtained and the accumulated concentration of the product can be increased. (2-2) Production of Methacrylic Acid Based on Reaction of Resting Cells For the method for producing methacrylic acid according to the invention, the following method can be also adopted in addition to the method which involves performing, in an aqueous medium containing renewable raw materials and/or biomass, culture of microbes accompanied with proliferation. The microbes may or may not have a proliferation property, and methacrylic acid can be also produced based on a resting cell reaction which is substantially not accompanied with proliferation, by contacting the microbes cultured in advance with an aqueous medium containing renewable raw materials and/or biomass. [Reaction Solution] The renewable raw materials that are contained in an aqueous medium containing renewable raw materials and/or biomass used for the resting cell reaction (that is, reaction solution) and the concentration can be the same as those for the production of methacrylic acid by culture. To the reaction solution, inorganic metal salt or the like may be added. Examples of the inorganic metal salt which can be used include monobasic potassium phosphate, dibasic potassium phosphate, magnesium phosphate, magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate, copper sulfate, and calcium carbonate. A concentration of the inorganic salts in the reaction solution is not particularly limited as long as methacrylic acid can be produced. The concentration is, for example, 0.0001 to 2 (w/v) %, preferably 0.0003 to 1.3 (w/v) %, and more preferably 0.001 to 1 (w/v) %. In addition to them, a trace amount of a metal, a vitamin, or the like is added to the reaction solution. Further, if necessary, various organic substances, inorganic substances, surfactants, that are required for the reaction or anti-foaming agents that are generally used can be added to the reaction solution. [Reaction Conditions] For the resting cell reaction, the broth of the microbes which have been cultured in advance may be used as it is, or the cells collected by filtration or centrifugal separation are used. The collected microbes can be used at any microbial concentration after re-suspending them in a suitable buffer solution or the like. Examples of the buffer solution which may be used include physiological saline, potassium phosphate buffer solution, tris-hydrochloric acid buffer solution, glycine-sodium hydroxide buffer solution, and borate-sodium hydroxide buffer solution. Further, a processed product of the collected microbes (for example, disrupted product, co-enzymes, or purified enzymes) can be used for the resting cell reaction. Further, it is also possible that the microbes or their processed products are immobilized on a suitable carrier by a known method and the immobilized product is used for the reaction. The conditions for culturing microbes are not particularly limited as long as it allows production of methacrylic acid. A culture can be performed under aerobic conditions or anaerobic conditions. The reaction method is not particularly limited either, and a known method such as shaking reaction, aeration and agitation reaction, or static reaction can be used. A pH, temperature, and reaction time are not particularly limited as long as they are the conditions allowing the production of methacrylic acid. The pH is preferably 3 to 10, more preferably 4 to 9, and even more preferably 5 to 8. The temperature is preferably 10 to 45° C., more preferably 15 to 40° C., and even more preferably 20 to 35° C. The culture time is preferably 10 to 180 hours, more preferably 15 to 150 hours, and even more preferably 20 to 120 hours. Further, for purpose of isolating methacrylic acid produced, it is also possible to add an organic solvent in advance and performing the reaction in a biphasic system. Examples of the organic acid include a linear, branched, or cyclic and saturated or unsaturated aliphatic hydrocarbon, a saturated or unsaturated aromatic hydrocarbon or the like, and they can be used either singly or as a mixture of two or more types. Specific examples include a hydrocarbon solvent (for example, pentane, hexane, cyclohexane, benzene, toluene, and xylene), a halogenated hydrocarbon solvent (for example, methylene chloride and chloroform), an ether solvent (for example, diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, and dimethoxyethane), and an ester solvent (for example, methyl formate, methyl acetate, ethyl acetate, butyl acetate, and methyl propionate). By adding the organic solvent in advance, methacrylic acid produced may migrate to an organic phase to have efficient progress of the reaction. The reaction conditions are suitably selected or optimized for each strain so as to maximize the ratio of the methacrylic acid production amount compared to the use amount of the renewable raw materials and/or biomass. Meanwhile, by suitably controlling the amount of carbon sources and reaction conditions, the methacrylic acid production amount can be also controlled. With regard to the method for producing methacrylic acid according to the invention, the aforementioned production of methacrylic acid based on culture and production of methacrylic acid based on the resting cell reaction can be suitably combined. According to the combination of the two methods, more efficient production of methacrylic acid can be achieved. Further, for the method for producing methacrylic acid according to the invention, a method of directly contacting the microbes with renewable raw materials and/or biomass can be also adopted, in addition to the method of contacting the microbes with an aqueous medium containing renewable raw materials and/or biomass, which is prepared as a medium or solution for the resting cell reaction. As the conditions preferred for accumulating methacrylic acid at 0.04 ppm or higher, the reaction is allowed to occur for three hours or longer at conditions of pH 5.5 to 7.5, while maintaining directly or indirectly the concentration of the renewable raw materials and/or biomass at 0.1% or higher and adjusting the temperature in the range of 20 to 40° C. Further, the concentration of the microbes in reaction solution is preferably maintained at high level in terms of obtaining efficient productivity. For example, by maintaining it at 2 g/l or more in dry weight, good production efficiency is obtained and the accumulated concentration of the product can be increased. (2-3) Recovery of Methacrylic Acid The methacrylic acid produced in a medium or reaction solution and its production amount can be detected and measured by using a common method like high speed liquid chromatography and LC-MS. Methacrylic acid can be isolated and purified from the medium or reaction solution by suitably using, if necessary in combination, a known process like filtration, centrifugal separation, vacuum concentration, ion exchange or adsorptive chromatography, solvent extraction, distillation, and crystallization. Methacrylic acid ester can be produced from the obtained methacrylic acid based on an esterification. Further, according to genetic introduction of an enzyme involved with esterification of methacrylic acid to microbes having the ability to produce a methacrylic acid ester (for example, microbial strains of (i) to (xxiv) described above), it is also possible to produce a methacrylic acid ester. (3) Step for Producing Methacrylic Acid Ester (3-1) Production of Methacrylic Acid Ester by Culture In the invention, production of methacrylic acid ester is performed by producing and accumulating methacrylic acid ester in cultured cells or culture by culturing the microbes having the ability of producing methacrylic acid and the genetic recombinant microbes, obtained by introducing the AAT gene to the derivative strain, in an aqueous medium containing the renewable raw materials and/or biomass, and collecting methacrylic acid ester from the cultured cells, culture, or vapor phase of the culture container. [Medium] The aqueous medium containing renewable raw materials and/or biomass (that is, medium) which is used for culturing the microbes is a solid medium or a liquid medium containing sufficient nutrients which include at least one kind of carbon source, on which the microbes can proliferate. According to one embodiment, the medium is prepared advantageously to have pH and salt concentration that are optimum for survival and proliferation of cells. The renewable raw materials and biomass are not particularly limited if it can produce methacrylic acid ester. The renewable raw materials and biomass can be a plant material, an animal material, or a biodegradable waste. Examples of the preferred renewable raw materials and biomass include polypeptone, meat extract, yeast extract, corn steep liquor, or an extract of bean or the like. The extract is used as it is or after partial purification. The renewable raw materials can be polysaccharides, oligosaccharides and monosaccharides such as glucose, galactose, mannose, fructose, xylose, or arabinose, or derivatives thereof. Further, as the renewable raw materials and biomass, lipids, amino acids, organic acids, and alcohols that are generated by derivatization or metabolism of those sugars can be used. Examples of the preferred renewable raw materials include sugars such as glucose, fructose, or xylose; amino acids such as valine, alanine, leucine, lysine, or glutamic acid; acids such as acetic acid, pyruvic acid, lactic acid, acetoacetic acid, acetolactic acid, 2-oxoisovaleric acid, butyric acid, isobutyric acid, propionic acid, malic acid, fumaric acid, citric acid, or succinic acid; and alcohols such as ethanol, n-propanol, isopropanol, n-butanol, or isobutanol. The renewable raw materials can be used either singly or in combination of two or more types. A concentration of the renewable raw materials and/or biomass in the medium is not particularly limited as long as methacrylic acid ester can be produced. The concentration is, for example, 0.05 to 20 (w/v) %, preferably 0.1 to 15 (w/v) %, and more preferably 0.2 to 10 (w/v) %. The reason for using them at 0.2 (w/v) % or higher is to have enhanced property of the microbes to produce methacrylic acid, and the reason for using them at 10 (w/v) % or lower is that no significant increase in effect is observed even when they are added at higher concentration. To the medium, alcohols or phenols are added depending on desired methacrylic acid ester. As for the alcohols or phenols, those described before are preferably used. The alcohols or phenols can be used either singly or in combination of two or more types. A concentration of the alcohols or phenols in the medium is not particularly limited as long as methacrylic acid ester can be produced. The concentration is, for example, 0.01 to 20 (w/v) %, preferably 0.05 to 10 (w/v) %, and more preferably 0.1 to 5 (w/v) %. Further, the alcohols or phenols can be added in advance to the medium, or continuously or intermittently added two or more divided times while performing the culture. An inorganic nitrogen source or an inorganic metal salts may be added to the medium. As the inorganic nitrogen source, ammonium salts of inorganic acid or organic acid such as ammonium chloride, ammonium sulfate, ammonium acetate, or ammonium phosphate are used. A concentration of the nitrogen source in the medium is not particularly limited as long as methacrylic acid ester can be produced. The concentration is, for example, 0.01 to 10 (w/v) %, preferably 0.05 to 8 (w/v) %, and more preferably 0.1 to 4 (w/v) %. Examples of the inorganic metal salt which can be used include monobasic potassium phosphate, dibasic potassium phosphate, magnesium phosphate, magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate, copper sulfate, and calcium carbonate. A concentration of the inorganic salts in the medium is not particularly limited as long as methacrylic acid ester can be produced. The concentration is, for example, 0.001 to 1.6 (w/v) %, preferably 0.005 to 1.3 (w/v) %, and more preferably 0.01 to 1 (w/v) %. The reason for using them at 0.01 (w/v) % or higher is to have enhanced property of the microbes to produce methacrylic acid, and the reason for using them at 1 (w/v) % or lower is that no significant increase in effect is observed even when they are added at higher concentration. In addition to them, a trace amount of a metal, a vitamin, or the like can be added to the medium, if necessary. Further, if necessary, various organic substances, inorganic substances, surfactants, that are required for growth of microbes, or anti-foaming agents that are generally used can be added to the medium. [Culture Conditions] A seeding of the microbes on the medium can be performed by a known method of the related art. The culture method is not particularly limited either, and a known method such as shaking culture, aeration and agitation culture, or static culture can be used. The conditions for culturing microbes are not particularly limited as long as the microbes can grow and produce methacrylic acid ester. Culture can be performed under aerobic conditions or anaerobic conditions. A pH, temperature, and culture time are not particularly limited as long as they are the conditions allowing growth of the microbes and production of methacrylic acid ester. The pH is preferably 3 to 10, more preferably 4 to 9, and even more preferably 5 to 8. The temperature is preferably 10 to 45° C., more preferably 15 to 40° C., and even more preferably 20 to 35° C. The culture time is preferably 10 to 1000 hours, more preferably 15 to 480 hours, and even more preferably 20 to 240 hours. Those culture conditions are selected or optimized for each strain so as to maximize the ratio of the methacrylic acid ester production amount compared to the use amount of the renewable raw materials and/or biomass. Meanwhile, by suitably controlling the amount of carbon sources and culture conditions, the methacrylic acid ester production amount can be also controlled. As the conditions preferred for accumulating methacrylic acid ester at 0.04 ppm or higher, the reaction is allowed to occur for three hours or longer at conditions of pH 5.5 to 7.5, while maintaining directly or indirectly the concentration of the renewable raw materials and/or biomass at 0.1% or higher and the concentration of the alcohols or phenols at 0.1% or higher and adjusting the temperature in the range of 20 to 40° C. Further, within the range that death ratio does not increase as the environment of broth becomes inappropriate for growth of microbes or cultured cells, the concentration of the microbes in broth is preferably maintained at high level in terms of obtaining efficient productivity. For example, by maintaining it at 2 g/l or more in dry weight, good production efficiency is obtained and the accumulated concentration of the product can be increased. (3-2) Production of Methacrylic Acid Ester Based on Reaction of Resting Cells For the method for producing a methacrylic acid ester according to the invention, the following method can be also adopted in addition to the method which involves performing, in an aqueous medium containing renewable raw materials and/or biomass, culture of microbes accompanied with proliferation. The microbes may or may not have a proliferation property, and methacrylic acid ester can be also produced based on a resting cell reaction which is substantially not accompanied with proliferation, by contacting the microbes cultured in advance with an aqueous medium containing renewable raw materials and/or biomass. [Reaction Solution] The renewable raw materials that are contained in an aqueous medium containing renewable raw materials and/or biomass used for the resting cell reaction (that is, reaction solution) and the concentration can be the same as those for the production of methacrylic acid ester by culture. The alcohols or phenols that are used for the resting cell reaction and the concentration can be the same as those for the production of methacrylic acid ester by culture. To the reaction solution, inorganic metal salt or the like may be added. Examples of the inorganic metal salt which can be used include monobasic potassium phosphate, dibasic potassium phosphate, magnesium phosphate, magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate, copper sulfate, and calcium carbonate. A concentration of the inorganic salts in the reaction solution is not particularly limited as long as methacrylic acid ester can be produced. The concentration is, for example, 0.0001 to 2 (w/v) %, preferably 0.0003 to 1.3 (w/v) %, and more preferably 0.001 to 1 (w/v) %. In addition to them, a trace amount of a metal, a vitamin, or the like is added to the reaction solution. Further, if necessary, various organic substances, inorganic substances, surfactants, that are required for the reaction or anti-foaming agents that are generally used can be added to the reaction solution. [Reaction Conditions] For the resting cell reaction, the broth of the microbes which have been cultured in advance may be used as it is, or the cells collected by filtration or centrifugal separation are used. The collected microbes can be used at any microbial concentration after re-suspending them in a suitable buffer solution or the like. Examples of the buffer solution which may be used include physiological saline, potassium phosphate buffer solution, tris-hydrochloric acid buffer solution, glycine-sodium hydroxide buffer solution, and borate-sodium hydroxide buffer solution. Further, a processed product of the collected microbes (for example, disrupted product, co-enzymes, or purified enzymes) can be used for the resting cell reaction. Further, it is also possible that the microbes or their processed products are immobilized on a suitable carrier by a known method and the immobilized product is used for the reaction. The conditions for the reaction are not particularly limited as long as it allows production of methacrylic acid ester. The reaction can be performed under aerobic conditions or anaerobic conditions. The reaction method is not particularly limited either, and a known method such as shaking reaction, aeration and agitation reaction, or static reaction can be used. A pH, temperature, and reaction time are not particularly limited as long as they are the conditions allowing production of methacrylic acid ester. The pH is preferably 3 to 10, more preferably 4 to 9, and even more preferably 5 to 8. The temperature is preferably 10 to 45° C., more preferably 15 to 40° C., and even more preferably 20 to 35° C. The culture time is preferably 5 to 180 hours, more preferably 10 to 150 hours, and even more preferably 15 to 120 hours. Further, for purpose of isolating methacrylic acid ester produced, it is also possible to add an organic solvent in advance and performing the reaction in a biphasic system. Examples of the organic acid include a linear, branched, or cyclic and saturated or unsaturated aliphatic hydrocarbon, a saturated or unsaturated aromatic hydrocarbon or the like, and they can be used either singly or as a mixture of two or more types. Specific examples include a hydrocarbon solvent (for example, pentane, hexane, cyclohexane, benzene, toluene, and xylene), a halogenated hydrocarbon solvent (for example, methylene chloride and chloroform), an ether solvent (for example, diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, and dimethoxyethane), and an ester solvent (for example, methyl formate, methyl acetate, ethyl acetate, butyl acetate, and methyl propionate). By adding the organic solvent in advance, methacrylic acid ester produced may migrate to an organic phase to have efficient progress of the reaction. The reaction conditions are suitably selected or optimized for each strain so as to maximize the ratio of the methacrylic acid ester production amount compared to the use amount of the renewable raw materials and/or biomass. Meanwhile, by suitably controlling the amount of carbon sources and reaction conditions, the methacrylic acid ester production amount can be also controlled. As the conditions preferred for accumulating methacrylic acid ester at 0.04 ppm or higher, the reaction is allowed to occur for three hours or longer at conditions of pH 5.5 to 7.5, while maintaining directly or indirectly the concentration of the renewable raw materials and/or biomass at 0.1% or higher and the concentration of the alcohols or phenols at 0.1% or higher and adjusting the temperature in the range of 20 to 40° C. Further, the concentration of the microbes in reaction liquid is preferably maintained at high level in terms of obtaining efficient productivity. For example, by maintaining it at 2 g/l or more in dry weight, good production efficiency is obtained and the accumulated concentration of the product can be increased. For performing the method for producing a methacrylic acid ester according to the invention, the aforementioned production of methacrylic acid ester based on culture and production of methacrylic acid ester based on the resting cell reaction can be suitably combined. According to the combination of the two methods, more efficient production of methacrylic acid ester can be achieved. Further, for the method for producing a methacrylic acid ester according to the invention, a method of directly contacting the microbes with renewable raw materials and/or biomass can be also adopted, in addition to the method of contacting the microbes with an aqueous medium containing renewable raw materials and/or biomass, which is prepared as a medium or solution for the resting cell reaction. (3-3) Recovery of Methacrylic Acid Ester The methacrylic acid ester produced in a medium or reaction solution and its production amount can be detected and measured by using a common method like high speed liquid chromatography and LC-MS. Further, the methacrylic acid ester vaporized in the reaction container or the vapor phase of the reaction container (that is, head space part) and the production amount can be defected and measured by using a common method like gas chromatography. Methacrylic acid ester can be isolated and purified from the medium or reaction solution by suitably using, if necessary in combination, a known process like filtration, centrifugal separation, vacuum concentration, ion exchange or adsorptive chromatography, solvent extraction, distillation, and crystallization. 2. Enzymes Involved with Synthesis of Methacrylic Acid and their Genes Hereinbelow, the enzymes that are involved with synthesis of methacrylic acid and their genes as one aspect of the invention will be described in detail. The inventors of the invention found that, as a result of conducting extensive searches for microbes having the ability to produce methacrylic acid derivatives, methacrylic acid can be produced by using microbes. Based on history of the searches and techniques of the related art, the synthetic route is presumably the decomposition pathway of valine. In view of the relationship with a genetic disease, studies on the decomposition pathway of valine are made for a human or a rat (Methods in Enzymology, 324: 241-258 (2000)). However, little is known about the enzymes of the decomposition pathway of valine in microbes, and the details have remained unclear. With regard to the mold Accordingly, for the purpose of using effectively the enzyme involved with synthesis of methacrylic acid in microbes, the inventors made investigations about the enzyme gene of other microbes. As a result, the following useful enzymes were found. Among the microbes having the ability to produce methacrylic acid as described in the invention, the genus With regard to the microbes of the genus With regard to the presence of a homolog gene of bacteria which exhibits high identity to ACAD8 which becomes human ACD, there have been descriptions in the literature (J. Mol. Evol. 69: 176-193 (2009)) (however, the activity has not been confirmed experimentally). Further, for the two bacteria of Against the genome sequence information of the two bacteria, homology search was performed for the amino acid sequence of human ACAD8. Genes of the total six kinds of ORF found to have the homology were amplified and obtained by PCR and ligated to the expression vector for [ACD] As a result, a very high activity was obtained from the recombinant introduced with the gene named PA_acd1 from In other words, as one of ACD useful for synthesis of methacrylic acid, there are (A) the enzyme consisting of the amino acid sequence (SEQ ID NO. 50 or 52) encoded by PA_acd1 or RE_acd1 and (B) the enzyme consisting of an amino acid which exhibits the amino acid-level identity of 45% or more, more preferably 60% or more, and even more preferably 80% or more to the amino acid sequence (SEQ ID NO. 50 or 52) encoded by PA_acd1 or RE_acd1 and exhibiting the ACD activity. Alternatively, it is (C) the enzyme having the ACD activity and consisting of an amino acid sequence with deletion, substitution, or addition of one or several amino acids in the amino acid sequence (SEQ ID NO. 50 or 52) encoded by PA_acd1 or RE_acd1. Further, PA_acd1 and RE_acd1 exhibited 69% identity for the 70 amino acids from the C terminus of the amino acid sequence encoded by them (SEQ ID NOS. 50 and 52). Meanwhile, with regard to PA_acd2, RE_acd2 not observed with any activity or acdH ( In the invention, another embodiment of the ACD which is useful for the synthesis of methacrylic acid is (D) the enzyme having the ACD activity and consisting of an amino acid sequence which exhibits the identity of 60% or more, more preferably 65% or more, and even more preferably 80% or more to the amino acid sequence of the 70 amino acid residues from C terminus of the amino acid sequence encoded by PA_acd1 or RE_acd1 (SEQ ID NO. 50 or 52). One of the ACD gene particularly useful for the method for producing methacrylic acid of the invention is a gene selected from the group consisting of the followings. (a) a gene encoding the protein consisting of an amino acid sequence represented by SEQ ID NO. 50 or 52, (b) a gene consisting of a nucleotide sequence represented by SEQ ID NO. 51 or 52, (c) a gene encoding the protein consisting of an amino acid sequence, which exhibits the identity of 45% or more to the protein consisting of an amino acid sequence represented by SEQ ID NO. 50 or 52, and having the ACD activity, and (d) a gene encoding the protein consisting of an amino acid sequence with deletion, substitution, or addition of one or several amino acids in the amino acid sequence represented by SEQ ID NO. 50 or 52 and having the ACD activity. In the invention, ACD is not particularly limited if it is useful as an enzyme for synthesizing methacrylic acid and also derived from microbes having the ability to produce methacrylic acid as described in the invention. More preferably, it is those derived from Hereinabove, the ACD as one of the enzymes involved with synthesis of methacrylic acid and obtainment of the gene thereof will be described. [BCKAD] Next, descriptions are made with regard to BCKAD which is involved with synthesis of methacrylic acid. BCKAD is an enzyme capable of producing isobutyryl-CoA from 2-oxoisovaleric acid. From the microbes of the invention having the ability to produce methacrylic acid, BCKAD and the gene thereof can be obtained. BCKAD derived from As a method for obtainment, a vector for expressing BCKAD can be constructed, for example, by designing a primer for amplifying the entire BCKAD operon from the genome sequence of With regard to the BCKAD of the invention, there is no particular limitation on the gene thereof, if it is useful as one enzyme useful for synthesis of methacrylic acid and is derived from microbes having the ability to produce methacrylic acid as described in the invention. However, examples thereof include a gene selected from the group consisting of the following (e) to (h), (i) to (l), or (m) to (p). (e) a gene encoding the four polypeptides having an amino acid sequence represented by SEQ ID NOS. 54, 56, 58, and 60. (f) a gene consisting of a nucleotide sequence represented by SEQ ID NOS. 55, 57, 59, and 61. (g) a gene capable of hybridizing under stringent conditions to a complementary sequence of the gene encoding the four polypeptides having an amino acid sequence represented by SEQ ID NOS. 54, 56, 58, and 60 and encoding the protein having the BCKAD activity.
In the invention, the gene encoding BCKAD is not limited to the aforementioned sequences, and a gene having a nucleotide sequence which has the identity of about 50% or more, preferably about 60% or more, more preferably about 70% or more, even more preferably about 80% or more, particularly preferably about 90% or more, particularly even more preferably about 95% or more, and most preferably about 98% or more to the nucleotide sequence described with the aforementioned SEQ ID NOs is also included in the gene encoding BCKAD as long as a protein having the BCKAD activity is encoded by it. In the invention, examples of the BCKAD include those having an amino acid sequence represented by SEQ ID NOS. 54, 56, 58, and 60, an amino acid sequence represented by SEQ ID NOS. 62, 64, 66, and 68, or an amino acid sequence represented by SEQ ID NOS. 70, 72, and 74. In the invention, the BCKAD is not limited to those having the aforementioned sequences, and a protein having the BCKAD activity and containing an amino acid sequence which has the identity of about 50% or more, preferably about 60% or more, more preferably about 70% or more, even more preferably about 80% or more, particularly preferably about 90% or more, particularly even more preferably about 95% or more, and most preferably about 98% or more to the amino acid sequence described with the aforementioned SEQ ID NOs is also included in the gene encoding BCKAD. The identity value described above is obtained by running a program for analyzing homology with use of GENETYX (manufactured by GENETYX Corporation), which is a software for sequence analysis. Parameters at that time are the same as the default setting (initial setting). In the BCKAD of the invention, a protein having the BCKAD activity and containing an amino acid sequence with deletion, substitution, and/or addition of one or several amino acids in the amino acid sequence represented by SEQ ID NOS. 54, 56, 58, and 60, the amino acid sequence represented by SEQ ID NOS. 62, 64, 66, and 68, or the amino acid sequence represented by the amino acid sequence represented by SEQ ID NOS. 70, 72, and 74 is also included. More specific examples thereof include a protein containing the following amino acid sequence and having the BCKAD activity. (i) An amino acid sequence with deletion of 1 to 20 (for example, 1 to 10, preferably 1 to 5, and even more preferably 1 to 2) amino acids in the amino acid sequence represented by SEQ ID NOS. 54, 56, 58, and 60, the amino acid sequence represented by SEQ ID NOS. 62, 64, 66, and 68, or the amino acid sequence represented by SEQ ID NOS. 70, 72, and 74.
When one or more amino acids of the amino acid sequence are substituted, it is preferable to have conservative substitution between similar amino acid residues. For example, amino acids are classified into hydrophobic amino acids (A, I, L, M, F, P, W, Y, V), hydrophilic amino acids (R, D, N, C, E, Q, G, H, K, S, T), amino acids having aliphatic side chains (G, A, V, L, I, P), amino acids having side chains that contain a hydroxy group (S, T, Y), amino acids having side chains that contain a sulfur atom (C, M), amino acids having side chains that contain carboxylic acid and amide (D, N, E, Q), amino acids having side chains that contain a base (R, K, H), amino acids having side chains that contain aromatics (H, F, Y, W), based on the characteristics of the side chains. The amino acids classified into each group are known to have a high possibility of maintaining the activity of the polypeptide when substitution is made between them, and it is preferable to have mutual substitution between such amino acids. Examples include substitution between glycine and proline, glycine and alanine or valine, leucine and isoleucine, glutaminic acid and glutamine, asparaginic acid and asparagine, cysteine and threonine, threonine and serine or alanine, and lysine and arginine. Further, in response to the aforementioned deletion, substitution, addition, and/or insertion of the amino acid sequence, a nucleotide sequence having a mutation like deletion, substitution, addition, and/or insertion occurred in several nucleotides of the nucleotide sequence represented by SEQ ID NOS. 55, 57, 59, and 61, the nucleotide sequence represented by SEQ ID NOS. 63, 65, 67, and 69, or the nucleotide sequence represented by SEQ ID NOS. 71, 73, and 75 is also included in the gene which encodes BCKAD, as long as it encodes the protein having the BCKAD activity described in the invention. Meanwhile, the number of the nucleotides that are subjected to deletion, substitution, addition, and/or insertion is 30 or less, preferably 15 or less, and particularly preferably 6 or less. Further, a DNA capable of hybridizing, under a stringent condition, to a DNA consisting of a nucleotide sequence complementary to the gene consisting of the nucleotide sequence represented by SEQ ID NOS. 55, 57, 59, and 61, the gene consisting of the nucleotide sequence represented by SEQ ID NOS. 63, 65, 67, and 69, or the gene consisting of the nucleotide sequence represented by SEQ ID NOS. 71, 73, and 75 is also included in the gene which encodes BCKAD, as long as it encodes the protein having the BCKAD activity. Hereinabove, descriptions are made regarding enzyme proteins and obtainment of their genes for ACD and BCKAD, as an example of an enzyme that is involved with synthesis of methacrylic acid. In the invention, other enzymes and genes thereof that are involved either directly or indirectly with synthesis of methacrylic acid can be also obtained in a similar manner. For example, enzymes involved with synthesis of methacrylic acid can be purified by using a common method with a use of the enzyme activity as an indicator. Further, the genetic information can be obtained by a genetic engineering method based on the proteins. Alternatively, the entire genome sequence is determined for the microbes having the ability to synthesize methacrylic acid as described in the invention. Selection can be made by searching a gene sequence having high homology by using homology search based on known information about the sequence of a gene which encodes the target enzyme, isolating or synthesizing the entire gene with a known method and introducing it to a general host vector system, expressing the candidate protein using microbes transformed with the vector system, and evaluating the activity of the target enzyme. Meanwhile, due to the availability of a next generation sequencer, a skilled person in the pertinent art can easily analyze the entire genome sequence of microbes. Further, the microbes having the ability to synthesize methacrylic acid as described in the invention include an acceptor of electrons, which are released in accordance with the dehydrogenation of ACD, proteins relating to the transfer system, and the genes thereof, and they are also included in the invention. In addition, the enzymes involved with synthesis of methacrylic acid, which are obtained from microbes having the ability to synthesize methacrylic acid can produce, either singly or collectively with others, methacrylic acid derivatives and intermediates thereof. For example, with BCKAD, isobutyryl-CoA can be produced from 2-oxoisovaleric acid, and with ACD, methacrylyl-CoA can be produced from isobutyryl-CoA. Thus, by combining the reactions of both BCKAD and ACD, it becomes possible to produce methacrylyl-CoA from 2-oxoisovaleric acid. Alternatively, by adding an enzyme which has an activity of hydrolyzing AAT or methacrylyl-CoA, each of methacrylic acid ester and methacrylic acid can be produced. The enzymes involved with synthesis of methacrylic acid can be obtained by isolating the gene as described above, producing a recombinant (transformant) by using a general host vector, and culturing the recombinant. Examples of the host include By contacting the enzymes obtained accordingly with a compound as a raw material under conditions allowing the enzymes to work, each target product can be obtained. Hereinbelow, the invention is explained in greater detail on the basis of the examples, but the invention is not limited to them. Using the soils and insects which have been collected from different areas in Japan as a source of microbes, search for methacrylic acid-producing microbes was conducted based on enrichment culture. Because the metabolitic intermediates of valine include methacrylyl-CoA, which is a derivative of methacrylic acid, a medium containing L-valine was used and the screening was performed using the assimilation property of valine as an indicator. [Isolation from Soils] An appropriate amount of soils was added to 5 mL of sterilized water and stirred. After allowing it to stand, a suitable amount of the supernatant was added to 10 ml liquid medium. The composition of the medium is shown below. K2HPO41.0 μl MgSO4.7H2O 0.2 g/l FeSO4.7H2O 0.01 g/l CaCl20.01 g/l L-Valine 5.0 g/l pH 7.0 Shake culture was performed at 30° C. for 3 to 7 days. The grown strain was transferred to the same medium and acclimated culture was performed for several times. After that, they were inoculated on an agar medium, that is, the same medium added with 1.5% agar, and cultured at 30° C. for 48 hours to form a colony. Using a platinum loop, the colony was scraped and inoculated on an agar medium (LB medium, 1.5% agar) and cultured at 30° C. for 48 hours to obtain the isolated strains (B25-2 strain, D22-1 strain, D43-1 strain, D25 strain, D26 strain, D29 strain, D41-2 strain, R1 strain, B13 strain). The composition of the LB medium is as follows: 1% bactotrypton, 0.5% bactoyeast extract, and 0.5% NaCl. [Isolation from Insect] The collected K2HPO41.0 g/l MgSO4.7H2O 0.2 g/l FeSO4.7H2O 0.01 g/l CaCl20.01 g/l L-Valine 5.0 g/l pH 7.0 Shake culture was performed at 30° C. for 3 to 7 days. The cultured strain was transferred to the same medium and acclimated culture was performed for several times. After that, they were inoculated on an agar medium, that is, the same medium added with 1.5% agar, and cultured at 30° C. for 48 hours to form a colony. Using a platinum loop, the colony was scraped and inoculated on an agar medium (LB medium, 1.5% agar) and cultured at 30° C. for 48 hours to obtain the isolated strains (G1 strain, G2 strain). The mycological properties of the isolated strains are shown in the following table. In the table, “+” indicates positive, “−” indicates negative and “+w” indicates a weak response. (1) Mycological Properties of According to a common method, the partial nucleotide sequence of 16S rDNA of the B25-2 strain (SEQ ID NO. 1) was determined. The partial nucleotide sequence of 16S rDNA of the B25-2 strain exhibited high homology to the nucleotide sequence of 16S rDNA of As a result of a brief molecular phylogenetic analysis based on the partial nucleotide sequence of 16S rDNA, B25-2 strain is included in a cluster formed of the species of B25-2 strain does not reduce a nitrate salt, exhibits an arginine hydrolase activity, does not hydrolyze gelatin, but assimilates glucose, D-mannose, potassium gluconate, or the like. Further, it does not assimilate L-arabinose and D-mannitol, produces a fluorescent pigment in Kings'B agar medium, shows motility, shows a positive response for both the catalase reaction and oxidase reaction, and does not hydrolyze starch. Those properties are believed not to contradict with the properties of As such, B25-2 strain was identified as (2) Mycological Properties of According to a common method, the partial nucleotide sequence of 16S rDNA of the D22-1 strain (SEQ ID NO. 2) was determined. The partial nucleotide sequence of 16S rDNA of the D22-1 strain exhibited high homology to the nucleotide sequence of 16S rDNA of As a result of a brief molecular phylogenetic analysis based on the partial nucleotide sequence of 16S rDNA, D22-1 strain is included in a cluster formed of the species of D22-1 strain does not reduce a nitrate salt, exhibits an arginine hydrolase activity but no urease activity, does not hydrolyze gelatin but assimilates glucose, D-mannose and N-acetyl-D-glucosamine, or the like. Further, it does not assimilate L-arabinose and D-mannitol, does not produce a fluorescent pigment in Kings'B agar medium, shows motility, and shows a positive response to both the catalase reaction and oxidase reaction. Those properties are believed to be in match with the properties of As such, D22-1 strain was identified as (3) Mycological Properties of According to a common method, the partial nucleotide sequence of 16S rDNA of the D43-1 strain (SEQ ID NO. 3) was determined. The partial nucleotide sequence of 16S rDNA of the D43-1 strain exhibited high homology to the nucleotide sequence of 16S rDNA of As a result of a brief molecular phylogenetic analysis based on the partial nucleotide sequence of 16S rDNA, D43-1 strain is included in a cluster formed of the species of D43-1 strain reduces a nitrate salt, exhibits an arginine hydrolase activity but no urease activity, does not hydrolyze gelatin but assimilates glucose, L-arabinose and D-mannose, or the like. Further, it does not assimilate D-mannitol and N-acetyl-D-glucosamine, produces a fluorescent pigment in Kings'B agar medium, shows motility, and shows a positive response to both the catalase reaction and oxidase reaction. Those properties are almost in match with the properties of As such, D43-1 strain was identified as (4) Mycological Properties of According to a common method, the partial nucleotide sequence of 16S rDNA of the D25 strain (SEQ ID NO. 4) was determined. The partial nucleotide sequence of 16S rDNA of the D25 strain exhibited high homology to the nucleotide sequence of 16S rDNA of As a result of a brief molecular phylogenetic analysis based on the partial nucleotide sequence of 16S rDNA, D25 strain is included in a cluster formed of the species of D25 strain reduces a nitrate salt, exhibits an arginine hydrolase activity but no urease activity, does not hydrolyze gelatin but assimilates glucose, L-arabinose and D-mannitol, or the like. Further, it does not assimilate D-mannose or maltose, does not produce a fluorescent pigment in Kings'B agar medium, shows motility, and shows a positive response to both the catalase reaction and oxidase reaction. Those properties are believed to be in match with the properties of As such, D25 strain was identified as (5) Mycological Properties of According to a common method, the partial nucleotide sequence of 16S rDNA of the D26 strain (SEQ ID NO. 5) was determined. The partial nucleotide sequence of 16S rDNA of the D26 strain exhibited high homology to the nucleotide sequence of 16S rDNA of As a result of a brief molecular phylogenetic analysis based on the partial nucleotide sequence of 16S rDNA, D26 strain is included in a cluster formed of the species of D26 strain reduces a nitrate salt, does not exhibit an arginine hydrolase activity and urease activity, does not hydrolyze gelatin but assimilates glucose, L-arabinose and D-mannose, or the like. Further, it does not assimilate maltose and adipic acid, produces a fluorescent pigment in Kings'B agar medium, shows motility, shows a positive response to both the catalase reaction and oxidase reaction, and does not hydrolyze starch. Although those properties have a similarity to those of As such, D26 strain was identified as (6) Mycological Properties of According to a common method, the partial nucleotide sequence of 16S rDNA of the D29 strain (SEQ ID NO. 6) was determined. The partial nucleotide sequence of 16S rDNA of the D29 strain exhibited high homology to the nucleotide sequence of 16S rDNA of As a result of a brief molecular phylogenetic analysis based on the partial nucleotide sequence of 16S rDNA, D29 strain forms a cluster with D29 strain reduces a nitrate salt, exhibits an arginine hydrolase activity but no urease activity, does not hydrolyze gelatin but assimilates glucose, L-arabinose and D-mannose, or the like. Further, it does not assimilate N-acetyl-D-glucosamine, maltose and adipic acid, does not produce a fluorescent pigment in Kings'B agar medium, shows motility, and shows a positive response to both the catalase reaction and oxidase reaction. Although those properties have a similarity to those of As such, D29 strain was identified as (7) Mycological Properties of According to a common method, the partial nucleotide sequence of 16S rDNA of the D41-2 strain (SEQ ID NO. 7) was determined. The partial nucleotide sequence of 16S rDNA of the D41-2 strain exhibited high homology to the nucleotide sequence of 16S rDNA of As a result of a brief molecular phylogenetic analysis based on the partial nucleotide sequence of 16S rDNA, D41-2 is included in a cluster formed of the species D41-2 strain reduces a nitrate salt, exhibits an arginine hydrolase activity, does not hydrolyze gelatin but assimilates glucose, L-arabinose and D-mannose, or the like. Further, it does not assimilate maltose and adipic acid, produces a fluorescent pigment in Kings'B agar medium, shows motility, and shows a positive response to both the catalase reaction and oxidase reaction. Although those properties have a similarity to those of As such, D41-2 strain was identified as (8) Mycological Properties of According to a common method, the partial nucleotide sequence of 16S rDNA of the G1 strain (SEQ ID NO. 9) was determined The partial nucleotide sequence of 16S rDNA of the G1 strain exhibited high homology to the nucleotide sequence of 16S rDNA of As a result of a brief molecular phylogenetic analysis based on the partial nucleotide sequence of 16S rDNA, G1 strain is included in a cluster formed of the species of G1 strain ferments glycerol, ribose, and glucose, does not ferment D-xylose, L-xylose, and galactose, does not exhibit the β-galactosidase activity or urease activity, uses citric acid, does not produce indole, produces acetoin, does not reduce a nitrate salt, does not grow at 45° C., grows under anaerobic conditions, and hydrolyzes starch. Although those properties are almost in match with those of As such, G1 strain was identified as (9) Mycological Properties of According to a common method, the partial nucleotide sequence of 16S rDNA of the G2 strain (SEQ ID NO. 10) was determined. The partial nucleotide sequence of 16S rDNA of the G2 strain exhibited high homology to the nucleotide sequence of 16S rDNA of As a result of a brief molecular phylogenetic analysis based on the partial nucleotide sequence of 16S rDNA, G2 strain is included in a cluster formed of the species of G2 strain ferments glycerol, ribose and glucose, does not ferment D-xylose, L-xylose, and galactose, does not exhibit the β-galactosidase activity or urease activity, uses citric acid, does not produce indole, produces acetoin, does not reduce a nitrate salt, does not grow at 45° C., grows under anaerobic conditions, and hydrolyzes starch. Although those properties are almost in match with those of As such, G2 strain was identified as (10) Mycological Properties of According to a common method, the partial nucleotide sequence of 16S rDNA of the R1 strain (SEQ ID NO. 11) was determined. The partial nucleotide sequence of 16S rDNA of the R1 strain exhibited high homology to the nucleotide sequence of 16S rDNA of As a result of a brief molecular phylogenetic analysis based on the partial nucleotide sequence of 16S rDNA, R1 strain is included in a cluster formed of the species of R1 strain oxidizes glycerol, ribose and D-xylose, does not oxidize D-arabinose and L-xylose, does not exhibit the arginine hydrolase activity, hydrolyzes gelatin, reduces a nitrate salt, forms a spore, does not grow at 45° C., and does not hydrolyze starch. Although those properties are similar to those of As such, R1 strain was identified as (11) Mycological Properties of According to a common method, the partial nucleotide sequence of 16S rDNA of the B13 strain (SEQ ID NO. 16) was determined. The partial nucleotide sequence of 16S rDNA of the B13 strain exhibited high homology to the nucleotide sequence of 16S rDNA of B13 strain does not reduce a nitrate salt, does not ferment glucose, exhibits the urease and β-galactosidase activity, hydrolyzes exculin and gelatin, assimilates glucose, D-mannose and maltose, does not assimilate L-arabinose and D-mannitol, does not exhibit motility, exhibits the catalase activity, and does not produce indole. Although those properties are believed to be in match with the properties of As such, B13 strain was identified as Using the isolated strains obtained from Example 1, production of methacrylic acid in a synthetic medium was performed. D22-1 strain, D41-2 strain or D43-1 strain was grown on an agar medium (LB medium, 1.5% agar) and one platinum loop of the cells was inoculated on 10 ml liquid medium. The composition of the medium is shown below. Under aerobic conditions at 30° C. with a rotary shaker (230 rpm), culture was performed for 19 to 22 hours (pre-culture). K2HPO41.0 g/l MgSO4.7H2O 0.2 g/l FeSO4.7H2O 0.01 g/l CaCl20.01 g/l L-Valine 5.0 g/l pH 7.0 2 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask). The composition of the medium is the same as that of the pre-culture medium. Under aerobic conditions at 30° C. with a rotary shaker (230 rpm), culture was performed for 44 to 72 hours (main culture). After the main culture, the main culture was subjected to centrifugal separation (12000 rpm, 10 min) and the supernatant fraction was fractionated. Compounds contained the culture supernatant were analyzed by HPLC. Conditions for HPLC analysis are as follows. Apparatus: e2695 (manufactured by Waters) Column: Ion exclusion type polymer column T-132-E for analysis of organic acids (manufactured by WAKO) Eluent: 0.1% (v/v) phosphoric acid solution Flow rate: 0.5 ml/min Column temperature: 40° C. Sample injection amount: 10 μl Time for analysis: 40 min Detector: UV The sample for analysis was suitably diluted with the eluent, filtered with a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC), and used. As a result of the analysis, a peak was observed at the same elution time (31.15 min) as methacrylic acid. In “Table 12”, the concentration of methacrylic acid which is in the supernatant of each culture at the time of terminating the main culture is shown. GC/MS analysis was performed for the above peak. Conditions for the GC/MS analysis are as follows. Apparatus: 6890/5875A (manufactured by Agilent Technologies) Column: DB-FFAP column (manufactured by J&W) Carrier: He Oven temperature: after 50° C. (1 min), temperature was raised to 150° C. at 5° C./min, and again raised to 250° C. at 20° C./min. Inlet temperature: 200° C. Column flow rate: 1 ml/min (constant flow mode) Split ratio: 1/50 Sample injection amount: 1 μl Detector: MSD (EI) The obtained total ion chromatograph is shown in Using the isolated strains obtained from Example 1, production of methacrylic acid in a natural medium was performed. G2 strain was grown on an agar medium (LB medium, 1.5% agar) and one platinum loop of the cells was inoculated on 10 ml liquid medium. The composition of the medium is shown below. Under aerobic conditions at 37° C. with a rotary shaker (230 rpm), culture was performed for 24 hours (pre-culture). Tryptone (manufactured by Becton, Dickinson and Company) 10 g/l Yeast extract (manufactured by Becton, Dickinson and Company) 5 g/l NaCl 10 g/l pH 7.0 1 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask). The composition of the medium is the same as that of the pre-culture medium. Under aerobic conditions at 37° C. with a rotary shaker (230 rpm), culture was performed for 24 hours (main culture). After the main culture, the main culture was subjected to centrifugal separation (12000 rpm, 10 min) and the supernatant fraction was fractionated. Compounds contained the culture supernatant were analyzed by the method described in Example 2. As a result, a peak was observed at the same elution time (31.15 min) as methacrylic acid. The concentration of methacrylic acid in the culture was 1.0 ppm. Using the isolated strains obtained from Example 1, production of methacrylic acid was performed based on resting cell reaction. B25-2 strain, D22-1 strain, D43-1 strain, D25 strain, D26 strain, D29 strain, D41-2 strain, G1 strain, G2 strain, R1 strain, and B13 strain were grown on an agar medium (LB medium, 1.5% agar) and one platinum loop of the cells was inoculated on 10 ml liquid medium. The composition of the medium is shown below. Under aerobic conditions at 30° C. with a rotary shaker (230 rpm), culture was performed for 19 to 22 hours (pre-culture). K2HPO41.0 g/l MgSO4.7H2O 0.2 g/l FeSO4.7H2O 0.01 g/l CaCl20.01 g/l L-Valine 5.0 g/l pH 7.0 2 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask). The composition of the medium is the same as that of the pre-culture medium. Under aerobic conditions at 30° C. with a rotary shaker (230 rpm), culture was performed for 69 to 76 hours (main culture). After the main culture, 40 mL of the main broth was transferred to a conical tube with volume of 50 mL and separated by centrifuge (12000 rpm, 10 min) to obtain the cells. To the cells, 10 mL solution for resting cell reaction was added to perform the resting cell reaction. The composition of the solution for resting cell reaction includes 5.0 g/l L-valine, 50 mM phosphate buffer, and pH 7.0. The reaction was performed for 24 hours under aerobic conditions at 30° C. with a rotary shaker (230 rpm). According to the method shown in Example 2, the compounds contained the solution for resting cell reaction were analyzed. As a result, a peak was observed at the same elution time (31.15 min) as methacrylic acid. In “Table 13”, the concentration of methacrylic acid which is in each reaction solution at the time of terminating the resting cell reaction is shown. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml Glucose 2.0 g/l 1 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask). Under aerobic conditions at 30° C. with a rotary shaker (230 rpm), culture was performed for 2 days (main culture). The composition of the medium for the main culture is described below. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml L-Valine 2.0 g/l After the main culture, the main broth was separated by centrifuge (7500 rpm, 15 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to two kinds of analysis conditions. Conditions for HPLC analysis are as follows. Analysis condition A Apparatus: e2695 (manufactured by Waters) Column: Ion exclusion type polymer column T-132-E for analysis of organic acids (manufactured by WAKO) Eluent: 0.1% (v/v) phosphoric acid solution Flow rate: 0.5 ml/min Column temperature: 40° C. Sample injection amount: 10 μl Time for analysis: 40 min Detector: UV Analysis Condition B Apparatus: JASCO UV-970, CO-960, PU-980, DG-1580-54 (manufactured by JASCO, Japan) Column: Inertsil RODS-3V (manufactured by GL Sciences) Eluent: 20% (v/v) methanol, 0.2% (v/v) phosphoric acid solution Flow rate: 1.0 ml/min Column temperature: 40° C. Sample injection amount: 5 μl Time for analysis: 15 min Detector: UV As a result of the analysis, a peak was observed at the same elution time as methacrylic acid for both the analysis condition A and the analysis condition B. The concentration of methacrylic acid in the supernatant of the culture was 0.2 ppm at the time of terminating the main culture. Polypeptone (manufactured by Becton, Dickinson and Company) 10 g Yeast extract (manufactured by Becton, Dickinson and Company) 2 g MgSO4.7H2O 1 g Distilled water 1 l Ager 15 g pH 7.0 Cells grown by plate culture were inoculated in 10 ml liquid medium (one platinum loop) and cultured under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 3 to 4 days (pre-culture). The composition of the medium for the pre-culture is described below. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml Glucose 2.0 g/l 1 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask). Under aerobic conditions at 30° C. with a rotary shaker (230 rpm), culture was performed for 2 days (main culture). The composition of the medium for the main culture is described below. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml L-Valine 2.0 g/l Glucose 2.0 g/l After the main culture, the main broth was separated by centrifuge (7500 rpm, 15 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to the analysis condition A described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid. In “Table 14”, the concentration of methacrylic acid which is in each culture supernatant at the time of terminating the main culture is shown. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml Glucose 2.0 g/l 1 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask). Under aerobic conditions at 30° C. with a rotary shaker (230 rpm), culture was performed for 3 to 6 days (main culture). The composition of the medium for the main culture is described below. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml L-Valine 2.0 g/l Glucose 2.0 g/l After the main culture, the main broth was separated by centrifuge (7500 rpm, 15 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to the analysis condition B described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid. In “Table 15”, the concentration of methacrylic acid which is in each culture supernatant at the time of terminating the main culture is shown. 1 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask). Under aerobic conditions at 30° C. with a rotary shaker (230 rpm), culture was performed for 8 days (main culture). Composition of the medium for the main culture is described below. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml L-Valine 2.0 g/l Glucose 2.0 g/l After the main culture, the main broth was separated by centrifuge (7500 rpm, 15 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to the two kinds of analysis condition described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid for both the analysis condition A and the analysis condition B. Concentration of methacrylic acid in the culture supernatant at the time of terminating the main reaction was 2.0 ppm and 2.4 ppm for the analysis condition A and the analysis condition B, respectively. Nutrient medium 8 g/l L-Valine 2.0 g/l After the main culture, the main broth was separated by centrifuge (7500 rpm, 15 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to the analysis condition B described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid. Concentration of methacrylic acid in the culture supernatant at the time of terminating the main reaction was 3.1 ppm. The pre-culture which has been remained under cryopreservation was thawed at room temperature and 0.5 mL was inoculated to 100 ml liquid medium (100 ml medium/500 ml volume conical flask). It was then cultured under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 2 days (main culture). Composition of the medium for the main culture is described below. Nutrient medium 8 g/l L-Valine 2.0 g/l After the main culture, the main broth was separated by centrifuge (7500 rpm, 15 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to the analysis condition B described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid and the concentration of methacrylic acid in the culture supernatant at the time of terminating the main culture was 37.0 ppm. Yeast extract (manufactured by Becton, Dickinson and Company) 20 g/l Polypeptone (manufactured by Becton, Dickinson and Company) 20 g/l Glucose 20 g/l 1 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask) and cultured under aerobic conditions at 24° C. with a rotary shaker (230 rpm) for 2 days (main culture). Composition of the medium for the main culture is described below. Glucose 2.0 g/l L-Valine 2.0 g/l (NH4)2SO46.0 g/l KCl 2.4 g/l NaCl 0.12 g/l H3PO43.0 g/l MgSO4.7H2O 2.4 g/l FeSO4.7H2O 0.01 g/l ZnSO4.7H2O 0.12 g/l MnSO40.4-6H2O 0.024 g/l CuSO4.5H2O 0.006 g/l CaCl20.12 g/l Vitamin Mix 30 ml Composition of Vitamin Mix is shown below. Biotin 0.2 g/l Calcium pantothenate 2 g/l Folic acid 0.002 g/l Thiamine hydrochloride 0.4 g/l Rivoflavin 0.2 g/l Nicotinic acid 0.4 g/l Pyridoxine hydrochloride 0.4 g/l Inositol 1 g/l p-Aminobenzoic acid 0.2 g/l After the main culture, the main broth was separated by centrifuge (7500 rpm, 15 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to the analysis condition A described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid and the concentration of methacrylic acid in the culture supernatant at the time of terminating the main culture was 0.1 ppm. L-Valine 2.0 g/l NaNO32.5 g/l K2HPO41.25 g/l MgSO4.7H2O 0.63 g/l KCl 0.63 g/l FeSO4.7H2O 0.013 g/l Wheat bran 5 g/l pH 7.0 After the main culture, the main broth was separated by centrifuge (7500 rpm, 15 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to the analysis condition A and the condition B described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid for both the condition A and the condition B. In “Table 16”, concentration of methacrylic acid which is in the supernatant of each culture at the time of terminating the main culture is shown. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml Glucose 2.0 g/l 1 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask) and cultured under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 3 to 6 days (main culture). Composition of the medium for the main culture is described below. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml L-Valine 2.0 g/l Glucose 2.0 g/l After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min). By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 3 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, 3 ml of the cell suspension and 3 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine and 50 mM phosphate buffer (pH 7.0). Five hours and twenty-four hours after starting the resting cell reaction, 1.6 ml of the reaction solution were collected. The reaction solution was separated by centrifuge (15000 rpm, 5 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to the analysis condition A described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid. In “Table 17”, concentration of methacrylic acid which is in the supernatant of the reaction solution of the resting cell reaction is shown. Polypeptone (manufactured by Becton, Dickinson and Company) 10 g Yeast extract (manufactured by Becton, Dickinson and Company) 2 g MgSO47.H2O 1 g Distilled water 1 l Ager 15 g pH 7.0 Cells grown by plate culture were inoculated (one platinum loop) to 10 ml liquid medium and cultured under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 3 to 4 days (pre-culture). Composition of the medium for the pre-culture is described below. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml Glucose 2.0 g/l 1 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask). Under aerobic conditions at 30° C. with a rotary shaker (230 rpm), culture was performed for 2 days (main culture). Composition of the medium for the main culture is described below. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml L-Valine 2.0 g/l Glucose 2.0 g/l After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min) By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 3 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, 3 ml of the cell suspension and 3 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine and 50 mM phosphate buffer (pH 7.0). Five hours and twenty-four hours after starting the resting cell reaction, 1.6 ml of the reaction solution were collected. The reaction solution was separated by centrifuge (15000 rpm, 5 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to the analysis condition A described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid. In “Table 18”, concentration of methacrylic acid which is in the supernatant of the reaction solution of the resting cell reaction is shown. 1 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask) and cultured under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 2 days (main culture). Composition of the medium for the main culture is described below. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml L-Valine 2.0 g/l Glucose 2.0 g/l After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min). By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 3 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, 3 ml of the cell suspension and 3 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine and 50 mM phosphate buffer (pH 7.0). Five hours ( 1 ml of the pre-culture was inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask) and cultured under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 2 days (main culture). Composition of the medium for the main culture is described below. Nutrient medium 8 g/l L-Valine 2.0 g/l After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min). By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 3 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, 3 ml of the cell suspension and 3 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine or isobutyric acid and 50 mM phosphate buffer (pH 7.0). Five hours and twenty-four hours after starting the resting cell reaction, 1.6 ml of the reaction solution were collected. The reaction solution was separated by centrifuge (15000 rpm, 5 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to the analysis condition A described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid. In “Table 20”, concentration of methacrylic acid which is in the supernatant of the reaction solution of the resting cell reaction is shown. Nutrient medium 8 g/l L-Valine 2.0 g/l After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min). By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 3 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, 3 ml of the cell suspension and 3 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine or isobutyric acid and 50 mM phosphate buffer (pH 7.0). Five hours and twenty-four hours (genus Polypeptone (manufactured by Becton, Dickinson and Company) 10 g Yeast extract (manufactured by Becton, Dickinson and Company) 2 g MgSO4.7H2O 1 g Sea water (Daigo's artificial sea water SP for marine microalgae, manufactured by Nihon Seiyaku Co. Japan) 750 ml Distilled water 250 ml L-Valine 2.0 g/l pH 7.2-7.4 After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min). By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 3 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, 3 ml of the cell suspension and 3 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine and 50 mM phosphate buffer (pH 7.0). Twenty-four hours after starting the resting cell reaction, 1.6 ml of the reaction solution were collected. The reaction solution was separated by centrifuge (15000 rpm, 5 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the supernatant of the reaction solution were analyzed according to the analysis condition A described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid and the concentration of methacrylic acid was 0.1 ppm. Polypeptone (manufactured by Becton, Dickinson and Company) 10 g Yeast extract (manufactured by Becton, Dickinson and Company) 2 g MgSO4.7H2O 1 g Sea water (Daigo's artificial sea water SP for marine microalgae, manufactured by Nihon Seiyaku Co. Japan) 750 ml Distilled water 250 ml Ager 15 g pH 7.2-7.4 The grown cells were inoculated to 100 mL liquid medium (100 ml medium/500 ml volume conical flask) and cultured under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 3 days (main culture). Composition of the medium for the main culture is described below. Polypeptone (manufactured by Becton, Dickinson and Company) 10 g Yeast extract (manufactured by Becton, Dickinson and Company) 2 g MgSO4.7H2O 1 g Sea water (Daigo's artificial sea water SP for marine microalgae, manufactured by Nihon Seiyaku Co. Japan) 750 ml Distilled water 250 ml L-Valine 2.0 g/l pH 7.2-7.4 After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min). By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 3 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, 3 ml of the cell suspension and 3 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine and 50 mM phosphate buffer (pH 7.0). Five hours and twenty-four hours after starting the resting cell reaction, 1.6 ml of the reaction solution were collected. The reaction solution was separated by centrifuge (15000 rpm, 5 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the supernatant of the reaction solution were analyzed according to the analysis condition A and condition B described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid and the concentration of methacrylic acid was 0.1 ppm after 5 hours and 0.1 ppm after 24 hours. Na2HPO4(anhydrous) 6.0 g/l KH2PO43.0 g/l NaCl 0.5 g/l NH4Cl 1.0 g/l 1M MgSO4.7H2O 1 ml 1M CaCl20.1 ml 1% Thiamine 1 ml Glucose 2.0 g/l The pre-culture which has been remained under cryopreservation was thawed at room temperature and 0.5 ml was inoculated to 100 ml liquid medium (100 ml medium/500 ml volume conical flask). It was then cultured under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 2 days (main culture). Composition of the medium for the main culture is described below. Nutrient medium 8 g/l L-Valine 2.0 g/l After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min). By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 3 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, 3 ml of the cell suspension and 3 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine and 50 mM phosphate buffer (pH 7.0). Five hours ( The pre-culture which has been remained under cryopreservation was thawed at room temperature and 0.5 ml was inoculated to 100 ml liquid medium (100 ml medium/500 ml volume conical flask). It was then cultured under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 2 days (main culture). Composition of the medium for the main culture is described below. Nutrient medium 8 g/l L-Valine 2.0 g/l After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min). By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 3 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, 3 ml of the cell suspension and 3 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine and 50 mM phosphate buffer (pH 7.0). Five hours and twenty-four hours after starting the resting cell reaction, 1.6 ml of the reaction solution were collected. The reaction solution was separated by centrifuge (15000 rpm, 5 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the supernatant of the reaction solution were analyzed according to the analysis condition B described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid and the concentration of methacrylic acid was 33.0 ppm after 5 hours and 37.0 ppm after 24 hours. Nutrient medium 8 g/l Glucose 2.0 g/l The grown cells were inoculated to 100 ml liquid medium (100 ml medium/500 ml volume conical flask) and cultured under aerobic conditions at 25° C. with a rotary shaker (230 rpm) for 5 days (main culture). Composition of the medium for the main culture is described below. Nutrient medium 8 g/l L-Valine 2.0 g/l After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min). By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 3 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, 3 ml of the cell suspension and 3 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine and 50 mM phosphate buffer (pH 7.0). Five hours and twenty-four hours after starting the resting cell reaction, 1.6 ml of the reaction solution were collected. The reaction solution was separated by centrifuge (15000 rpm, 5 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μm filter (manufactured by ADVANTEC). The compounds contained in the supernatant of the reaction solution were analyzed according to the analysis condition A described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid and the concentration of methacrylic acid was 0.4 ppm after 5 hours and 0.3 ppm after 24 hours. Yeast extract (manufactured by Becton, Dickinson and Company) 20 g/l Polypeptone (manufactured by Becton, Dickinson and Company) 20 g/l Glucose 20 g/l Ager 15 g/l The grown cells were inoculated (one platinum loop) to 10 ml liquid medium and cultured under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 2 to 7 days (pre-culture). The culture was performed at 30° C. (genus Medium 1 Yeast extract (manufactured by Becton, Dickinson and Company) 20 g/l Polypeptone (manufactured by Becton, Dickinson and Company) 20 g/l Glucose 20 g/l Medium 2 Glucose 2.0 g/l L-Valine 2.0 g/l (NH4)2SO46.0 g/l KCl 2.4 g/l NaCl 0.12 g/l H3PO43.0 g/l MgSO4.7H2O 2.4 g/l FeSO4.7H2O 0.01 g/l ZnSO4.7H2O 0.12 g/l MnSO40.4-6H2O 0.024 g/l CuSO4.5H2O 0.006 g/l CaCl20.12 g/l Vitamin Mix 30 ml Composition of Vitamin Mix is shown below. Biotin 0.2 g/l Calcium pantothenate 2 g/l Folic acid 0.002 g/l Thiamine hydrochloride 0.4 g/l Riboflavin 0.2 g/l Nicotinic acid 0.4 g/l Pyridoxine hydrochloride 0.4 g/l Inositol 1 g/l p-Aminobenzoic acid 0.2 g/l 1 ml of the pre-culture was inoculated to 100 ml liquid medium (100 ml medium/500 ml volume conical flask). It was then cultured under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 2 to 3 days (main culture). The culture was performed at 30° C. (genus Glucose 2.0 g/l L-Valine or Isobutyric acid 2.0 g/l (NH4)2SO46.0 g/l KCl 2.4 g/l NaCl 0.12 g/l H3PO43.0 g/l MgSO4.7H2O 2.4 g/l FeSO4.7H2O 0.01 g/l ZnSO4.7H2O 0.12 g/l MnSO4.4-6H2O 0.024 g/l CuSO4.5H2O 0.006 g/l CaCl20.12 g/l Vitamin Mix 30 ml Composition of Vitamin Mix is shown below. Biotin 0.2 g/l Calcium pantothenate 2 g/l Folic acid 0.002 g/l Thiamine hydrochloride 0.4 g/l Riboflavin 0.2 g/l Nicotinic acid 0.4 g/l Pyridoxine hydrochloride 0.4 g/l Inositol 1 g/l p-Aminobenzoic acid 0.2 g/l After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min) By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 3 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, 3 ml of the cell suspension and 3 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine or isobutyric acid and 50 mM phosphate buffer (pH 7.0). In “Table 23”, conditions for the culture and resting cell reaction are shown. Five hours ( L-Valine 2.0 g/l NaNO32.5 g/l K2HPO41.25 g/l MgSO4.7H2O 0.63 g/l KCl 0.63 g/l FeSO4.7H2O 0.013 g/l Wheat bran 5 g/l pH 7.0 After the main culture, the entire volume of the main culture was transferred to a centrifuge tube with volume of 225 ml and then centrifuged (5000 rpm, 15 min). By removing the supernatant, the cells were obtained. To the cells, 40 ml of 50 mM phosphate buffer (pH 7.0) were added and the cells were suspended and centrifuged again under the same conditions. By removing the supernatant, the washed cells were obtained. To the washed cells, 10 ml of 50 mM phosphate buffer (pH 7.0) were added to prepare a cell suspension. To a conical tube with volume of 50 mL, the cell suspension was transferred and 10 ml of the solution for resting cell reaction were added to perform the resting cell reaction. The reaction was allowed to occur under aerobic conditions at 30° C. with a rotary shaker (230 rpm) for 24 hours. Composition of the solution for resting cell reaction includes 5.0 g/l L-valine and 50 mM phosphate buffer (pH 7.0). Five hours and twenty-four hours after starting the resting cell reaction, about 2 ml of the reaction solution were collected. The reaction solution was separated by centrifuge (15000 rpm, 5 min) and the supernatant fraction was subjected to a filtration treatment which uses a DISMIC-13CP Cellulose Acetate 0.2 μM filter (manufactured by ADVANTEC). The compounds contained in the culture supernatant were analyzed according to the analysis condition A and condition B described in Example 5. As a result, a peak was observed at the same elution time as methacrylic acid. In “Table 25”, concentration of methacrylic acid which is in the supernatant of the reaction solution of the resting cell reaction is shown. By using the homology analysis program GENETYX ver. 10, which is a software for processing genetic information by GENETYX CORPORATION, identity between nucleotide sequences of 16S rDNA or LSU rDNA in each microbe, which are shown in SEQ ID NOS. 1 to 8, 9 to 15, 18 to 20, 22 to 26, 30 to 31, 42 to 44, 45 to 46, and 47 to 49, was compared. The results are shown in “Table 26 to 33.” SEQ ID NO. 1 to 8 Specifically, to enhance the chloramphenicol resistance, a natural mutation was caused by subculturing the strain PR4 while the concentration of chloramphenicol in MYK medium (0.5% polypeptone, 0.3% bact yeast extract, 0.3% malt extract, 0.2% KH2PO4, 0.2% K2HPO4) is gradually increased from 10 mg/mL to 120 mg/mL. Accordingly, the derivative strain RhCmSR-09 strain having resistance to 120 mg/mL chloramphenicol was obtained. Subsequently, the RhCmSR-09 strain was admixed with the LigD homolog gene (Accession No.: YP_002767969) of the PR4KS strain was the target gene. After amplification by PCR of about 5.4 kb DNA containing peripheral sequences of the LigD gene, it was cloned into the plasmid vector pK19mobsacB1 described in JP-A No. 2011-200133, in which the sacB gene is introduced in the downstream or in the same direction of the kanamycin resistant gene, to obtain the plasmid pTJ001. Conditions for PCR are as follows. Sterilized water 22 μl 2×PrimeSTAR (manufactured by Takara Bio Inc.) 25 μl GB-138 1 μl GB-139 1 μl PR4KS genome (50 ng/μl) 1 μl Total volume 50 Temperature Cycle 35 Cycles of the Reaction Including 98° C. for 10 Seconds, 55° C. for 10 Seconds, and 72° C. for 120 Seconds Plasmid pTJ002 for deletion of LigD homolog gene in which the full-length sequence of the LigD homolog gene (about 2.3 kb) inside pTJ001 is deleted to maintain only the upstream and downstream sequences of the LigD homolog gene was produced (see, Sterilized water 22 μl 2×PrimeSTAR (manufactured by Takara Bio Inc.) 25 μl GB-140 1 μl GB-141 1 μl pTJ001 1 μl Total volume 50 μl Temperature Cycle 30 Cycles of the Reaction Including 98° C. for 10 Seconds, 50° C. for 10 Seconds, and 72° C. for 180 Seconds Upon the completion of PCR, determination of the fragment was performed by using 1 μl sample and 0.7% agarose gel electrophoresis. As a result, the fragment amplification was observed. With regard to the aforementioned steps for producing the plasmid pTJ002, Wizard Genomic DNA Purification Kit (manufactured by Promega) was used for the genome extraction form the PR4 strain, Gel/PCR Purification Kit (manufactured by FAVORGEN) was used for purification of the DNA fragment digested with restrictions enzymes and the PCR product, DNA Ligation Kit <Mighty Mix> (manufactured by Takara Bio Inc.) was used for conjugation between DNAs, and QIAprep miniprep kit (manufactured by QIAGEN) was used for the plasmid extraction. By having the (1) Obtainment and Analysis of pLK005 By using pK4 (see, JP-A No. 5-64589), Each of the plural colonies shown on the agar medium was cultured on the MYK medium and the plasmid was recovered from the transformant. By using the recovered plasmid, As a result of examining the nucleotide sequence of the plasmid for which increased kanamycin resistance is observed, a change in the sequence in the upstream region of the kanamycin resistant gene of pK4 was observed (eight-nucleotide sequence of GTTGTAGG is repeated). The plasmid observed with increased kanamycin resistance was named pLK005. (2) Production of pSJ040 Plasmid pSJ034 was produced from plasmid pSJ023 according to the method described in JP-A No. 10-337185. There are three sites for the restriction enzyme EcoRI in pSJ034, and plasmid pSJ040 was produced in which one of those sites is modified to SpeI. With regard to the production method, pSJ034 was partially degraded by the restriction enzyme EcoRI and blunting of the restriction sites were performed by using Takara Blunting Kit. In the presence of SpeI linker, the ligation reaction was performed and the (3) Construction of pSJ201 By digesting pLK005 with HindIII, a fragment of about 2.1 kb was produced. Meanwhile, by digesting pSJ040 with HindIII, a fragment of about 9.8 kb was produced. By using those two fragments, the ligation reaction was performed and the (1) Production of Plasmid for Gene Deletion Using in Fusion Method Production of plasmid for gene deletion using In-Fusion HD Cloning kit (manufactured by Takara Bio Inc.) which uses RE_acd1/RE_echA/RE_hchA/RE_mmsB of PR4KS strain as a target gene was performed (see, DNA of the upstream and downstream of the target gene was amplified by PCR. PCR conditions are as described below. Template (PR4 wild type genomic DNA) 1 μl 2× PrimeSTAR Max Premix (manufactured by Takara Inc.) 25 μl Fw Primer (20 μM) 1 μl Rv Primer (20 μM) 1 μl D.W. 22 μl Total 50 μl Temperature Cycle 30 Cycles of the Reaction Including 98° C. for 10 Seconds, 60° C. for 10 Seconds, and 72° C. for 120 Seconds Upon the completion of PCR, determination of the fragment was performed by using 1 μl sample and 0.7% agarose gel electrophoresis. As a result, the fragment amplification was observed. The PCR product (fragment 1 and fragment 2) was subjected to buffer exchange by using Gel/PCR Purification Kit (manufactured by FAVORGEN) and used for the reaction using In-Fusion HD Cloning Kit which is described below. (2) Ligation Between Vector and Target Fragment Using in-Fusion HD Cloning Kit and Transformation By using In-Fusion HD Cloning Kit, ligation between the above fragment and vector was performed. The reactions conditions are described below. Composition of Reaction Solution 5× In-Fusion HD Enzyme Premix 2 μl Vector fragment 1.5 μl DNA fragment 11 μl DNA fragment 22 μl D.W. 3.5 μl Total 10 μl After incubating for 15 minutes at 50° C., the above reaction solution was cooled on ice and used for transformation of (3) Production of Homologous Recombinant Derivative Strain of PR4KSΔligD Derivative Strain and Derivative Strain with Deleted Gene To 20 μl of competent cells of PR4KSΔligD strain, 1 μl of pMMA302 was added and incubated on ice for 10 minutes. Entire volume of the solution after the incubation was transferred to an ice-cooled electroporation cuvette (0.1 cm) and applied with high voltage of 1.5 kV (200Ω). Immediately thereafter, 600 μl of the LB liquid medium was added and kept for 6 hours at 30° C. 200 μl was added to a LB Km10 agar medium and cultured at 30° C. for 4 days. The grown colonies were streaked on a LB Km10 agar medium and, after growing for 4 days, colony PCR was performed according to the following conditions to confirm the homologous recombinant derivative strain. Template 4.0 μl 2× MightyAmp Buffer (manufactured by Takara Inc.) 5.0 μl Fw Primer (20 μM) 0.25 μl Rv Primer (20 μM) 0.25 μl D.W. 0.3 μl MightyAmp DNAPolymerase (manufactured by Takara Inc.) 0.2 μl Total 10.0 μl Temperature Cycle 30 Cycles of the Reaction Including 98° C. for 10 Seconds and 68° C. for 180 Seconds Colonies recognized to be a homologous recombinant derivative strain was suspended in 200 μl of LB medium and 100 μl was applied to LB+10% Sucrose agar medium followed by culture for 3 days. From the grown colonies, those having kanamycin sensitivity were selected and deletion of the target gene was confirmed from them by colony PCR. As a result, a strain in which 4 genes, that is, RE_acd1, RE_echA, RE_hchA, RE_mmsB, are deleted from the PR4KSΔligD derivative strain was obtained, and it was named DMA008 strain. A plasmid for expression of ACD or AAT in microbes that belong to the genus In order to produce a plasmid for expressing each of ACD or AAT, DNA of each gene was amplified by PCR. PCR conditions are as described below. Template for MpAAT1 plasmid pAAT001 (see Example 45) Composition of Reaction Solution Template 1 μl 2× PrimeSTAR Max Premix (manufactured by TAKARA Inc.) 25 μl Fw Primer (20 μM) 1 μl Rv Primer (20 μM) 1 μl D.W. 22 μl Total 50 μl Temperature Cycle: 30 Cycles of the Reaction Including 98° C. for 10 Seconds, 60° C. for 10 Seconds, and 72° C. for 60 Seconds Upon the completion of PCR, the PCR product was subjected to buffer exchange by using Gel/PCR Purification Kit (manufactured by FAVORGEN) and the obtained fragment was treated with restriction enzymes XbaI and Sse8387I. Further, pSJ201 produced in Example 26 was also treated with the restriction enzymes XbaI and Sse8387I. After performing ethanol precipitation, it was dissolved again with sterilized water and subjected to the Shrimp Alkaline Phosphetase (SAP) treatment. The PCR fragment and a large fragment derived from pSJ201 were purified by, after 0.7% agarose gel electrophoresis, using Gel/PCR Purification Kit (manufactured by FAVORGEN). The reaction conditions for the restriction enzyme treatment, conditions for SAP treatment, and the ligation reaction conditions are as follows. Composition for Restriction Enzyme Treatment Reaction PCR amplified fragment 20 μl 10×M 5 μl 0.1% BSA 5 μl XbaI (manufactured by TAKARA Inc.) 2 μl Sse8387I (manufactured by TAKARA Inc.) 2 μl D.W. 16 μl Total 50 μl Composition for SAP Treatment Reaction Vector fragment (pSJ201) 44 μl 10×SAP Buffer 5 μl SAP (manufactured by Promega) 1 μl Total 50 μl Composition for Ligation Reaction Vector fragment 4 μl Target fragment 1 μl Ligation Mix (manufactured by TAKARA Inc.) 3 μl Total 8 μl By using the reaction solution for ligation as a mixture of the above composition, transformation of Plasmid production was performed for producing a methacrylic acid ester using microbes of the genus At the downstream of RE_acd1 gene of plasmid pMMA401 for expressing RE_acd1, the “nitrilase promoter+MpAAT1 gene” fragment, which has been obtained by PCR using as a template the plasmid pAAT301 for expression of MpAAT1 gene, was inserted. Amplification of the “nitrilase promoter+MpAAT1 gene” fragment was performed as described below. Template (pAAT301) 1 μl 2× PrimeSTAR Max Premix (manufactured by TAKARA Inc.) 10 μl Fw Primer (10 μM) 0.6 μl Rv Primer (10 μM) 0.6 μl D.W. 7.8 μl Total 20 μl Temperature Cycle: 30 Cycles of the Reaction Including 98° C. for 5 Seconds, 60° C. for 5 Seconds, and 72° C. for 45 Seconds The “nitrilase promoter+MpAAT1 gene” fragment as obtained above was treated with the restriction enzyme Sse8387I. Meanwhile, pMMA401 was also subjected to the SAP treatment after being treated with Sse8387I. Those DNA fragments were purified, after performing 0.7% agarose gel electrophoresis, by using Gel/PCR Purification Kit (manufactured by FAVORGEN). The conditions for restriction enzyme treatment reaction and the conditions for ligation reaction are as described below. Composition for the Restriction Enzyme Treatment Reaction (AAT Fragment) PCR amplification fragment 40 μl 10×M buffer 5 μl 0.1% BSA 4 μl Sse8387I (manufactured by TAKARA Inc.) 1 μl Total 50 μl Composition for the restriction enzyme treatment reaction (Vector fragment) pMMA401 (vector) 3 μl 10×M buffer 4 μl 0.1% BSA 4 μl AP 1 μl Sse8387I (manufactured by Promega) 1 μl D.W. 27 μl Total 40 μl Composition for Ligation Reaction pMMA401 1 μl Insertion fragment 2 μl Ligation Mix (manufactured by TAKARA Inc.) 3 μl Total 6 μl By using the ligation reaction solution which has been mixed according to the above composition, transformation of DMA008 strain obtained from Example 27 (3) was transformed with the plasmid pMMA401. The obtained recombinant (DMA008/pMMA401) was used for producing methacrylic acid based on the resting cell reaction. One platinum loop inoculation was made to 2 mL of M9/Frc/Km10 liquid medium shown below (wassermann test tube), and cultured for 2 days under aerobic conditions at 30° C. using a rotary shaker (180 rpm) (pre-culture). M9/Frc/Km10 Liquid Medium 6.0 g/l Na2HPO4 3.0 g/l KH2PO4 0.5 g/l NaCl 1.0 g/l NH4Cl 1 mM MgSO4.7H2O 1 mM CaCl2 0.01 g/l Thiamine 2.0 g/l Fructose 10 μg/l Kanamycin 1 μl of the pre-broth was inoculated to 100 mLM9/Frc/Km10 liquid medium (100 μl medium/500 μl volume conical flask), and under aerobic conditions at 30° C. with a rotary shaker (230 rpm), culture was performed for 3 days (main culture). After the main culture, 40 μl of the main-broth was transferred to a conical tube with volume of 50 mL and subjected to centrifugal separation (12000 rpm, 10 min) to obtain cells. The following reaction was performed by using the cells. To a conical tube with volume of 50 mL, 1 mL of the reaction solution was added and the reaction was performed for 24 hours under aerobic conditions at 30° C. with a rotary shaker (180 rpm). Composition of Reaction Solution OD630=10 bacterial cells (final concentration) 5.0 g/l 2-oxoisovaleric acid (final concentration) 50 mM phosphate buffer/pH 7.0 (final concentration) After the reaction, an appropriate amount of the supernatant of the reaction solution was collected and subjected to the analysis according to the following HPLC conditions. As a result, methacrylic acid of 12 ppm was detected. Conditions for HPLC Analysis Apparatus: Waters 2695 Column: ICsep USP L-17, ϕ4.0 mm×250 mm Mobile phase: 0.01 N H2SO4 Flow amount: 0.35 μl/min Run time: 20 min Column temperature: 40° C. Sample temperature: 20° C. Detection: UV 210 nm DMA008 strain obtained from Example 27 (3) was transformed with each of the plasmid pACDAAT1, pACDAAT2, pACDAAT3, pACDAAT4, pACDAAT6, and pACDAAT8. The obtained recombinant (DMA008/pACDAAT1, DMA008/pACDAAT2, DMA008/pACDAAT3, DMA008/pACDAAT4, DMA008/pACDAAT6 and DMA008/pACDAAT8) was used for producing a methacrylic acid ester based on the resting cell reaction. One platinum loop inoculation was made to 2 mL of LB Km10 liquid medium (wassermann test tube), and cultured for 2 days under aerobic conditions at 30° C. using a rotary shaker (180 rpm) (pre-culture). 1 μl of the pre-broth was inoculated to 100 mL LB Km10 (100 μl medium/500 μl volume conical flask), and under aerobic conditions at 30° C. with a rotary shaker (230 rpm), culture was performed for 3 days (main culture). Meanwhile, as a control, plasmid DMA008/pLK005 was used. After the main culture, 40 μl of the main-broth was transferred to a conical tube with volume of 50 mL and subjected to centrifugal separation (12000 rpm, 10 min) to obtain cells. The following reaction was performed by using the cells. To a glass sample bottle with volume of 10 mL, 1 mL of the reaction solution was added and the reaction was performed for 18 hours under aerobic conditions at 30° C. with a rotary shaker (180 rpm). Composition of Reaction Solution OD630=10 bacterial cells (final concentration) 5.0 g/l 2-oxoisovaleric acid (final concentration) 40 mM alcohol (final concentration) 50 mM phosphate buffer/pH 7.5 (final concentration) As an alcohol, n-butanol was used. After the reaction, 1 mL acetonitrile was added to the reaction solution and mixed well. After filtration using a syringe filter DISMIC/hole diameter 0.45 μm (manufactured by ADVANTEC), analysis was made by the HPLC analysis described in Example 49. In Table 34, the results of analyzing the product after 18 hours are shown. Production of Butyl Methacrylate by DMA008 strain obtained from Example 27 (3) was transformed with plasmid pACDAAT1. The obtained recombinant (DMA008/pACDAAT1) was used for producing a methacrylic acid ester based on the resting cell reaction. Further, as a control, plasmid DMA008/pLK005 was used. By using the method described in Example 31, the recombinant was cultured to obtain the cells. Composition of Reaction Solution OD630=10 microbial cells (final concentration) 5.0 g/l 2-oxoisovaleric acid (final concentration) 40 mM alcohol (final concentration) 50 mM phosphate buffer/pH 7.5 (final concentration) As an alcohol, n-butanol, isobutanol, and 2-ethylhexylalcohol were used. After the reaction, 1 mL acetonitrile was added to the reaction solution and mixed well. After filtration using a syringe filter DISMIC/hole diameter 0.45 μm (manufactured by ADVANTEC), analysis was made by the HPLC analysis described in Example 9B. In Table 35, the results of analyzing the product after 18 hours are shown. Production of Methacrylic Acid Ester by Isolation of a gene which is involved with synthesis of methacrylic acid in microbes of the genus <Production of Genomic DNA> <Cloning into Expression Vector> By using the genomic DNA as a template and designing an oligonucleotide such that it is in the form in which a restriction enzyme recognition site, which is easily introducible to an expression vector, is added, a DNA fragment containing a gene presumed to encode ACD was produced by PCR method. Sterilized water 22 μL 2× PrimeSTAR (manufactured by Takara Bio Inc.) 25 μL Forward primer 1 μL Reverse primer 1 μL Genomic DNA 1 μL Total volume 50 μL Temperature Cycle: 30 Cycles of the Reaction Including 98° C. for 10 Seconds, 55° C. for 15 Seconds, and 72° C. for 150 Seconds The band of the obtained amplified product was purified with QIAquick Gel Extraction Kit (QIAGEN). For PA_acd1, the purified DNA was digested with the restriction enzyme NcoI (the restriction recognition site is included in the forward primer) and Sse8387I (the restriction recognition site is included in the reverse primer). For PA_acd2 to PA_acd4, the restriction was made with the restriction enzyme BspHI (the restriction recognition site is included in the forward primer) and Sse8387I (the restriction recognition site is included in the reverse primer). Separation was performed by agarose gel electrophoresis, and the target band was cut out from the gel and purified. For the purification, Gel/PCR Purification Kit (manufactured by FAVORGEN) was used, and 30 μL of sterilized water was used for elution. By mixing the purified DNA (5 μL), vector pTrc99A (1 μL) previously digested with NcoI and Sse8387I, distilled water (4 μL) and solution I (DNA Ligation Kit ver. 2 (Takara Bio Inc.)) (10 μL) and incubating for 12 hours at 16° C., ligation between the PCR amplified product and the vector was made. After inoculating the To 200 μL of the competent cells as prepared above, 10 μL of the ligation solution was added, maintained for 30 minutes at 0° C., and applied with a heat shock at 42° C. for 30 seconds. After cooling at 0° C. for 2 minutes, 1 mL of the SOC medium (20 mM glucose, 2% bactotrypton, 0.5% bactoyeast extract, 10 mM NaCl, 2.5 mM KCl, 1 mM MgSO4, 1 mM MgCl2) was added and followed by culture under shaking at 37° C. for 1 hour. After the culture, each was applied in an amount of 100 μL to the LBAmp agar medium (LB medium containing ampicillin 100 mg/l and 1.5% agar) and further cultured at 37° C. Plural colonies of the transformant which have been grown on the agar medium were cultured overnight at 37° C. on 1.5 μl LBAmp medium (LB medium containing ampicillin at 100 mg/l). After collecting the cells, the plasmid DNA was prepared by using QIAprep Spin Miniprep kit (manufactured by QIAGEN). The nucleotide sequence of the obtained recombinant plasmid DNA was determined by using CEQ DTCS Quick Start Kit and Fluorescence sequence CEQ 2000XL DNA Analysis (both manufactured by BECKMAN COULTER, USA), and named plasmid pMMA002 to pMMA005 (Table 36). ACD homolog gene was also inserted to the pET16b vector according to the same procedure as above, and the obtained plasmids were named pMMA102 to pMMA105 (Table 36). Meanwhile, since pET16b has no Sse8387I site, a linker containing the Sse8387I restriction site inserted to BamHI site of pET16b was prepared in advance, and it was used as a vector. Isolation of a gene which is involved with synthesis of methacrylic acid in microbes of the genus <Production of Genomic DNA> <Cloning into High Expression Vector> By using the genomic DNA as a template and designing an oligonucleotide such that it is in the form in which a restriction enzyme recognition site, which is easily introducible to an expression vector, is added, a DNA fragment containing a gene presumed to encode ACD was produced by PCR method. Amplification by a PCR reaction was performed in the same manner as Example 33. The band of the obtained amplified product was purified with QIAquick Gel Extraction Kit (QIAGEN) and digested with the restriction enzyme PciI (the restriction recognition site is included in the forward primer) and Sse8387I (the restriction recognition site is included in the reverse primer). The following operations were performed like Example 33 to obtain plasmid pMMA009 and 010 having pTrc99A as a vector and plasmid pMMA109 and 110 having pET16b as a vector (Table 37). By using the expression plasmid containing ACD homolog gene produced in Example 33 and 34, The recombinant The transformed 1 mL was collected from the obtained cell suspension, and the cell extract was prepared as follows. By using ultrasonic homogenizer VP-300 (manufactured by DYTEC, Japan), disruption was performed for 3 minutes with pulse output at interval of 1 second under ice cooling. Next, by performing centrifuge (10,000×g, 5 minutes, 4° C.), the obtained supernatant was collected as cell extract. The protein analysis by SDS gel electrophoresis was performed as follows. After appropriately diluting the cell extract, it was mixed with a sample solution for polyacrylamide gel electrophoresis (0.1M Tris-HCl (pH 6.8), 4% w/v SDS, 0.2M dithiothreitol, 20% v/v glycerol, trace amount of bromophenol blue) and heated at 98° C. for 5 minutes for denaturation. 10% polyacrylamide gel was prepared, and by using 5 μL of the denatured sample per lane, the electrophoretic analysis was performed ( The ACD activity was measured according to production of methacrylyl-CoA having isobutyryl-CoA as a substrate. To a solution (1.84 mL) containing 1-methoxy-5-methylphenazinum methyl sulfate, flavine adenine dinucleotide, and isobutyryl-CoA at final concentration of 6 mM, 0.4 mM, and 1 mM, respectively in 100 mM sodium phosphate buffer (pH 8.0), 0.16 μl of the cell extract which has been obtained like Example 35 was added to have 2 μl. After the reaction at 37° C. for 30 minutes, protein removal was performed by ultrafiltration using Centricut Ultramini W-10 (manufactured by Kurashiki Boseki), the reaction was terminated and analysis by HPLC was performed under following conditions. The results are shown in Table 38. It was able to confirm that high ACD activity is observed from PA_acd1 and RE_acd1 and methacrylyl-CoA can be produced from isobutyryl-CoA by those enzymes. Conditions for HPLC Analysis Column: Inertsil ODS-3V, 4.6 mm×250 mm Mobile phase: 30% MeOH, 50 mM H3PO4, pH 5.7 Flow amount: 1.0 μl/min column temperature: 35° C. Detection: UV 254 nm (210 nm) Injection amount 10 μl reaction solution was diluted by 10 times with a mobile phase and measured Gene cloning, production of an expression plasmid, and production of a recombinant were performed in the same manner as Example 33. The DNA fragment containing the entire gene operon which encodes the BCKAD complex gene was produced, by using the genomic DNA of The recombinant Because there was no knowledge about BCKAD gene from the bacteria of the genus With regard to Cluster 1, the four genes consist of a nucleotide sequence represented by SEQ ID NOS. 63, 65, 67, 69 like the Cloning of BCKAD complex gene of Cluster 1, production of an expression plasmid, and production of a recombinant were performed in the same manner as Example 33. The DNA fragment containing the entire gene operon which encodes the BCKAD complex gene was produced, by using the genomic DNA of Cloning of BCKAD complex gene of Cluster 2, production of an expression plasmid, and production of a recombinant were performed as follows. It was produced, by using the genomic DNA of The above PCR product and vector pTrc99A which has been digested in advance with the NcoI and Sse8387I were linked by performing recombination of terminal sequence using In-Fusion HD Cloning Kit (manufactured by Takara Bio) and following the manufacturer's instruction. 2 μL of the infusion reaction solution was used and transformation of the The BCKAD activity was measured according to production of methacrylyl-CoA having 2-oxoisovaleric acid as a substrate. To a solution (0.7 mL) containing MgCl2, thiamine pyro acid, CoA-SH, and DTT at final concentration of 1 mM, 0.2 mM, 1 mM and 2 mM, respectively in 100 mM sodium phosphate buffer (pH 7.0), 0.2 μl of the cell extract obtained like Example 37 was added to have 0.9 μl. After the reaction at 37° C. for 30 minutes by adding 0.1 mL of calcium 2-oxoisovalerate (final concentration 4 mM), protein removal was performed by ultrafiltration using Centricut Ultramini W-10 (manufactured by Kurashiki Boseki), the reaction was terminated and analysis by HPLC was performed under following conditions. As a result, production of isobutyryl-CoA was observed at 0.83 mM or 0.88 mM for JM109/pWA108 and BL21 (DE3)/pWA008, respectively. Conditions for HPLC Analysis Column: Inertsil ODS-3V, 4.6 mm×250 mm Mobile phase: 35% MeOH, 50 mM H3PO4, pH 5.7 Flow amount: 1.0 μl/min column temperature: 35° C. Detection: UV 254 nm (210 nm) Injection amount 10 μl reaction solution was diluted by 10 times with a mobile phase and measured To a solution (0.6 mL) containing 1 mM MgCl2, 0.2 mM thiamine pyro acid, 1 mM CoA-SH, 2 mM DTT, 2 mM nicotine amide adenine nucleotide (NAD), 0.04 mM flavine adenine dinucleotide (FAD), 2 mM valine, each in final concentration in 100 mM sodium phosphate buffer (pH 7.0), 0.1 μl of the cell extract (JM109/pMMA002 and JM109/pWA108) obtained like Example 35 and 40 was added to have 0.8 ml. After the reaction at 37° C. for 30 minutes with addition of 0.1 mL calcium 2-oxoisovalerate (final concentration of 4 mM), production of isobutyryl-CoA was confirmed by HPLC. By adding 0.1 mL of 1-methoxy-5-methylphenazinum methyl sulfate (final concentration 6 mM), the reaction was allowed to occur again for 3 hours. After the reaction, ultrafiltration was performed by using Centricut Ultramini W-10 (manufactured by Kurashiki Boseki). The reaction was terminated by removing proteins and analysis by HPLC was performed. As a result, production of methacrylyl-CoA of 2 mM was observed. To a solution (1.84 mL) containing 6 mM 1-methoxy-5-methylphenazinum methyl sulfate, 0.4 mM FAD and 1 mM isobutyryl-CoA, each in final concentration in 100 mM sodium phosphate buffer (pH 8.0), 0.16 ml of the cell extract having an ACD activity, which has been obtained like Example 35, was added and adjusted to 2 μl. After the reaction at 37° C. for 30 minutes, the analysis was performed under HPLC conditions shown in Example 41. As a result, production of methacrylyl-CoA was observed while the peak of isobutyryl-CoA has disappeared. By using the reaction solution obtained as above in which methacrylyl-CoA is produced and reacting it with banana flesh having the AAT activity and n-butyl alcohol, production of butyl methacrylate was observed. Specifically, after removing the skin, banana flesh was sliced to a thickness of about 1 mm, and cut again to four pieces. 1 g of the sliced banana, 0.9 mL of the reaction solution for synthesizing methacrylyl-CoA, 0.1 mL of 3.5 M KCl solution, and 5 μL of n-butyl alcohol were added to a 50 ml flask and sealed, and the reaction was allowed to occur at 30° C. for 2 hours. After the reaction, 150 μL was collected from of head space of the 100 mL flask and analyzed according to the following GC conditions. As a result, it was found that butyl methacrylate of 0.015 mM was produced. Conditions for GC Analysis Column: DB-WAX, 30 m×0.32 mm Column temperature: 50° C. 5 min→5° C./min→100° C. (total 15 min) Carrier gas: He Inject: 200° C. splitless (sampling time of 1 min) Detect: 250° C. FID Injection amount: 150 μL Meanwhile, concentration of butyl methacrylate was calculated as follows: an aqueous solution with known concentration is prepared, 2 mL of the aqueous solution is added to a 100 mL flask, and after incubation at 30° C. for 30 min, collection is made from the head space with the same method as above, GC analysis is made, and then a calibration curve is constructed. The DNA fragment which contains the ACD gene (PA_acd1 gene) is inserted to the downstream of BCKAD of pWA108 produced in Example 37 by using In-Fusion HD Cloning kit (manufactured by Takara Bio Inc.) to prepare the plasmid pMMA201 and pMMA202 for co-expressing BCKAD and ACD. Further, in the same manner, the DNA fragment which contains the BCKAD gene is inserted to the downstream of PA_acd1 of pMMA002 produced in Example 33 to produce the plasmid pMMA203 and pMMA204 for co-expression. Details are described below. (1) Production of Plasmid pMMA201 By using pMMA102 produced in Example 33 as a template, PA_acd1 gene was amplified by PCR method. PCR conditions are as described below. Template (pMMA102) 1 μl 2× PrimeSTAR Max Premix (manufactured by TAKARA Inc.) 25 μl FW Primer (20 μM) 1 μl Rv Primer (20 μM) 1 μl D.W. 22 μl Total 50 μl Temperature Cycle: 30 Cycles of the Reaction Including 98° C. for 10 Seconds, 60° C. for 10 Seconds, and 72° C. for 120 Seconds When the PCR is completed, the fragment was determined based on 0.7% agarose gel electrophoresis by using 1 μl sample. As a result, amplification of a fragment of about 1.1 kb was observed. The PCR product was briefly purified by Gel/PCR Purification Kit (manufactured by FAVORGEN) to obtain a PCR fragment. Meanwhile, the plasmid pWA108 with the restriction enzyme Sse8387I was digested to have a vector-side fragment. Both fragments described above were used for the reaction shown below which uses In-Fusion HD Cloning Kit. Composition of Reaction Solution 5× In-Fusion HD Enzyme Premix 2 μl Vector-side fragment 1.5 μl PCR fragment 1 μl D.W. 3.5 μl Total 10 μl After incubating for 15 minutes at 50° C., the above reaction solution was cooled on ice and used for transformation of (2) Production of Plasmid pMMA202 By using pMMA102 produced in Example 33 as a template, PA_acd1 gene was amplified by PCR method. PCR primers are as described below. In the same manner as above, the PCR fragment and the plasmid pWA108 digested with the restriction enzyme Sse8387I were ligated to each other by using In-Fusion HD Cloning Kit and the target plasmid was named pMMA202. (3) Production of Plasmid pMMA203 By using p pWA008 produced in Example 37 as a template, BCKAD gene was amplified by PCR method. PCR primers are as described below. The reaction method and obtaining the PCR fragment are performed in the same manner as those described in (1) above. Meanwhile, the plasmid pMMA002 containing PA_acd1 gene was digested with the restriction enzyme Sse8387I to give a vector-side fragment. In the same manner as above (1), both fragments were subjected to the reaction using In-Fusion HD Cloning Kit, and transformation of (4) Production of Plasmid pMMA204 By using pWA008 produced in Example 37 as a template, BCKAD gene was amplified by PCR method. PCR primers are as described below. The reaction method and obtaining the PCR fragment are performed in the same manner as those described in (1) above. In the same manner as above, the PCR fragment and the plasmid pMMA002 which has been digested with the restriction enzyme Sse8387I were ligated to each other by using In-Fusion HD Cloning Kit and the target plasmid was named pMMA204. Cell extract of the JM109/pMMA204 strain was obtained in the same manner as the method described in Example 35. As a control strain, JM109/pTrc99A was used. With the same method as the method described in Example 40, 0.1 ml of calcium 2-oxoisovalerate (final concentration of 4 mM) was added to the cell extract of JM109/pMMA204. After the reaction at 37° C. for 30 minutes, production of isobutyryl-CoA was confirmed by HPLC, and 0.1 mL of 1-methoxy-5-methylphenazinum methyl sulfate (final concentration 6 mM) was added. The reaction was allowed to occur again for 3 hours. After the reaction, removal of the protein (terminating the reaction) was performed by ultrafiltration using Centricut Ultramini W-10 (manufactured by Kurashiki Boseki). Then, analysis was made by HPLC according to the following conditions. Conditions for HPLC Analysis Column: Capcell Pak ODS-UG120 (Shiseido), particle diameter μm, 2.0 mm I.D.×250 mm Mobile phase: 25% MeOH, 50 mM H3PO4, pH 5.7 Flow amount: 1.0 μl/min Column temperature: 35° C. Detection: UV 254 nm (210 nm) Injection amount 10 μl reaction solution was diluted by 10 times with a mobile phase and measured As a result, production of 0.1 mM methacrylyl-CoA was observed. It was possible to confirm that BCKAD and ACD expressed by By using the recombinant JM109/pMMA201 strain, JM109/pMMA202 strain, JM109/pMMA203 strain and JM109/pMMA204 strain were inoculated to LBAmp medium (ampicillin 100 mg/l) containing 1 ml of 100 μg/mL ampicillin and pre-cultured at 37° C. for 6 hours. 0.1 mL of the culture was collected and added to the same medium (containing 1 mM IPTG) and cultured under shaking at 37° C. for 18 hours. The obtained culture was collected in an amount of 10 mL and added to 90 mL of the LBAmp medium containing 0.5% calcium 2-oxoisovaleric acid, followed by culture under shaking at 37° C. for 25 hours. Once the culture is completed, the culture was filtered and analysis was made by HPLC according to the following conditions. Conditions for HPLC Analysis Column: Wakopak Wakobeads-T-132-E, ϕ7.8 mm×300 mm Mobile phase: 0.1% phosphoric acid Flow amount: 0.5 μl/min column temperature: 40° C. Detection: UV 210 nm Injection amount: 5 ul As a result, production of methacrylic acid and methacrylyl-CoA was not observed but the production of isobutyric acid of 14.2 mM was observed. Thus, from the in vivo reaction in Concentration of Isobutyric Acid Produced According to the same method as the method described in Example 35, JM109/pMMA201 strain was cultured. From the obtained culture, the cells were collected by centrifuge (3,700×g, 10 minutes, 4° C.), washed with 10 mM sodium phosphate buffer (pH 7.0), and suspended in the same buffer solution to obtain cell suspension. By using the cell suspension, about 3 ml of the resting cell reaction solution was prepared and the reaction was performed at 30° C., 180 rpm for 24 hours. Composition of Resting Cell Reaction Solution 50 mM Sodium phosphate buffer solution (pH7.0) 0.5% Calcium 2-oxoisovalerate OD10 Cell suspension. Once the culture is completed, the culture was filtered and analysis was made by HPLC according to the conditions described in Reference example 4. As a result, production of methacrylic acid was not observed but production of isobutyric acid of 15.2 mM was observed. Similar to Reference example 4, it was shown to be impossible to have synthesis of methacrylic acid or methacrylyl-CoA using According to the method described in Example 33 to 32, an expression recombinant in which acdH gene derived from After removing the skin, banana flesh was sliced using a cutter to a thickness of about 1 mm, and cut again to four pieces. 2 g of the sliced banana, 2 mL of the solution containing 2 3 mM methacrylyl-CoA and 0.35 M KCl, and 5 μL of isobutyl alcohol were added in order to a 100 ml flask. After sealing, the reaction was allowed to occur at 30° C. The reaction mixture containing isobutyl methacrylate which has been produced after 1, 2 or 3 hours was collected in an amount of 150 μl from the head space of the 100 ml flask and then analyzed by GC under following conditions. The results are shown in Table 41. Column temperature: 50° C.-5 min→5° C./min→100° C. (total 15 min) Carrier gas: He Inject: 200° C. splitless (sampling time 1 min) Detect: 250° C. FID injection amount: 150 μl Meanwhile, concentration of methacrylic acid ester was calculated as follows: an aqueous solution with known concentration is prepared first, 2 mL of the aqueous solution is added to a 100 mL flask, and after incubation at 30° C. for 30 min, collection is made from the head space with the same method as above, GC analysis is made, and then a calibration curve is constructed. The same process as Reference example 7 was performed except that n-butyl alcohol is used instead of isobutyl alcohol. The results are shown in Table 42. 2 g of the plant specimen shown in Table 43, 2 ml of the solution containing 2.3 mM methacrylyl-CoA and 0.35 M KCl, and 10 μl of n-butyl alcohol were added in order to a 100 ml flask. After sealing, the reaction was allowed to occur at 30° C. Analysis of methacrylic acid ester was performed in the same manner as Reference example 7. The results are shown in Table 43. 2 g of the plant specimen shown in Table 44, 2 ml of the solution containing 2 3 mM methacrylyl-CoA and 0.35 M KCl, and 6.4 ml of ethyl alcohol were added in order to a 100 ml flask. After sealing, the reaction was allowed to occur at 30° C. Analysis of methacrylic acid ester was performed in the same manner as Reference example 7. The results are shown in Table 44. 2 g of the plant specimen shown in Table 45, 2 ml of the solution containing 2.3 mM methacrylyl-CoA and 0.35 M KCl, and 4.4 μl of methyl alcohol were added in order to a 100 ml flask. After sealing, the reaction was allowed to occur at 30° C. Analysis of methacrylic acid ester was performed in the same manner as Reference example 7. The results are shown in Table 45. Synthesis of the plant-derived AAT gene represented by SEQ ID NOS. 77, 79 and 81 was performed by Takara Bio Inc. Apple AAT (MpAAT1): amino acid sequence (SEQ ID NO. 76), nucleotide sequence (SEQ ID NO. 77) Strawberry AAT (SAAT): amino acid sequence (SEQ ID NO. 78), nucleotide sequence (SEQ ID NO. 79) Strawberry AAT (VAAT): amino acid sequence (SEQ ID NO. 80), nucleotide sequence (SEQ ID NO. 81) Those synthetic gene fragments were inserted to the vector pMD19, and each of them was named pAAT001 to 003 (Table 46). By having those AAT001 to 003 as a template and designing an oligonucleotide such that it is in the form in which a restriction enzyme recognition site, which is easily introducible to an expression vector, is added, a DNA fragment containing the AAT gene was produced by PCR method. sterilized water 22 μL 2× PrimeSTAR (manufactured by Takara Bio Inc.) 25 μL Forward primer 1 μL Reverse primer 1 μL Genomic DNA 1 μL Total volume 50 μL Temperature Cycle 30 Cycles of the Reaction Including 98° C. for 10 Seconds, 55° C. for 15 Seconds, and 72° C. for 150 Seconds Band of the amplified product obtained was purified by QIAquick Gel Extraction Kit (QIAGEN). Each purified DNA was digested with the restriction enzyme PagI (restriction recognition site is included in the forward primer) and Sse8387I (restriction recognition site is included in the reverse primer). After performing the separation by agarose gel electrophoresis, the target band was cut out from the gel and purified. For the purification, Gel/PCR Purification Kit (manufactured by FAVORGEN) was used and elution was made using 30 μL of sterilized water. By mixing the purified DNA (5 μL), the vector pTrc99A (1 μL) which has been digested in advance with NcoI and Sse8387I, distilled water (4 μL) and solution I (DNA Ligation Kit ver. 2 (Takara Bio Inc.)) (10 μL) and incubating them for 12 hours at 16° C., the PCR amplified product and the vector were ligated to each other. To 200 μL of the competent cell which has been prepared in the same manner as Example 33, 10 μL of the above ligation solution was added. After keeping it at 0° C. for 30 minutes, a heat shock of 42° C. was applied for 30 seconds, and after cooling at 0° C. for 2 minutes, 1 mL of the SOC medium was added followed by culture under shaking at 37° C. for 1 hour. After the culture, each was applied in an amount of 100 μL to the LBAmp agar medium (LB medium containing ampicillin 100 mg/l and 1.5% agar) and further cultured at 37° C. Plural colonies of the transformant which have been grown on the agar medium were cultured overnight at 37° C. on 1.5 ml LBAmp medium (LB medium containing ampicillin at 100 mg/I). After collecting the cells, the plasmid DNA was prepared by using QIAprep Spin Miniprep kit (manufactured by QIAGEN). The nucleotide sequence of the each obtained recombinant plasmid DNA was determined by using CEQ DTCS Quick Start Kit and Fluorescence sequence CEQ 2000XL DNA Analysis (both manufactured by BECKMAN COULTER, USA), and named plasmid pAAT101 to pAAT103 (Table 46). The AAT gene was also inserted to the pET16b vector according to the same operation, and obtained plasmids were named pAAT201 to pAAT203 (Table 46). Meanwhile, because the pET16b does not contain a Sse8387I site, pET16b added at BamHI site with a linker containing Sse8387I restriction sequence is produced in advance, and used as a vector. By introducing the plasmid pAAT101 to pAAT103 to JM109 strain, the recombinants JM109/pAAT101 to pAAT103 were obtained. By introducing the plasmid pAAT201 to pAAT203 to BL21 (DE3) strain, the recombinant BL21 (DE3)/pAAT201 to pAAT203 were obtained. (1) Culturing Recombinant The recombinant (2) Culturing Recombinant The recombinant (3) Preparation of Cell Extract A cell extract was prepared from the cell suspension obtained above. By using ultrasonic homogenizer VP-15S (manufactured by DYTEC, Japan), the cell suspension was disrupted for 1 minute under conditions including output control 4, DUTY CYCLE 40%, PULS, TIMER=B mode 10 s. Next, by performing centrifuge (10,000×g, 5 minutes, 4° C.), 1 mL of the obtained supernatant was collected (cell extract). By using the cell extract which has been prepared by the method described in Example 46, the following reaction was performed. By adding 0.2 ml of the cell extract to a 10 μl-volume sample bottle (for GC) added with a septum to which 0.8 μl of a solution of methacrylyl-CoA and alcohol has been added such that the final concentration of the reaction solution includes 7 mM methacrylyl-CoA and 40.5 mM n-butanol, the reaction was started. The sample bottle added with a septum was incubated at 30° C. for 1 to 5 hours for having the reaction. Gas in the head space of sample bottle added with a septum was analyzed in the same manner as Reference example 7. The results are shown in Table 47. By using methanol, ethanol, or n-butanol as the alcohol and the extract derived from BL21 (DE3)/pAAT201 (Apple) as the cell extract, the reaction was performed in the same manner as Example 47. The results of analyzing the product after 5 hours are shown in Table 48. By using isobutanol, phenol, benzyl alcohol or 2-ethylhexyl alcohol as the alcohol and the cell extract of BL21 (DE3)/pAAT201 (Apple) obtained from Example 46, the following reaction was performed. By adding 0.2 ml of the cell extract to a 10 μl-volume sample bottle (for GC) added with a septum to which 0.8 ml of a solution of methacrylyl-CoA and alcohol has been added such that the final concentration of the reaction solution includes 1 mM methacrylyl-CoA and 40 mM alcohol, the reaction was started. The sample bottle added with a septum was incubated at 30° C. for 1 to 5 hours for having the reaction. When the reaction is completed, 1 mL of acetonitrile was added to the reaction solution in the sample bottled added with a septum followed by mixing well. After filtration using a syringe filter DISMIC/hole diameter 0.45 μm (manufactured by ADVANTEC), it was subjected to HPLC analysis. In Table 49, the results of analyzing the product after 5 hours are shown. Synthesis of Methacrylic Acid Ester (Isobutyl Methacrylate, Phenyl Methacrylate, Benzyl Methacrylate, and 2-Ethylhexyl Methacrylate) by Using Cell Extract of AAT Gene Recombinant Apparatus: Waters 2695 Column: Shiseido CAPCELL PAK C18 UG120 5 μm Mobile phase: 65% MeOH, 0.2% phosphoric acid Flow amount: 0.25 μl/min column temperature: 35° C. Detection: UV 210 nm Injection amount: 10 μL Plasmids for expressing yeast-derived AAT gene were prepared in the same manner as Example 45 (Table 50), and after transforming Plasmid for Expressing Yeast-Derived AAT Gene The cell extract was prepared in the same manner as Example 46 and the reaction for synthesizing butyl methacrylate was performed by having methacrylyl-CoA and n-butanol as a substrate in the same manner as Example 47. As a result, no production of butyl methacrylate was observed. Meanwhile, when acetyl-CoA and n-butanol are used as a substrate, production of butyl acetate was observed. In other words, the AAT derived from yeast was not observed with the ability to produce a methacrylic acid ester. Production of Ester by Using Yeast AAT Gene Recombinant According to the method for producing methacrylic acid of the invention, methacrylic acid can be produced from recyclable biogenous resources (renewable raw materials) by using microbes without depending on a chemical method. According to the ACH method of the related art, a treatment of oxidizing acetone cyanhydrin by acid is required so that a large amount of waste acid is generated. Further, as separation or purification is needed for each step, it causes high energy consumption. Meanwhile, according to the method for producing methacrylic acid of the invention, methacrylic acid can be produced efficiently and simply in a single step directly from a biomass. In addition, a less load is applied in terms of safety, environment, facility, works, and cost. Further, by converting the raw materials of methacrylic acid to those derived from a biomass, it becomes also possible to reduce the carbon dioxide discharge amount to an environment. SEQ ID NO. 82: MMA-044 SEQ ID NO. 83: MMA-045 SEQ ID NO. 84: MMA-003 SEQ ID NO. 85: MMA-004 SEQ ID NO. 88: MMA-031 SEQ ID NO. 89: MMA-032 SEQ ID NO. 92: MAA-15 SEQ ID NO. 93: MAA-16 SEQ ID NO. 94: GB-138 SEQ ID NO. 95: GB-139 SEQ ID NO. 96: GB-140 SEQ ID NO. 97: GB-141 SEQ ID NO. 98: MMA-061 SEQ ID NO. 99: MMA-062 SEQ ID NO. 100: MMA-063 SEQ ID NO. 101: MMA-064 SEQ ID NO. 102: MMA-069 SEQ ID NO. 103: MMA-070 SEQ ID NO. 104: MMA-133 SEQ ID NO. 105: MMA-131 SEQ ID NO. 106: MMA-003 SEQ ID NO. 107: MMA-004 SEQ ID NO. 108: MMA-020 SEQ ID NO. 109: MMA-006 SEQ ID NO. 110: MMA-018 SEQ ID NO. 111: MMA-008 SEQ ID NO. 112: MMA-019 SEQ ID NO. 113: MMA-010 SEQ ID NO. 114: MMA-021 SEQ ID NO. 115: MMA-022 SEQ ID NO. 116: MMA-023 SEQ ID NO. 117: MMA-024 SEQ ID NO. 118: MAA-15 SEQ ID NO. 119: MAA-16 SEQ ID NO. 120: MMA-187 SEQ ID NO. 121: MMA-140 SEQ ID NO. 122: MMA-188 SEQ ID NO. 123: MMA-189 SEQ ID NO. 124: MMA-001 SEQ ID NO. 125: MMA-002 SEQ ID NO. 126: MMA-114 SEQ ID NO. 127: MMA-109 SEQ ID NO. 128: MMA-039 SEQ ID NO. 129: MMA-040 SEQ ID NO. 130: MMA-042 SEQ ID NO. 131: MMA-041 SEQ ID NO. 132: MMA-043TECHNICAL FIELD
BACKGROUND ART
CITATION LIST
Patent Document
Non-Patent Document
DISCLOSURE OF THE INVENTION
Problem to be Solved by the Invention
Means for Solving Problem
(4) The production method of any one of (1) to (3), in which the microbes having the ability to produce methacrylic acid are microbes capable of producing methacrylic acid from organic matters containing isobutyric acid or valine.
(5) The production method of any one of (1) to (4), in which the microbes having the ability to produce methacrylic acid are microbes having 16S rRNA gene which consists of a nucleotide sequence showing an identity of 81% or more to any one of nucleotide sequences described in SEQ ID NOS. 1 to 41.
(6) The production method of any one of (1) to (4), in which the microbes having the ability to produce methacrylic acid are microbes having LSUrRNA gene which consists of a nucleotide sequence showing an identity of 81% or more to any one of nucleotide sequences described in SEQ ID NOS. 42 to 49.
(7) The production method of any one of (1) to (6), in which the microbes having the ability to produce methacrylic acid are microbes belonging to the genus
(8) The production method of any one of (1) to (7), in which a methacrylic acid ester is produced by having an alcohol or a phenol to act on methacrylyl-CoA in the presence of AAT.
(9) The production method of (8), in which AAT is derived from a plant.
(10) The microbes having the ability to produce methacrylic acid of (7).
(11) An enzyme involved with synthesis of methacrylic acid, which is derived from the microbes of (10).
(12) A gene encoding the enzyme of (11).
(13) Methacrylic acid and/or an ester thereof produced by microbes having the ability to produce methacrylic acid from renewable raw materials and/or biomass arising from the utilization of the renewable raw materials as a carbon source and/or energy source.
(14) Culture product of microbes containing the microbes having the ability to produce methacrylic acid and methacrylic acid and/or an ester thereof.
(15) The enzyme of (11) which consists of a protein selected from the group consisting of the following (a) to (c):
(a) a protein which consists of an amino acid sequence represented by SEQ ID NO. 50 or 52
(b) a protein which consists an amino acid sequence showing an identity of 45% or more to a protein consisting of an amino acid sequence represented by SEQ ID NO. 50 or 52 and which has the ACD activity, and
(c) a protein which consists of an amino acid sequence with deletion, substitution, or addition of one or several amino acids in an amino acid sequence represented by SEQ ID NO. 50 or 52 and which has the ACD activity.
(16) A method for producing methacrylic acid and/or an ester thereof including using the enzyme of (15).
(17) The production method of any one of (1) to (7), in which the microbes having the ability to produce methacrylic acid are microbes belonging to the genus
(7A) The production method for producing a methacrylic acid ester of (5A), in which the plant belongs to a family selected from the group consisting of the family Musa, the family Rosales, the family Ericales, the family
(8A) The production method for producing a methacrylic acid ester of (5A), in which the plant belongs to genus selected from the group consisting of the genus
(9A) The production method for producing a methacrylic acid ester of (5A), in which the plant is any one selected from the group consisting of banana, strawberry, apple, Japanese apricot, pear, blueberry, kiwi, melon, papaya, and avocado.
(10A) The production method for producing a methacrylic acid ester of any one of (1A) to (9A), in which a genetically modified microbe with a gene introduced to express AAT is used.
(11A) The production method for producing a methacrylic acid ester of (5A), in which the plant is any one selected from plants belonging to the genus
(12A) The production method for producing a methacrylic acid ester of (5A), in which the plant is any one selected from plants belonging to the genus
(13A) The production method for producing a methacrylic acid ester of (5A), in which the plant is any one selected from the group consisting of banana, apple, Japanese apricot, pear, blueberry, kiwi, melon, papaya, and avocado.
(14A) The production method for producing a methacrylic acid ester of (5A), in which the plant is any one selected from the group consisting of banana, apple, pear, kiwi, melon, papaya, and avocado.
(3B) to (5B) to the same host or a different host and using the protein.
CH2═C(CH3)COO—R (Formula 1)Effect of the Invention
BRIEF DESCRIPTION OF DRAWINGS
EMBODIMENTS FOR CARRYING OUT THE INVENTION
(ii) G1 strain (Accession number: NITE BP-1458), G2 strain (Accession number: NITE BP-1459) strain, R1 strain (Accession number: NITE BP-1460),
(iii) B13 strain (Accession number: NITE BP-1461) which belongs to the genus
(iv)
(v)
(vi)
(vii)
(viii)
(ix)
(x)
(xi)
(xii)
(xiii)
(xiv)
(xv)
(xvi)
(xvii)
(xviii)
(xix)
(xx)
(xxi)
(xxii)
(xxiii)
(xxiv)
[Method for Selecting Microbes by Screening or the Like]
[Gene Recombinant Strain]
(2) Microbes which belong to the genus
(3) Microbes which belong to the genus
(4) Microbes which belong to the genus
(5) Microbes which belong to the genus
(6) Microbes which belong to the genus
(7) Microbes which belong to the genus
(8) Microbes which belong to the genus
(9) Microbes which belong to the genus
(10) Microbes which belong to the genus
(11) Microbes which belong to the genus
(12) Microbes which belong to the genus
(13) Microbes which belong to the genus
(14) Microbes which belong to the genus
(15) Microbes which belong to the genus
(16) Microbes which belong to the genus
(17) Microbes which belong to the genus
(18) Microbes which belong to the genus
(19) Microbes which belong to the genus
(20) Microbes which belong to the genus
(21) Microbes which have 16S rDNA containing the nucleotide sequence with the identity of 81% or more, preferably 88% or more, more preferably 95% or more, more preferably 97% or more, more preferably 98% or more, and even more preferably 99.5% or more to the partial nucleotide sequence of 16S rDNA of the
(22) Microbes which belong to the genus
(23) Microbes which belong to the genus
(24) Microbes which belong to the genus
(h) a gene consisting of an amino acid sequence with deletion, substitution, and/or addition of one or several amino acids in the amino acid sequence represented by SEQ ID NOS. 54, 56, 58, and 60, and encoding the protein having the BCKAD activity.
(i) a gene encoding the four polypeptides having an amino acid sequence represented by SEQ ID NOS. 62, 64, 66, and 68.
(j) a gene consisting of a nucleotide sequence represented by SEQ ID NOS. 63, 65, 67, and 69.
(k) a gene capable of hybridizing under stringent conditions to a complementary sequence of the gene encoding the four polypeptides having an amino acid sequence represented by SEQ ID NOS. 62, 64, 66, and 68 and encoding the protein having the BCKAD activity.
(l) a gene consisting of an amino acid sequence with deletion, substitution, and/or addition of one or several amino acids in the amino acid sequence represented by SEQ ID NOS. 62, 64, 66, and 68, and encoding the protein having the BCKAD activity.
(m) a gene encoding the three polypeptides having an amino acid sequence represented by SEQ ID NOS. 70, 72, and 74.
(n) a gene consisting of a nucleotide sequence represented by SEQ ID NOS. 71, 73, and 75.
(o) a gene capable of hybridizing under stringent conditions to a complementary sequence of the gene encoding the three polypeptides having an amino acid sequence represented by SEQ ID NOS. 70, 72, and 74 and encoding the protein having the BCKAD activity.
(p) a gene consisting of an amino acid sequence with deletion, substitution, and/or addition of one or several amino acids in the amino acid sequence represented by SEQ ID NOS. 70, 72, and 74, and encoding the protein having the BCKAD activity.
(ii) An amino acid sequence with substitution of 1 to 20 (for example, 1 to 10, preferably 1 to 5, and even more preferably 1 to 2) amino acids in the amino acid sequence represented by SEQ ID NOS. 54, 56, 58, and 60, the amino acid sequence represented by SEQ ID NOS. 62, 64, 66, and 68, or the amino acid sequence represented by SEQ ID NOS. 70, 72, and 74 with other amino acids.
(iii) An amino acid sequence with addition of 1 to 20 (for example, 1 to 10, preferably 1 to 5, and even more preferably 1 to 2) amino acids in the amino acid sequence represented by SEQ ID NOS. 54, 56, 58, and 60, the amino acid sequence represented by SEQ ID NOS. 62, 64, 66, and 68, or the amino acid sequence represented by SEQ ID NOS. 70, 72, and 74.
(iv) An amino acid sequence with insertion of 1 to 20 (for example, 1 to 10, preferably 1 to 5, and even more preferably 1 to 2) amino acids to the amino acid sequence represented by SEQ ID NOS. 54, 56, 58, and 60, the amino acid sequence represented by SEQ ID NOS. 62, 64, 66, and 68, or the amino acid sequence represented by SEQ ID NOS. 70, 72, and 74.
(v) An amino acid sequence having a combination of (i) to (iv).
EXAMPLES
Example 1: Search for Methacrylic Acid-Producing Microbes
1. Morphological properties Culture conditions Nutrient agar medium 30° C. Shape of cell Bacillus (0.6 to 0.7 × 1.5 to 2.0 μm) Presence or absence of cell pleomorphism − Motility (attachment state of flagella) + Presence or absence of spore (spore − location) 2. Cultural properties Culture conditions Nutrient agar medium 30° C. Color Pale yellow color Gloss + Pigment production − Culture conditions Nutrient broth medium 30° C. Presence or absence of surface growth − Presence or absence of turbidity in + medium Culture conditions Gelatin stab culture 30° C. Growth state + Gelatin liquefaction − Culture conditions Litmus milk 30° C. Solidification − Liquefaction − 3. Physiological properties Gram stain − Nitrate salt reduction − Denitrification − MR test − VP test + Indole production − Hydrogen sulfide production − Hydrolysis of starch − Use of citric acid (Koser) + (Christensen) + Use of inorganic Nitrate salt + nitrogen source Ammonium salt + Urease activity − Catalase + Oxidase + Growth range 5 + pH 8 + 9 + Growth range 15 + Temperature 20 + (° C.) 37 − 45 − Anaerobic growing property + O•F Test (oxidation/fermentation) +/− 4. Acid production/gas production from carbohydrates L-Arabinose +/− D-Xylose −/− D-Glucose +/− D-Mannose +/− D-Fructose −/− D-Galactose +/− Maltose −/− Saccharose −/− Lactose −/− Trehalose −/− D-Sorbitol −/− D-Mannitol −/− Inositol −/− Glycerin −/− 5. Other physiological properties β-Galactosidase activity − Arginine dehydrolase activity + Lysine decarboxylase activity − Tryptophan deaminase activity − Gelatinase activity − 1. Morphological properties Culture conditions Nutrient agar medium 30° C. Shape of cell Bacillus (0.7 to 0.8 × 1.2 to 2.0 μm) Presence or absence of cell pleomorphism − Motility (attachment state of flagella) +(Ciliate) Presence or absence of spore (spore − location) 2. Cultural properties Culture conditions Nutrient agar medium 30° C. Color Pale yellow color Gloss + Pigment production − Culture conditions Nutrient broth medium 30° C. Presence or absence of surface growth − Presence or absence of turbidity in + medium Culture conditions Gelatin stab culture 30° C. Growth state + Gelatin liquefaction − Culture conditions Litmus milk 30° C. Solidification − Liquefaction − 3. Physiological properties Gram stain − Nitrate salt reduction − Denitrification − MR test + VP test + Indole production − Hydrogen sulfide production − Hydrolysis of starch − Use of citric acid (Koser) − (Christensen) + Use of inorganic Nitrate salt + nitrogen source Ammonium salt + Urease activity − Catalase + Oxidase + Growth range 5 + pH 8 + 9 − Growth range 15 + Temperature 20 + (° C.) 37 − 45 − Anaerobic growing property + O•F Test (oxidation/fermentation) +/− 4. Acid production/gas production from carbohydrates L-Arabinose −/− D-Xylose −/− D-Glucose +/− D-Mannose +/− D-Fructose −/− D-Galactose +/− Maltose −/− Saccharose −/− Lactose −/− Trehalose −/− D-Sorbitol −/− D-Mannitol −/− Inositol −/− Glycerin +w/− 5. Other physiological properties β-Galactosidase activity − Arginine dehydrolase activity + Lysine decarboxylase activity + Tryptophan deaminase activity − Gelatinase activity − 1. Morphological properties Culture conditions Nutrient agar medium 30° C. Shape of cell Bacillus (0.8 to 0.9 × 1.2 to 1.5 μm) Presence or absence of cell pleomorphism − Motility (attachment state of flagella) +(Ciliate) Presence or absence of spore (spore − location) 2. Cultural properties Culture conditions Nutrient agar medium 30° C. Color Pale yellow color Gloss + Pigment production − Culture conditions Nutrient broth medium 30° C. Presence or absence of surface growth − Presence or absence of turbidity in + medium Culture conditions Gelatin stab culture 30° C. Growth state + Gelatin liquefaction − Culture conditions Litmus milk 30° C. Solidification − Liquefaction − 3. Physiological properties Gram stain − Nitrate salt reduction + Denitrification − MR test − VP test + Indole production − Hydrogen sulfide production − Hydrolysis of starch − Use of citric acid (Koser) + (Christensen) + Use of inorganic Nitrate salt + nitrogen source Ammonium salt + Urease activity − Catalase + Oxidase + Growth range 5 + pH 8 + 9 +w Growth range 15 + Temperature 20 + (° C.) 37 − 45 − Anaerobic growing property + O•F Test (oxidation/fermentation) +/− 4. Acid production/gas production from carbohydrates L-Arabinose +/− D-Xylose −/− D-Glucose +/− D-Mannose +/− D-Fructose −/− D-Galactose +/− Maltose −/− Saccharose −/− Lactose −/− Trehalose −/− D-Sorbitol −/− D-Mannitol −/− Inositol −/− Glycerin +/− 5. Other physiological properties β-Galactosidase activity − Arginine dehydrolase activity + Lysine decarboxylase activity + Tryptophan deaminase activity − Gelatinase activity − 1. Morphological properties Culture conditions Nutrient agar medium 30° C. Shape of cell Bacillus (0.8 to 0.9 × 1.2 to 2.0 μm) Presence or absence of cell pleomorphism − Motility (attachment state of flagella) +(Ciliate) Presence or absence of spore (spore − location) 2. Cultural properties Culture conditions Nutrient agar medium 30° C. Color Pale yellow color Gloss + Pigment production − Culture conditions Nutrient broth medium 30° C. Presence or absence of surface growth − Presence or absence of turbidity in + medium Culture conditions Gelatin stab culture 30° C. Growth state + Gelatin liquefaction − Culture conditions Litmus milk 30° C. Solidification − Liquefaction − 3. Physiological properties Gram stain − Nitrate salt reduction − Denitrification − MR test − VP test + Indole production − Hydrogen sulfide production − Hydrolysis of starch − Use of citric acid (Koser) + (Christensen) + Use of inorganic Nitrate salt + nitrogen source Ammonium salt + Urease activity − Catalase + Oxidase + Growth range 5 + pH 8 + 9 − Growth range 15 + Temperature 20 + (° C.) 37 − 45 − Anaerobic growing property + O•F Test (oxidation/fermentation) +/− 4. Acid production/gas production from carbohydrates L-Arabinose +/− D-Xylose −/− D-Glucose +/− D-Mannose +/− D-Fructose −/− D-Galactose +/− Maltose −/− Saccharose −/− Lactose −/− Trehalose −/− D-Sorbitol −/− D-Mannitol −/− Inositol −/− Glycerin +/− 5. Other physiological properties β-Galactosidase activity − Arginine dehydrolase activity + Lysine decarboxylase activity + Tryptophan deaminase activity − Gelatinase activity − 1. Morphological properties Culture conditions Nutrient agar medium 30° C. Shape of cell Bacillus (0.7 to 0.8 × 1.2 to 1.5 μm) Presence or absence of cell pleomorphism − Motility (attachment state of flagella) +(Ciliate) Presence or absence of spore (spore − location) 2. Cultural properties Culture conditions Nutrient agar medium 30° C. Color Pale yellow color Gloss + Pigment production − Culture conditions Nutrient broth medium 30° C. Presence or absence of surface growth − Presence or absence of turbidity in + medium Culture conditions Gelatin stab culture 30° C. Growth state + Gelatin liquefaction − Culture conditions Litmus milk 30° C. Solidification − Liquefaction − 3. Physiological properties Gram stain − Nitrate salt reduction + Denitrification − MR test − VP test + Indole production − Hydrogen sulfide production − Hydrolysis of starch − Use of citric acid (Koser) + (Christensen) + Use of inorganic Nitrate salt + nitrogen source Ammonium salt + Urease activity − Catalase + Oxidase + Growth range 5 + pH 8 + 9 − Growth range 15 + Temperature 20 + (° C.) 37 − 45 − Anaerobic growing property + O•F Test (oxidation/fermentation) +/− 4. Acid production/gas production from carbohydrates L-Arabinose +/− D-Xylose −/− D-Glucose +/− D-Mannose +/− D-Fructose −/− D-Galactose +/− Maltose −/− Saccharose −/− Lactose −/− Trehalose −/− D-Sorbitol −/− D-Mannitol −/− Inositol −/− Glycerin +/− 5. Other physiological properties β-Galactosidase activity − Arginine dehydrolase activity − Lysine decarboxylase activity − Tryptophan deaminase activity − Gelatinase activity − 1. Morphological properties Culture conditions Nutrient agar medium 30° C. Shape of cell Bacillus (0.7 to 0.8 × 1.5 to 2.0 μm) Presence or absence of cell pleomorphism − Motility (attachment state of flagella) +(Ciliate) Presence or absence of spore (spore − location) 2. Cultural properties Culture conditions Nutrient agar medium 30° C. Color Pale yellow color Gloss + Pigment production − Culture conditions Nutrient broth medium 30° C. Presence or absence of surface growth − Presence or absence of turbidity in + medium Culture conditions Gelatin stab culture 30° C. Growth state + Gelatin liquefaction − Culture conditions Litmus milk 30° C. Solidification − Liquefaction − 3. Physiological properties Gram stain − Nitrate salt reduction + Denitrification − MR test − VP test + Indole production − Hydrogen sulfide production − Hydrolysis of starch − Use of citric acid (Koser) + (Christensen) + Use of inorganic Nitrate salt + nitrogen source Ammonium salt + Urease activity − Catalase + Oxidase + Growth range 5 + pH 8 + 9 +w Growth range 15 + Temperature 20 + (° C.) 37 +w 45 − Anaerobic growing property + O•F Test (oxidation/fermentation) +/− 4. Acid production/gas production from carbohydrates L-Arabinose +/− D-Xylose −/− D-Glucose +/− D-Mannose +/− D-Fructose −/− D-Galactose +/− Maltose −/− Saccharose −/− Lactose −/− Trehalose −/− D-Sorbitol −/− D-Mannitol −/− Inositol −/− Glycerin +w/− 5. Other physiological properties β-Galactosidase activity − Arginine dehydrolase activity + Lysine decarboxylase activity + Tryptophan deaminase activity − Gelatinase activity − 1. Morphological properties Culture conditions Nutrient agar medium 30° C. Shape of cell Bacillus (0.7 to 0.8 × 1.2 to 1.5 μm) Presence or absence of cell pleomorphism − Motility (attachment state of flagella) +(Ciliate) Presence or absence of spore (spore − location) 2. Cultural properties Culture conditions Nutrient agar medium 30° C. Color Pale yellow color Gloss + Pigment production − Culture conditions Nutrient broth medium 30° C. Presence or absence of surface growth − Presence or absence of turbidity in + medium Culture conditions Gelatin stab culture 30° C. Growth state + Gelatin liquefaction − Culture conditions Litmus milk 30° C. Solidification − Liquefaction − 3. Physiological properties Gram stain − Nitrate salt reduction + Denitrification − MR test − VP test + Indole production − Hydrogen sulfide production − Hydrolysis of starch − Use of citric acid (Koser) − (Christensen) + Use of inorganic Nitrate salt + nitrogen source Ammonium salt + Urease activity − Catalase + Oxidase + Growth range 5 + pH 8 + 9 +w Growth range 15 + Temperature 20 + (° C.) 37 − 45 − Anaerobic growing property + O•F Test (oxidation/fermentation) +/− 4. Acid production/gas production from carbohydrates L-Arabinose +/− D-Xylose −/− D-Glucose −/− D-Mannose +/− D-Fructose −/− D-Galactose +/− Maltose −/− Saccharose −/− Lactose −/− Trehalose −/− D-Sorbitol −/− D-Mannitol −/− Inositol −/− Glycerin +w/− 5. Other physiological properties β-Galactosidase activity − Arginine dehydrolase activity + Lysine decarboxylase activity + Tryptophan deaminase activity − Gelatinase activity − 1. Morphological properties Culture conditions Nutrient agar medium 30° C. Shape of cell Bacillus (1.0 × 1.5 to 2.5 μm) Presence or absence of cell pleomorphism − Motility (attachment state of flagella) +(Peritrichous flagella) Presence or absence of spore (spore +(Center to closed to end) location) 2. Cultural properties Culture conditions Nutrient agar medium 30° C. Color Cream color Gloss − Pigment production − Culture conditions Nutrient broth medium 30° C. Presence or absence of surface growth − Presence or absence of turbidity in + medium Culture conditions Gelatin stab culture 30° C. Growth state + Gelatin liquefaction + Culture conditions Litmus milk 30° C. Solidification + Liquefaction − 3. Physiological properties Gram stain + Nitrate salt reduction − Denitrification + MR test + VP test + Indole production − Hydrogen sulfide production − Hydrolysis of starch + Use of citric acid (Koser) − (Christensen) + Use of inorganic Nitrate salt − nitrogen source Ammonium salt − Urease activity − Catalase + Oxidase + Growth range 5 + pH 8 + 9 + Growth range 15 + Temperature 20 + (° C.) 37 + 45 − Anaerobic growing property + O•F Test (oxidation/fermentation) −/− 4. Acid production/gas production from carbohydrates L-Arabinose −/− D-Xylose −/− D-Glucose +/− D-Mannose −/− D-Fructose +/− D-Galactose −/− Maltose +/− Saccharose −/− Lactose −/− Trehalose +/− D-Sorbitol −/− D-Mannitol −/− Inositol −/− Glycerin +/− 5. Other physiological properties β-Galactosidase activity − Arginine dehydrolase activity + Lysine decarboxylase activity − Tryptophan deaminase activity − Gelatinase activity + 1. Morphological properties Culture conditions Nutrient agar medium 30° C. Shape of cell Bacillus (1.0 × 1.5 to 2.5 μm) Presence or absence of cell pleomorphism − Motility (attachment state of flagella) +(Peritrichous flagella) Presence or absence of spore (spore +(Center to close to end) location) 2. Cultural properties Culture conditions Nutrient agar medium 30° C. Color Cream color Gloss − Pigment production − Culture conditions Nutrient broth medium 30° C. Presence or absence of surface growth − Presence or absence of turbidity in + medium Culture conditions Gelatin stab culture 30° C. Growth state + Gelatin liquefaction + Culture conditions Litmus milk 30° C. Solidification + Liquefaction − 3. Physiological properties Gram stain + Nitrate salt reduction − Denitrification + MR test + VP test + Indole production − Hydrogen sulfide production − Hydrolysis of starch + Use of citric acid (Koser) − (Christensen) + Use of inorganic Nitrate salt − nitrogen source Ammonium salt − Urease activity − Catalase + Oxidase + Growth range 5 + pH 8 + 9 + Growth range 15 + Temperature 20 + (° C.) 37 + 45 − Anaerobic growing property + O•F Test (oxidation/fermentation) −/− 4. Acid production/gas production from carbohydrates L-Arabinose −/− D-Xylose −/− D-Glucose +/− D-Mannose −/− D-Fructose +/− D-Galactose −/− Maltose +/− Saccharose +/− Lactose −/− Trehalose +/− D-Sorbitol −/− D-Mannitol −/− Inositol −/− Glycerin +/− 5. Other physiological properties β-Galactosidase activity − Arginine dehydrolase activity + Lysine decarboxylase activity − Tryptophan deaminase activity − Gelatinase activity + 1. Morphological properties Culture conditions Nutrient agar medium 30° C. Shape of cell Bacillus (0.7 to 0.8 × 1.5 to 2.5 μm) Presence or absence of cell pleomorphism − Motility (attachment state of flagella) +(Peritrichous flagella) Presence or absence of spore (spore +(Center to close to end) location) 2. Cultural properties Culture conditions Nutrient agar medium 30° C. Color Pale yellow color Gloss + Pigment production − Culture conditions Nutrient broth medium 30° C. Presence or absence of surface growth − Presence or absence of turbidity in + medium Culture conditions Gelatin stab culture 30° C. Growth state + Gelatin liquefaction − Culture conditions Litmus milk 30° C. Solidification − Liquefaction − 3. Physiological properties Gram stain + Nitrate salt reduction + Denitrification − MR test − VP test − Indole production − Hydrogen sulfide production − Hydrolysis of starch − Use of citric acid (Koser) − (Christensen) − Use of inorganic Nitrate salt − nitrogen source Ammonium salt − Urease activity − Catalase + Oxidase − Growth range 5 − pH 8 + 9 + Growth range 15 + Temperature 20 + (° C.) 37 + 45 − Anaerobic growing property − O•F Test (oxidation/fermentation) −/− 4. Acid production/gas production from carbohydrates L-Arabinose −/− D-Xylose +/− D-Glucose +/− D-Mannose −/− D-Fructose +/− D-Galactose −/− Maltose +/− Saccharose +/− Lactose −/− Trehalose +/− D-Sorbitol −/− D-Mannitol +/− Inositol −/− Glycerin +/− 5. Other physiological properties β-Galactosidase activity − Arginine dehydrolase activity − Lysine decarboxylase activity − Tryptophan deaminase activity − Gelatinase activity + 1. Morphological properties Culture conditions Nutrient agar medium 30° C. Shape of cell Bacillus (0.6 to 0.77 × 1.2 to 1.5 μm) Presence or absence of cell pleomorphism − Motility (attachment state of flagella) − Presence or absence of spore (spore − location) 2. Cultural properties Culture conditions Nutrient agar medium 30° C. Color Yellow color Gloss + Pigment production + Culture conditions Nutrient broth medium 30° C. Presence or absence of surface growth − Presence or absence of turbidity in + medium Culture conditions Gelatin stab culture 30° C. Growth state + Gelatin liquefaction + Culture conditions Litmus milk 30° C. Solidification + Liquefaction − 3. Physiological properties Gram stain − Nitrate salt reduction − Denitrification − MR test − VP test + Indole production − Hydrogen sulfide production − Hydrolysis of starch − Use of citric acid (Koser) − (Christensen) − Use of inorganic Nitrate salt + nitrogen source Ammonium salt + Urease activity + Catalase + Oxidase + Growth range 5 − pH 8 + 9 + Growth range 15 + Temperature 20 + (° C.) 37 + 45 − Anaerobic growing property + O•F Test (oxidation/fermentation) +/− 4. Acid production/gas production from carbohydrates L-Arabinose −/− D-Xylose −/− D-Glucose +/− D-Mannose +/− D-Fructose −/− D-Galactose +/− Maltose +/− Saccharose −/− Lactose +/− Trehalose −/− D-Sorbitol −/− D-Mannitol −/− Inositol −/− Glycerin +/− 5. Other physiological properties β-Galactosidase activity + Arginine dehydrolase activity − Lysine decarboxylase activity − Tryptophan deaminase activity − Gelatinase activity + Example 2: Production of Methacrylic Acid Using Synthetic Medium
D22-1 22 72 0.05 D41-2 19 44 0.06 D43-1 22 72 0.06 Example 3: Production of Methacrylic Acid Using Natural Medium
Example 4: Production of Methacrylic Acid Based on Resting Cell Reaction
B25-2 17 0.2 D22-1 17 0.3 D43-1 15 0.2 D25 17 1.0 D26 18 0.8 D29 18 0.2 D41-2 13 0.7 G1 21 10 G2 21 10 R1 20 12 B13 31 10 Example 5: Production of Methacrylic Acid in Synthetic Medium Using Genus
Example 6: Production of Methacrylic Acid in Synthetic Medium Using Genus
Brevundimonas 3 3 2 0.1 subvibrioides NBRC16000 Ochrobactrum 3 3 2 1.0 grignonense NBRC102586 Ochrobactrum 3 3 2 0.2 lupini NBRC102587 Paracoccus 3 4 2 0.3 aminophilus NBRC16710 Example 7: Production of Methacrylic Acid in Synthetic Medium Using Genus
Sphingomonas 3 1 6 0.2 paucimobilis NBRC13935 Ochrobactrum 3 3 3 0.6 intermedium NBRC15820 Paenibacillus 3 2 3 0.1 sp. NBRC13157 Mesorhizobium 6 4 3 0.2 loti ATCC700743 Example 8: Production of methacrylic acid in synthetic medium using genus
Example 9: Production of Methacrylic Acid in Natural Medium Using Genus
Example 10: Production of Methacrylic Acid in Natural Medium Using Genus
Example 11: Production of Methacrylic Acid Using Yeast
Example 12: Production of Methacrylic Acid Using Mildew
Concentration of methacrylic acid (ppm) Analysis Analysis Microbial strain condition A condition B Aspergillus flavus 0.3 0.5 NBRC8558 Aspergillus oryzae 0.1 0.04 NBRC4255 Example 13: Production of Methacrylic Acid Based on Resting Cell Reaction Using Genus
Number of Number of Concentration of days for days for methacrylic acid (ppm) pre-culture main culture After After Microbial strain (days) (days) 5 hours 24 hours Sphingomonas 1 6 0.2 0.1 paucimobilis NBRC 13935 Pedobacter 3 3 1.2 2.8 heparinus NBRC12017 Bacillus 2 3 0.1 0.4 subtilis NBRC12210 Listonella 3 3 ND 0.4 anguillarum ATCC19264 (ND: Not Detected) Example 14: Production of Methacrylic Acid Based on Resting Cell Reaction Using Genus
Number of Number of Concentration of days for days for methacrylic acid (ppm) pre-culture main culture After After Microbial strain (days) (days) 5 hours 24 hours Ochrobactrum 3 2 1.4 18.1 grignonense NBRC 102586 Ochrobactrum 3 2 1.0 4.9 lupini NBRC 102587 Paracoccus 4 2 0.3 2.5 aminophilus NBRC16710 Example 15: Production of Methacrylic Acid Based on Resting Cell Reaction Using Genus
Bacillus megaterium NBRC15308 0.1 Bacillus simplex ATCC49097 0.1 Streptomyces griseus NBRC13350 0.1 Example 16: Production of Methacrylic Acid Based on Resting Cell Reaction Using Genus
Concentration of methacrylic acid (ppm) Substrate for After After Microbial strain resting reaction 5 hours 24 hours Comamonas terrigena Isobutyric acid 1.7 5.2 NBRC13299 Acinetobacter junii Valine ND 0.3 ATCC17908 Xanthobacter autotrophicus Valine 0.1 0.1 ATCC35674 (ND: Not Detected) Example 17: Production of Methacrylic Acid Based on Resting Cell Reaction Using Genus
Concentration of Number of days methacrylic acid (ppm) for main After After Microbial strain culture (days) 5 hours 24 hours Ochrobactrum sp. 3 2.9 5.7 NBRC12951 Ochrobactrum intermedium 4 3.4 14.4 NBRC13694 Ochrobactrum anthropi 4 0.7 1.6 ATCC49237 Achromobacter denitrificans 3 0.3 NBRC12669 Acinetobacter haemolyticus 3 0.1 ATCC17906 Example 18: Production of Methacrylic Acid Based on Resting Cell Reaction Using Genus
Example 19: Production of Methacrylic Acid Based on Resting Cell Reaction Using Genus
Example 20: Production of methacrylic acid based on resting cell reaction using genus
Example 21: Production of Methacrylic Acid Based on Resting Cell Reaction Using Genus
Example 22: Production of Methacrylic Acid Based on Resting Cell Reaction Using Thermophillic Bacteria
Example 23: Production of Methacrylic Acid Based on Resting Cell Reaction Using Yeast
Resting Pre-culture Main culture cell Number Number reaction Microbial strain Medium of days Substrate of days Substrate Saccharomyces Medium 1 1 Isobutyric 3 Isobutyric cerevisiae acid acid NBRC1136 Saccharomyces Medium 1 1 Isobutyric 3 Isobutyric cerevisiae acid acid NBRC2347 Saccharomyces Medium 2 4 Isobutyric 2 Isobutyric paradoxus acid acid NBRC10609 Candida Medium 2 3 Valine 2 Valine parapsilosis ATCC22019 Saccharomyces cerevisiae NBRC1136 0.1 Saccharomyces cerevisiae NBRC2347 0.2 Saccharomyces paradoxus NBRC10609 0.2 Candida parapsilosis ATCC22019 0.2 Example 24: Production of Methacrylic Acid Based on Resting Cell Reaction Using Mildew
Concentration of methacrylic acid (ppm) After 5 hours After 24 hours Analysis Analysis Analysis Analysis condition condition condition condition Microbial strain A B A B Aspergillus niger ND ND 0.1 1.7 ATCC6275 Aspergillus flavus 0.5 0.7 1.1 1.4 NBRC8558 Aspergillus oryzae 0.4 0.4 0.7 0.8 NBRC4255 (ND: Not Detected) Example 25: Identity Comparison Using Genus
Pseudomonas sp. D29 99% 98% 97% 97% 96% 95% 95% Pseudomonas sp. D41-2 99% 98% 97% 97% 95% 96% 96% Pseudomonas sp. D43-1 98% 98% 98% 98% 97% 96% 96% Pseudomonas putida NBRC12996 97% 97% 98% 98% 97% 98% 97% Pseudomonas sp. B25-2 97% 97% 98% 98% 96% 97% 97% Pseudomonas sp. B22-1 96% 95% 97% 97% 96% 99% 98% Pseudomonas sp. D25 95% 96% 96% 98% 97% 99% 98% Pseudomonas sp. D26 95% 96% 96% 97% 97% 98% 98%
SEQ ID NO. 9 to 15
Bacillus subtilis NBRC12210 93% 90% 89% 89% 92% 91% Bacillus sp. R1 93% 92% 92% 91% 89% 89% Bacillus badius ATCC14574 90% 92% 89% 90% 88% 88% Bacillus megaterium NBRC15308 89% 92% 89% 92% 90% 90% Bacillus simplex ATCC49097 89% 91% 90% 92% 89% 89% Bacillus sp. G1 92% 89% 88% 90% 89% Bacillus sp. G2 91% 89% 88% 90% 89% 99% 99%
SEQ ID NOS. 18 to 20
Brevundimonas 96% 96% diminuta ATCC11568 Brevundimonas 96% 95% subvibrioides NBRC16000 Brevundimonas 96% 95% vesicularis ATCC11426
SEQ ID NOS. 22 to 26
Ochrobactrum intermedium NBRC13694 100% 100% 98% 97% Ochrobactrum lupini NBRC 102587 100% 100% 98% 97% Ochrobactrum sp. NBRC12951 100% 100% 98% 97% Ochrobactrum intermedium NBRC15820 98% 98% 98% 97% Ochrobactrum grignonense NBRC102586 97% 97% 97% 97%
SEQ ID NOS. 30 to 31
Acinetobacter haemolyticus 95% ATCC17906 Acinetobacter junii ATCC17908 95%
SEQ ID NOS. 42 to 44
Saccharomyces 100% 98% cerevisiae NBRC1136 Saccharomyces 100% 98% cerevisiae NBRC2347 Saccharomyces 98% 98% paradoxus NBRC10609
SEQ ID NOS. 45 to 46
Candida utilis NBRC1086 81% Candida parapsilosis ATCC22019 81%
SEQ ID NOS. 47 to 49
Aspergillus niger 96% 96% ATCC6275 Aspergillus flavus 96% 100% NBRC8558 Aspergillus oryzae 96% 100% NBRC4255 Reference Example 1: Preparation of Recipient PR4KS for Conjugal Transfer
Reference Example 2: Cloning of LigD Homolog Gene and Production of Plasmid for Gene Deletion
Primers GB-138: (SEQ ID NO. 94) 5′-GGCCTGCAGGTACCGATCATCACCATCGGTGTC-3′ GB-139: (SEQ ID NO. 95) 5′-GGTCTAGACTGAGCAGTGTTCCAATGCG-3′
Composition of Reaction Solution
Primers GB-140: (SEQ ID NO. 96) GAGGAAATGGTCACAGGGCGAGAATAGGTTG GB-141: (SEQ ID NO. 97) GCCCTGTGACCATTTCCTCATTGTGCTGG
Composition of Reaction Solution
Reference Example 3: Production of the PR4KS Derivative Strain in which LigD Homolog Gene is Deleted
Example 26: Production of Plasmid pLK005 for Bacteria of Genus
Example 27: Production of Derivative Strain in which RE_acd1/RE_echA/RE_hchA/RE_mmsB gene of PR4KSΔligD Derivative Strain is Deleted
Primer for fragment 1 MMA-061: (SEQ ID NO. 98) CGACTCTAGAGGATCGCTCAGTACATCTACGAGAC MMA-062: (SEQ ID NO. 99) AGTGTGAGGAAAGTGTTCCGATCAGTTCAT Primer for fragment 2 MMA-063: (SEQ ID NO. 100) CACTTTCCTCACACTCGTCGAGAGTATGAG MMA-064: (SEQ ID NO. 101) CGGTACCCGGGGATCAGCGCGACGAACAACGAGAC
Composition of Reaction Solution
Primer MMA-069: (SEQ ID NO. 102) GCGCATCTACAAGGAAGAGATC MMA-070: (SEQ ID NO. 103) GCGACGCTCATCGAGATCTC
Composition of Reaction Solution
Example 28: Production of Plasmid for Expression of ACD or AAT in Bacteria of genus
Primer for RE_acd1 MMA-114 (SEQ ID NO. 126) GGTCTAGAATGTTTACTCTGACCGATGACGAGCG MMA-022 (SEQ ID NO. 115) GGCCTGCAGGCCGTCACGCTTTTCGATCAATAC Primer for MpAAT1 MMA-109 (SEQ ID NO. 127) GGTCTAGAATGAAATCATTCTCAGTACTTCAG MMA-045 (SEQ ID NO. 83) CGGTACGCGCGGATCTTCCAGAG
Template for RE_acd1
Example 29: Production of Plasmid for Expression of Both ACD and AAT for Transformation of Genus
Primer MMA-133 (Sse-ProFw): (SEQ ID NO. 104) TGACCTGCAGGTGCACTCCGCTGCGACATGTATCGA MMA-131 (Sse-001Rv): (SEQ ID NO. 105) ACTCTAGCCTGCAGGTCATTGACTAGTTGATCTAAGGTTGTTACA
Composition for PCR Reaction
Example 30: Production of Methacrylic Acid Using Genus
Example 31: Production of Butyl Methacrylate Using Genus
DMA008/pLK005 0 DMA008/pACDAAT1 7.51 DMA008/pACDAAT2 2.06 DMA008/pACDAAT3 4.34 DMA008/pACDAAT4 0.46 DMA008/pACDAAT6 2.18 DMA008/pACDAAT8 0.52 Example 32: Production of Methacrylic Acid Ester Using Genus
Production amount (mM) Butyl Isobutyl 2-Ehtylhexyl Recombinant methacrylate methacrylate methacrylate DMA008/pLK005 0 0 0 DMA008/pACDAAT1 0.01 0.006 0.02 Example 33: Cloning of ACD Homolog (ACD) Gene from
Isobutyryl CoA Obtained plasmid dehydrogenase PCR Primer pTrc99A homolog Forward Reverse Vector pET Vector PA_acd1 MMA-003 MMA-004 pMMA002 pMMA102 PA_acd2 MMA-020 MMA-006 pMMA003 pMMA103 PA_acd3 MMA-018 MMA-008 pMMA004 pMMA104 PA_acd4 MMA-019 MMA-010 pMMA005 pMMA105 Oligonucleotide primer MMA-003: (SEQ ID NO. 106) 5′-GACCCATGGATTTCGACCTCACCGAAGAAC-3′ MMA-004: (SEQ ID NO. 107) 5′-GCCCTGCAGGATGCGATGGTTCGCGGCGTTC-3′ MMA-020: (SEQ ID NO. 108) 5′-GGACATGTTTCGTGATCCGGAAACCCTGAAC-3′ MMA-006: (SEQ ID NO. 109) 5′-GGCCTGCAGGCGAAGGATCGACGCTAGCCCTG-3′ MMA-018: (SEQ ID NO. 110) 5′-GGACATGTTTCCCTGCGAAGAAGAGATCCAG-3′ MMA-008: (SEQ ID NO. 111) 5′-GGCCTGCAGGCGCCGTTGCGGAAACGACGG-3′ MMA-019: (SEQ ID NO. 112) 5′-GGCCATGGTACCGAGAACCCTGTTCAGCTC-3′ MMA-010: (SEQ ID NO. 113) 5′-GGCCTGCAGGCTGGACGAGGAGGTGCTCGC-3′
Composition of Reaction Solution
Example 34: Cloning of ACD Homolog Gene from
Isobutyryl CoA Obtained plasmid dehydrogenase PCR Primer pTrc99A homolog Forward Reverse Vector pET Vector RE_acd1 MMA 021 MMA 022 pMMA009 pMMA109 RE_acd2 MMA 023 MMA 024 pMMA010 pMMA110 Oligonucleotide primer MMA-021: (SEQ ID NO. 114) 5′-GGACATGTTTACTCTGACCGATGACGAGCG-3′ MMA-022: (SEQ ID NO. 115) 5′-GGCCTGCAGGCCGTCACGCTTTTCGATCAATAC-3′ MMA-023: (SEQ ID NO. 116) 5′-CCACATGTCCGATTACCTTGCCACCGGAGC-3′ MMA-024: (SEQ ID NO. 117) 5′-GGCCTGCAGGATCTTCTTGGGGTTCGTCACAAC-3′ Example 35: Production of Cell Extract from Recombinant in which ACD Homolog Gene is Expressed and Analysis of Protein Expression
Example 36: Measurement of ACD Activity of Cell Extract
pTrc99A PA_acd1 JM109/pMMA002 0.63 PA_acd2 JM109/pMMA003 0 PA_acd3 JM109/pMMA004 <0.01 PA_acd4 JM109/pMMA005 0.024 RE_acd1 JM109/pMMA009 0.063 RE_acd2 JM109/pMMA010 0 acdH JM109/pMMA001 <0.01 pET19b PA_acd1 BL21(DE3)/pMMA102 0.44 PA_acd2 BL21(DE3)/pMMA103 0 PA_acd3 BL21(DE3)/pMMA104 0.010 PA_acd4 BL21(DE3)/pMMA105 <0.01 RE_acd1 BL21(DE3)/pMMA109 0.009 RE_acd2 BL21(DE3)/pMMA110 0 acdH BL21(DE3)/pMMA102 <0.01 Example 37: Cloning of BCKAD Gene, Production of Recombinant with High Expression, Preparation of Cell Extract, and Analysis of Protein Expression
Gene of Obtained plasmid 2-oxoisovaleric acid PCR Primer pTrc99A pET dehydrogenase complex Forward Reverse Vector Vector BCKAD MMA 15 MMA 16 pWA108 pWA008 Oligonucleotide primer MAA-15: (SEQ ID NO. 118) 5′-GGCCTGTCATGAGTGATTACGAGCCG-3′ MAA-16: (SEQ ID NO. 119) 5′-CGGCCCTGCAGGTTCGCGGGAATCAGATGTGC-3′ Example 38: Cloning of BCKAD Gene from Bacteria of Genus
Oligonucleotide primer MMA-187: (SEQ ID NO. 120) 5′-GGTCATGACTCTTGTCGAGCCCTTG-3′ MMA-140: (SEQ ID NO. 121) 5′-GACCTGCAGGTCCTCTTCTGGTCATGGTTC-3′ Example 39: Cloning of BCKAD Gene from Bacteria of Genus
Oligonucleotide primer MMA-188: (SEQ ID NO. 122) 5′-AGGAAACAGACCATGATCGACAACCTCGATTA-3′ MMA-189: (SEQ ID NO. 123) 5′-CTTGCATGCCTGCAGGCTCACTCGTTCCTTTTTACAG-3′ Example 40: Measurement of Activity of Cell Extract of Recombinant which Expresses BCKAD Gene at High Level
Example 41: Synthesis of Methacrylyl-CoA from 2-Oxoisovaleric Acid Using Mixture of Cell Extracts of Recombinant with High Expression of BCKAD Gene and Recombinant in which ACD Homolog Gene is Expressed
Example 42: Synthesis of Butyl Methacrylate
Example 43: Production of Plasmid for
Fw Primer MMA-039 (SEQ ID NO. 128) TAGAGTCGACCTGCACGAGATCTCGATCCCGCGAAAT Rv Primer MMA-040 (SEQ ID NO. 129) GCTTGCATGCCTGCACAGCAGCCAACTCAGCTTCCTTT
Composition of Reaction Solution
Fw Primer MMA-042 (SEQ ID NO. 130) TAGAGTCGACCTGCACCTCTAGAAATAATTTTGTTTA Rv Primer MMA-040 (SEQ ID NO. 129) GCTTGCATGCCTGCACAGCAGCCAACTCAGCTTCCTTT Fw Primer MMA-041 (SEQ ID NO. 131) CCATCGCATCCTGCACGAGATCTCGATCCCGCGAAAT Rv Primer MMA-040 (SEQ ID NO. 129) GCTTGCATGCCTGCACAGCAGCCAACTCAGCTTCCTTT Fw Primer MMA-043 (SEQ ID NO. 132) CCATCGCATCCTGCACCTCTAGAAATAATTTTGTTTA Rv Primer MMA-040 (SEQ ID NO. 129) GCTTGCATGCCTGCACAGCAGCCAACTCAGCTTCCTTT Example 44: (In Vitro) Synthesis of Methacrylyl-CoA from 2-Oxoisovaleric Acid Using Cell Extract of
Reference Example 4: (In Vivo) Synthesis of Methacrylyl-CoA from 2-Oxoisovaleric Acid Using Recombinant
JM109/pMMA201 13.5 JM109/pMMA202 13.4 JM109/pMMA203 13.4 JM109/pMMA204 14.2 Reference Example 5: Synthesis of Methacrylic Acid from 2-Oxoisovaleric Acid Using Recombinant
Reference Example 6: Cloning of ACD Gene (acdH) from
Oligonucleotide primer MMA-001: (SEQ ID NO. 124) 5′-CACCATGGACCACAAGCTCTCCCCCGAAC-3′ MMA-002: (SEQ ID NO. 125) 5′-GCCCTGCAGGCTCAGCCCACCAGCCCCAAC-3′ Reference Example 7: Synthesis of Isobutyl Methacrylate by AAT
Production amount of isobutyl methacrylate Time Production amount of isobutyl methacrylate (mM) 1 0.19 2 0.38 3 0.45
Conditions for GLC Analysis
Column: DB-WAX, 30 m×0.32 mm
Reference Example 8: Synthesis of Butyl Methacrylate by AAT
Production amount of butyl methacrylate Time Production amount of butyl methacrylate (mM) 2 0.20 5.5 0.30 Reference Example 9: Synthesis 2 of Butyl Methacrylate by AAT
Production amount of butyl methacrylate Reaction Production amount of Plant Part for use time butyl methacrylate (mM) Strawberry Fruit flesh • sliced to thickness of about 1 mm 3 0.010 Kiwi Fruit flesh • sliced to thickness of about 1 mm 5 0.012 Apple Fruit skin • sliced to thickness of about 1 mm 5 0.016 Melon Fruit flesh • sliced to thickness of about 1 mm 6 0.015 Pear Fruit skin • sliced to thickness of about 1 mm 4 0.013 Papaya Fruit skin • sliced to thickness of about 1 mm 4 0.027 Avocado Fruit skin • sliced to thickness of about 1 mm 6 0.035 Blueberry Fruit skin • sliced to thickness of about 1 mm 6 0.009 Plum Fruit skin • sliced to thickness of about 1 mm 4 0.002 Reference Example 10: Synthesis of Ethyl Methacrylate by AAT
Production amount of ethyl methacrylate Reaction Production amount of Plant Part for use time ethyl methacrylate (mM) Apple Fruit skin • sliced to thickness of about 1 mm 5 0.110 Papaya Fruit skin • sliced to thickness of about 1 mm 6 0.003 Avocado Fruit skin • sliced to thickness of about 1 mm 6 0.006 Reference Example 11: Synthesis of Methyl Methacrylate by AAT
Production amount of methyl methacrylate Reaction Production amount of methyl Plant Part for use time methacrylate (mM) Apple Fruit skin • sliced to thickness of about 1 mm 5 0.043 Papaya Fruit skin • sliced to thickness of about 1 mm 6 0.004 Avocado Fruit skin • sliced to thickness of about 1 mm 6 0.007 Example 45: Production of Recombinant
Oligonucleotide primer MMA-044: (SEQ ID NO. 82) 5′-GTTTGCACGCCTGCCGTTCGACG-3′ MMA-045: (SEQ ID NO. 83) 5′-CGGTACGCGCGGATCTTCCAGAG-3′
Composition of Reaction Solution
Plasmid for expressing plant-derived AAT gene SEQ Template Plasmid for expression ID NO. Plant (gene name) plasmid pTrc99A pET16b 2 Apple (MpAAT1) pAAT001 pAAT101 pAAT201 4 Strawberry (SAAT) pAAT002 pAAT102 pAAT202 6 Strawberry (VAAT) pAAT003 pAAT103 pAAT203 Example 46: Preparation of Cell Extract from Recombinant
Example 47: Synthesis of Butyl Methacrylate by Using Cell Extract of AAT Gene Recombinant
Production of butyl methacrylate by using AAT gene Production amount (mM) Recombinant 1 Hour 3 Hours 5 Hours JM109/pAAT102 0.001 0.003 0.004 JM109/pAAT103 0 0.001 0.002 BL21(DE3)/pAAT201 0.003 0.014 0.026 BL21(DE3)/pET16b 0 0 0 Example 48: Synthesis of Methacrylic Acid Ester by Using Cell Extract of AAT Gene Recombinant
Production of methacrylic acid ester by using AAT gene recombinant Production amount after 5 hours (mM) Methyl Ethyl Butyl Recombinant methacrylate methacrylate methacrylate BL21(DE3)/pAAT201 0.021 0.045 0.091 Example 49: Synthesis 2 of Methacrylic Acid Ester by Using Cell Extract of AAT Gene Recombinant
Production amount after 5 hours (mM) Isobutyl Phenyl Benzyl 2-Ethylhexyl Recombinant methacrylate methacrylate methacrylate methacrylate BL21(DE3)/ 0.009 0.001 0.17 0.31 pAAT201
Conditions for HPLC Analysis
Comparative Example 1
Reaction for Synthesis of Methacrylic Acid Ester by Using Cell Extract of Yeast-Derived AAT Gene Recombinant
Template Plasmid for expression SEQ ID NO. Gene name plasmid pTrc99A pET16b 133 ATF1 pAAT005 pAAT105 pAAT205 135 ATF2 pAAT006 pAAT106 pAAT206 Production amount (mM) Butyl methacrylate Butyl acetate 1 3 5 30 1 3 Recombinant Hour Hours Hours Minutes Hour Hours JM109/pAAT105 0 0 0 0.089 0.145 0.170 JM109/pAAT106 0 0 0 0.104 0.189 0.290 JM109/pTrc99A 0 0 0 0 0 0 INDUSTRIAL APPLICABILITY